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1 Summary  
During formation of the brain in mammals, neural stem cells (NSCs) transit 
through sequential periods of expansion, neurogenesis and gliogenesis.  
Notch signaling maintains NSCs and blocks transcription of pro-neurogenic 
factors.  Notch ligands are expressed by differentiating progenitors and 
activate lateral inhibition signals through Notch.  It has long been proposed 
that Notch signaling occurs bi-directionally through ligands such as Jagged1 
(Jag1), which are also type I membrane proteins.  However, the molecular 
mechanisms controlling the transition from stem cell division, where Notch 
plays a maintenance role, to daughter cell differentiation are poorly 
understood. 
To study the role of Jag1, in niche maintenance I began by transducing 
NSCs lining the subventricular zone (SVZ) with full length Jag1 (Jag1FL).  
Surprisingly, Jag1 induced a fate switch to Sox10+ oligodendrocyte 
precursors.  NSCs grown under differentiating conditions in vitro recapitulated 
this phenotype to some degree.  RNA-Sequencing analysis was performed to 
study the transcriptome changes of Jag1FL-IRES-GFP transduced NSCs.  
This screen revealed an upregulation (induction) of key genes involved in 
oligodendroctye maturation and myelination, which were further confirmed by 
qRT-PCR.  Ongoing NSC grafting experiments are being performed to 
analyze the effects of Jag1FL-IRES-GFP+ NSCs on mice exhibiting focal 
myelin lesions.  These proof of concept experiments hold promise for 
elucidating an, as of yet unknown role of Jag1 in remyelination.  Through 
biochemical analyses, we have demonstrated that the Jag1 intracellular 
domain (JICD) can act as a transcription factor signaling in a cell autonomous 
fashion upon activation.  Through chromatin immunoprecipitation, I have 
identified potential genomic regions and Wnt signaling target genes, directly 
bound by nuclear JICD.  Taken together with the in vivo data, this proposes a 
new role for Jag1 in NSCs maintenance, and displays its potential for 
regulating fate switch to an oligodendrocytic lineage. 
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2 Introduction 
2.1 Development of the mammalian central nervous system  
Our understanding of the complexity of the human brain has advanced a 
great deal in the last 25 years.  We have made major inroads into 
understanding how the brain transfers, stores, and retrieves information.  
However, our understanding of the processes governing brain development 
has lagged behind to some degree.  Developmental neurobiology has made 
advances, including the discovery of NSCs and NSC niches that remain into 
adulthood. Hence, it is now clear that diverse progenitor cell types give rise to 
all cell lineages of the brain.  These advances in knowledge have benefited 
from novel approaches to lineage trace cell populations, advances in high-
resolution microscopy, increased cell specific markers and transgenic alleles, 
and genome-wide analysis of gene expression down to the cellular level. With 
the advent of cellular reprogramming and programming of human induced 
pluripotent cells (iPS), we are now entering an age in which functional human 
neurons can be generated and studied in vitro to obtain a greater 
understanding of gene function and dysfunction.  These advances open up 
avenues that were previously impossible, where patient-derived iPS cells 
could potentially be used therapeutically for the treatment of neural 
degenerative diseases.  As technologies and our understanding of neuron 
differentiation continue to advance the field of neurobiology and its potential 
biomedical applications will expand greatly. 
2.1.1 Neurulation:	  formation	  of	  the	  central	  nervous	  system	  anlage	  
During early stages of postgastrulation embryonic development the 
ectoderm differentiates to form the epidermis and the neural ectoderm, the 
primordium of the nervous system (for review see (Tam and Loebel 2007)).  In 
vertebrates, the central nervous system (CNS) begins as the neural plate, an 
ectodermal-derived structure which folds dorsally to form the neural tube 
through a process called neurulation.  Neurulation is divided into the 
sequential phases of primary and secondary neurulation initiated through a 
combination of growth factors and inhibitory signals secreted by the 
Introduction 
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underlying axial mesoderm (notochord), dorsal ectoderm, and Spemann 
organizer, respectively.  The neural tube then differentiates rostrally into the 
future brain and caudally to form the spinal cord and most of the peripheral 
nervous system, which will not be covered here.  The rostral part of the neural 
tube segregates into three swellings, establishing the forebrain, midbrain and 
hindbrain. In parallel, the rostrocaudal tube segments into modules called 
neuromeres (Copp, Greene et al. 2003). 
2.1.2 Neurulation	  and	  the	  formation	  of	  the	  neural	  tube	  
The mammalian brain and most of the spinal cord are formed during the 
first phase of neurulation, which is commonly divided into 4 phases. In mice 
neurulation begins at around embryonic day (E) 8 with the induction of the 
neural plate when the inhibitory signals Chordin, Noggin and Follistatin are 
secreted by the Spemann organizer (Smart 1973). These factors block bone 
morphogenic protein 4 (Bmp4) signaling, inducing dorsal epiblast cells and 
allowing the anteroposterior midline of the ectoderm to adopt a 
neuroectodermal fate. These neuroectodermal cells undergo an apicobasal 
thickening and generate the neural plate along the dorsal midline of the 
embryo. Once committed, neuroectodermal cells no longer require inhibitory 
signals for neural plate formation to proceed (Fig. 1) (Copp, Greene et al. 
2003, Copp 2005). 
The neural plate undergoes a remodeling phase, whereby convergent-
extension increases the length (rostrocaudally) while simultaneously 
narrowing the width (transversely). During these processes, the neural plate 
continues to thicken apicobasally generating cellular forces that begin to bend 
the neural plate and induce neural tube formation. As the lateral folds of the 
neural plate converge to the midline, the ectoderm of the future epidermis 
delaminates from the neuroepithelium of the neural plate and fusion of both 
the ectoderm and dorsal neural tube proceeds (Copp, Greene et al. 2003, 
Copp 2005). The neural tube zips closed posteriorly from the hindbrain and 
anteriorly from the mid-hindbrain junction, while remaining open over the 
future 4th ventricle posterior to the cerebellum.  By E9 in the mouse, fusion is 
complete and the neural tube is closed forming the primitive ventricles of the 
future brain regions (Tong and Alvarez-Buylla 2014). 
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Figure 1.  Stages of central nervous system development. 
The brain and most of the spinal cord are formed during primary neurulation, which is 
commonly divided into 4 phases. a) Epiblast cells are induced to a neuroectoderm fate, 
generating the neural plate. b) The remodeling phase in which the neural plate undergoes 
convergent-extension and begins to fold along the median hinge point (MHP) and dorsolateral 
hinge points (DLHPs). c) The two neural folds converge at the midpoint and then proceed to 
fuse, leading to the dorsal closure of the neural tube. d) By embryonic day 9 in the mouse, 
fusion is complete. BMP – Bone morphogenic protein (adapted from (Jessell and Sanes 
2000, Liu and Niswander 2005)). 
 
Far less is known about secondary neurulation, which is the formation of 
the posterior region of the neural tube and caudal-most portion of the spinal 
cord. Secondary neurulation begins from a solid mass of cells forming from 
the tail bud.  These cells form the medullary cord, which then cavitates to form 
multiple lumina. Finally, these lumina fuse into a single lumen continuing the 
central canal of the neural tube in the most rostral aspects. Contrary to 
primary neurulation, here the process is more a hollowing out of a mass of 
cells rather than tube formation from an ectodermal plate of cells (Shimokita 
and Takahashi 2011). 
2.1.3 Molecular	  basis	  of	  regionalization	  of	  the	  mammalian	  neural	  tube	  
The neuroepithelium of the neural tube follows a sequential series of 
overlapping, and competing patterning steps during brain development. 
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Timing is critical, particularly in structures such as the cerebral cortex where 
even moderate changes in gene expression pattern can lead to serious 
developmental, motor, behavioral, psychological and cognitive disorders 
(Geschwind and Rakic 2013). The best characterized morphogens and 
signaling pathways involved in regional identity include Sonic hedgehog 
(Shh), retinoic acid (RA), fibroblast growth factor (FGF), Wingless (Wnt), and 
BMP signaling (Fig. 2) (Rallu, Corbin et al. 2002, Lupo, Harris et al. 2006).  
Shh is secreted by the notochord (axial mesoderm) beneath the floor plate of 
the neural tube and controls neuronal cell fate in a concentration-dependent 
manner (Cohen, Briscoe et al. 2013). RA is secreted from the mesoderm and 
defines the posterior CNS, including the hindbrain and spinal cord. RA 
contributes to segmentation of the hindbrain into eight distinct compartments 
called rhombomeres, which later give rise to the medulla, pons and 
cerebellum (Maden 2007).  FGF activity along with RA and Wnts leads to the 
caudalization of the neural tissue (Sansom and Livesey 2009, Tiberi, 
Vanderhaeghen et al. 2012).  Wnt signaling is crucial in development of the 
neural tube, particularly in establishing anteroposterior polarity.  Several Wnt 
antagonists including Cerberus, Dickkopf and Tlc are important in patterning 
the dorsal telencephalon (Piccolo, Agius et al. 1999, Bafico, Liu et al. 2001, 
Houart, Caneparo et al. 2002, Ciani and Salinas 2005, Hebert and Fishell 
2008). Diffusion of BMPs and their antagonists along the neural plate creates 
a gradient of high BMP activity dorsally to low activity ventrally. This leads to 
the specification of distinct pools of progenitors in the dorsal spinal cord (Liu 
and Niswander 2005, Lupo, Harris et al. 2006). 
2.1.4 Structural	  organization	  and	  function	  of	  the	  developing	  neural	  tube	  
As the neural tube progressively becomes more regionalized the 
organization of distinct structural domains arises. Segmentation of the neural 
tube in the mouse begins initially by assigning anterior-posterior identity along 
the neuraxis dividing into the spinal cord, hindbrain, midbrain and forebrain.  
The hindbrain (or rhombencephalon) is further divided into rhombomeres 
which give rise to the metencephalon (the pons and the cerebellum) as well 
as the myelencephalon (the medulla oblongata). The midbrain (or 
mesencephalon) is located caudal to the hindbrain and rostral to the forebrain. 
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The forebrain (prosencephalon) divides into the diencephalon (prethalamus, 
thalamus, hypothalamus, subthalamus, epithalamus, and pretectum) and the 
telencephalon (cerebrum).  Further divisions of the cerebrum segregate it into 
the cerebral cortex, the basal ganglia, and the limbic system (Fig. 2). For a full 
review of the cellular compartments and boundaries in vertebrate brain 
development, please see Kiecker and Lumsden, 2005 (Kiecker and Lumsden 
2005). 
 
Figure 2.  Regionalization during neural tube formation is dependent on overlapping 
agonistic and antagonistic morphogen gradients. 
Dorsoventral patterning of the neural tube is largely dependent on bone morphogenic protein 
(BMP) and Sonic hedgehog (Shh) signaling.  Some of the key factors involved in patterning 
the anteroposterior axis include wingless (Wnt) and its antagonists (Cerberus, Dickkopf, Tlc), 
fibroblast growth factor (FGF), and retinoic acid (RA).  Distribution of these factors leads to 
the eventual segmentation of the neural tube into the forebrain, midbrain, hindbrain and spinal 
cord.  FGF8 expression delineates the midbrain-hindbrain boundary (MHB). (Adapted from 
(Rallu, Corbin et al. 2002, Kiecker and Lumsden 2005)) 
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2.2 Embryonic Neurogenesis 
2.2.1 Onset	  of	  Neurogenesis	  in	  the	  Telencephalon	  
The mammalian neocortex modulates processing of sensory information, 
motor activity, and mediates cognition.  The cerebral cortex develops in an 
inside-out temporal fashion and is comprised of six histologically distinct 
neuronal layers, forming the isocortex.  These layers differ in neuronal 
composition, connectivity, and density. The earliest born neurons populate the 
deep layers of the cortex (VI and V), and the later born neurons migrate past 
the deep layer neurons to form the upper layers (IV, III and II) (Franco and 
Muller 2013).  Diverse neuronal subtypes that contribute to the complex 
neural circuitry are specified by a multitude of factors.  In recent years, much 
progress has been made towards understanding the molecular pathways and 
mechanisms controlling neuronal cell-type diversity in the cortex. However, 
detailed mechanistic knowledge of the interplay between the transcriptional 
networks and upstream factors has yet to be elucidated (Molyneaux, Arlotta et 
al. 2007).  
2.2.2 The	  transition	  of	  the	  neuroepithelium	  to	  NSCs	  
Neurogenesis involves multiple processes that include proliferation, fate 
commitment, differentiation, maturation, expansion, migration and functional 
integration of newborn neurons into neuronal circuits. In the developing 
mouse CNS there are at least two distinct classes of progenitor cells, the 
apical progenitors (APs) and the basal progenitors (BPs; also termed 
intermediate progenitors).  The APs include neuroepithelial progenitors 
(NEPs) which generate radial glia cells (RGCs) and short neural precursors, 
all of which have stem cell character (Fishell and Kriegstein 2003, Kriegstein 
and Gotz 2003, Gotz and Huttner 2005, Gal, Morozov et al. 2006). By E9, the 
neuroepithelium is a single layer of NEPs that form the pseudostratified 
neuroepithelium.  Due to the displacement of the cell body (karyon) of the 
NEPs during cell division, the ventricular zone resembles a multicellular 
structure. The migration of the nucleus (karyon) during cell cycle is referred to 
as interkinetic nuclear migration, and is cell cycle dependent (Fig. 3) 
(Takahashi, Nowakowski et al. 1993).  Mitosis occurs at the apical side of the 
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cell at the lumen of the neural tube while S phase takes place at the basal 
boundary of the ventricular zone, and G1 and G2 occur during directed 
migration of the nucleus (Fig. 4) (Taverna and Huttner 2010, Lui, Hansen et 
al. 2011).  As NEPs and RGCs transition from symmetric proliferation to 
asymmetric neurogenic divisions during neurogenesis their cell cycle 
lengthens almost entirely due to a lengthening of the G1 phase (Takahashi, 
Nowakowski et al. 1995). 
NSCs in the ventricular zone (VZ) of the neural tube connect with each 
other through tight and adherens junctions at their apical ends. The 
maintenance of cell polarity is dependent upon the adherens junctions and 
polarity is critical for NSC function (Gotz and Huttner 2005, Fish, Dehay et al. 
2008, Franco and Muller 2013).  Between E9 and E10 (before the onset of 
neurogenesis) NEPs maintain their radial morphology, but begin to exhibit 
astroglia hallmarks and downregulate tight junctions and other epithelial 
markers, ultimately transforming into a more restricted distinct cell type called 
RGCs (Huttner and Brand 1997, Malatesta, Hartfuss et al. 2000, Kriegstein 
and Gotz 2003). The nuclei of RGCs continue to migrate along the apical-
basal axis during cell cycle, but interkinetic nuclear movement becomes 
continually more restricted to the apical end of the extending basal process.  
By the time neurogenesis begins in the forebrain, between E10 and E11 in the 
mouse, RGCs start to upregulate markers characteristic of astroglia such as 
glutamate transporter (GLAST), brain-lipid-binding protein (BLBP), glial 
fibrillary acidic protein (GFAP), and vimentin (Gotz and Huttner 2005).  Apical 
end feet of the RGCs remain anchored to each other through adherens 
junctions.  Deletion of essential endocytic genes, Numb and Numbl, from 
RGCs results in the disorganization of adherens junctions and loss of cellular 
polarity (Kuo, Mirzadeh et al. 2006, Rasin, Gazula et al. 2007). 
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Figure 3.  Scheme of a coronal hemisection of the developing mouse telencephanlon 
and the stem and progenitor populations. 
As neurogenesis continues, neural stem cells (NSCs) retain contact with the outside of the 
neural tube and their apical end feet line the tube resulting in long polarized processes. NSCs 
undergo interkinetic nuclear migration during cell cycle. DNA replication (S-phase) always 
takes place when the cell body reaches the ventricular (VZ)-subventricular zone (SVZ) 
boundary, mitosis (M) and karyokinesis take place at the luminal surface (apical) of the neural 
tube. Committed progeny of the NSCs, basal progenitors migrate to the SVZ where they may 
divide before differentiating into immature neurons that migrate to the superficial layers of the 
forming cortical plate (CP) and future cerebral cortex.  
 
As development continues, a class of intermediate progenitors called basal 
progenitors (BPs) is formed. Unlike NEPs and RGCs, BPs do not have apical 
connections to the lumen of the neural tube but instead undergo a limited 
number of cell divisions in the subventricular zone (SVZ), a region basal and 
adjacent to the VZ (Fig. 4) (Haubensak, Attardo et al. 2004, Noctor, Martinez-
Cerdeno et al. 2004).  BPs in the SVZ upregulate the transcription factors 
Cux1, Cux2 and Tbr2 and although limited self-renewing divisions have been 
shown, they subsequently undergo symmetric differentiating cell divisions to 
generate two neurons (Nieto, Monuki et al. 2004, Englund, Fink et al. 2005, 
Cubelos, Sebastian-Serrano et al. 2008).  
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Figure 4.  Neurogenesis and migration of neurons in the mouse cortex. 
Neural epithelial progenitors (NEPs) in the ventricular zone (VZ) of the developing 
telencephalon generate the many neuronal subtypes of the six-layered cerebral cortex (see 
2.2.6).  Before neurogenesis commences, NEPs undergo a series of symmetric divisions in 
the VZ expanding the stem cell pool.  As neurogenesis proceeds, the VZ NEPs transform into 
radial glial cells (RGCs) and generate basal progenitors (BPs), which populate the 
subventricular zone (SVZ).  Newly formed neurons either derived directly from NSCs or from 
the BPs migrate radially outwards forming the different cortical layers in an inside out fashion.  
Each layer of the cerebral cortex is composed of different neuronal subtypes, which are 
generated sequentially throughout neurogenesis.  RGCs can also give rise to oligodendrocyte 
precursor cells (OPCs), which eventually differentiate into oligodendrocytes.  Towards the end 
of neurogenesis the radial scaffolding of the RGCs is dismantled and RGCs become 
gliogenic, generating cortical and subventricular zone (SVZ) astrocytes and a sheet of 
ependymal cells lining the ventricles. (Directly from (Kriegstein and Alvarez-Buylla 2009) ) 
2.2.3 Asymmetric	  versus	  symmetric	  cell	  divisions	  
During cortical development, neural progenitors can undergo three modes 
of cell division.  Before neurogenesis begins NEPs divide symmetrically 
giving-rise to two NEP daughter cells, allowing for rapid expansion of the 
progenitor pool.  Later NSCs can undergo asymmetric divisions, allowing for 
both self-renewal of the NSC and generation of a differentiated daughter cell 
(Miyata, Kawaguchi et al. 2001, Noctor, Flint et al. 2001).  The committed 
daughter cells are either a single neuron or a BP, which can undergo further 
cell divisions.  RGCs act as a framework for the newborn neurons to migrate 
into the cerebral cortex.  The third mode of cell division involves an 
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amplification step at the BP stage, increasing the BP pool before finally 
differentiating into neurons.  Since a single RGC can give rise to multiple BPs, 
and a single BP can give rise to two or more neurons, the SVZ is generally 
recognized as one of the main sites of amplification during neurogenesis 
(Fishell and Kriegstein 2003, Knoblich 2008, Kriegstein and Alvarez-Buylla 
2009). 
Regulation of RGC numbers as they divide to give rise directly to neurons 
or BPs is crucial in controlling neurogenesis.  Too many daughter cells 
dividing directly into neurons results in overall neurogenesis being severely 
reduced due to a lack of BP amplification.  Although mitotic spindle orientation 
is not the only determinant, it has been shown to play a direct role in RGC 
daughter cell fate (Knoblich 2008). 
Asymmetric segregation of cytoplasmic determinants has also been shown 
to be key in regulating asymmetric cell divisions.  Some well-characterized 
players include EGFR, MALS-3, Dyrk1a, Trim32, Stau32, and polarity protein 
Par3, but it is predicted many more determinants are actually involved (Sun, 
Goderie et al. 2005, Srinivasan, Roosa et al. 2008, Schwamborn, Berezikov et 
al. 2009, Ferron, Pozo et al. 2010, Kusek, Campbell et al. 2012).  Time-lapse 
imaging of embryonic neocortical slice culture and adult SVZ cultures showed 
asymmetric inheritance of the Notch ligand, Delta-like 1 (Dll1), the E3 ubiquitin 
ligase Mind bomb-1 (Mib1), and the Notch agonist Numb (Fig. 5d) (Bultje, 
Castaneda-Castellanos et al. 2009, Dong, Yang et al. 2012, Kawaguchi, 
Furutachi et al. 2013).  Cells inheriting these factors undergo differentiation 
while the Notch presenting cell remains in an undifferentiated state (Paridaen 
and Huttner 2014).  Whether this asymmetric inheritance is unique to Dll1, or 
is common amongst other Notch ligands, has yet to be shown.  Interestingly 
the outcome for cells inheriting asymmetrically segregated factors varies 
amongst vertebrates (Fig. 5b,c).  Although the mechanism has yet to be 
elucidated it seems Par3 in mice remains with the future RGC, while in 
zebrafish this is segregated with the Notch inhibitor Mib1, resulting in 
differentiation (Paridaen and Huttner 2014). 
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Figure 5.  Asymmetric segregation of molecular determinants in asymmetric cell 
divisions of RGCs. 
Segregation of cytoplasmic determinants is believed to be one of the key factors in regulating 
asymmetric cell divisions.  a) Symmetric segregation of fate determinants is thought to occur 
during symmetric divisions of RGCs. b) However asymmetries, in particular the Par3 complex 
in vertebrates appears to lead to different fates for the daughter cells.  c) The segregation of 
cell determinants varies amongst vertebrates, with daughter cells fated to become neurons in 
Zebrafish accumulating higher levels of Par3, opposite to that of mice.  d) Additionally, 
asymmetric distribution of Notch components is believed to lead to differential levels of Notch 
signaling in daughter cells. (Directly from (Paridaen and Huttner 2014)) 
2.2.4 Post-­‐transcriptional	  Control	  of	  Neurogenesis	  in	  RGCs	  
How neural progenitors control the transition from stem cell maintenance 
and expansion to fate restriction is not fully understood, particularly in the 
developing cerebral cortex.  MicroRNAs (miRNA) are endogenous 20-24 
nucleotide RNAs that, through complimentary base-pairing, bind and regulate 
target mRNAs of protein-coding genes.  Regulation is controlled by the 
miRNA-induced silencing complex (miRISC) which directs post-transcriptional 
silencing by mediating degradation or transcriptional repression of the mRNA 
transcript (Pasquinelli 2012).  Using techniques such as miRNA microarrays 
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and small RNA deep-sequencing it has been revealed that there is a distinct 
profile of miRNA expression in the developing mammalian brain (Lagos-
Quintana, Rauhut et al. 2002, Landgraf, Rusu et al. 2007, Bak, Silahtaroglu et 
al. 2008, He, Liu et al. 2012).  Links between neurodegeneration and relative 
levels of miRNAs has been shown to exist through experiments globally 
disrupting miRNA biogenesis during neural development (Kosik 2006).  The 
role of the miRNA microprocessor in neurogenesis was also recently 
identified.  In the absence of Hes protein repression NSCs in the dorsal 
forebrain accumulate Ngn2 resulting in the upregulation of NeuroD1 and a 
commitment to neuronal differentiation (Guillemot 2005, Heng, Nguyen et al. 
2008).  However, levels of both Neurog2 mRNA and Ngn2 protein are directly 
regulated through the protein Drosha, a key component of the microprocessor 
(Knuckles, Vogt et al. 2012).  Therefore, the microprocessor is required for 
maintaining NSCs and the timing of neurogenesis (Abe and Bonini 2013). 
miRNAs have been shown to directly regulate key components of the 
Notch signaling pathway.  For example, miRNA-184 promotes adult NSC 
proliferation and inhibits neuronal differentiation by directly silencing Numblike 
(Numbl), a known regulator of brain development (Liu, Teng et al. 2010).  
miRNA silencing of Notch ligands has been shown, in particular targeting of 
Jag1 transcripts by miRNA-124, miRNA-21, -34a, -124a, and -200 (Hashimi, 
Fulcher et al. 2009, Brabletz, Bajdak et al. 2011, Liu, Chopp et al. 2011, 
Vallejo, Caparros et al. 2011, Bhalala, Srikanth et al. 2013).  So far, only a 
small number of miRNAs have been identified and characterized in the CNS.  
Identifying additional miRNAs and elucidating their functional role in regulating 
and maintaining NSCs will be important for our understanding of 
neurogenesis and neurodegenerative diseases. 
2.2.5 Pathways	  and	  transcription	  Factors	  involved	  in	  embryonic	  neurogenesis	  
Numerous pathways, transcription factors, and signaling molecules 
converge in agonistic and antagonistic crosstalk during neurogenesis.  Some 
key pathways include the well-studied Wnt, Notch, FGF and Shh signaling.  
Many have a direct role in fate determination of RGCs, and act in harmony 
with transcription factors such as the family of basic-helix-loop-helix (bHLH) 
factors which exert both proneural and pro-NSC maintenance effects 
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(Paridaen and Huttner 2014).  Additionally, spatial temporal timing of 
transcription factors is key in fate determination, especially in developing 
structures such as the cortex (Greig, Woodworth et al. 2013). 
2.2.6 Progenitor	  fate	  commitment	  and	  restriction	  through	  sequential	  expression	  
of	  transcription	  factors	  during	  cortical	  neurogenesis	  
Currently there is evidence to support two alternative models of temporal 
expansion and differentiation in the cortex. The ‘common progenitor’ model 
proposes that NSCs restrict their fate temporally as neurogenesis progresses, 
sequentially generating neurons unique to each layer of the isocortex. 
Alternatively, the ‘multiple progenitor’ model proposes that NSCs could begin 
as a heterogeneous pool, in which each NSC subtype would be guided by 
intrinsic and extrinsic signals to generate specific neuronal subtypes or 
astrocytes (Greig, Woodworth et al. 2013).  
Heterochronic transplantation experiments performed in ferrets by 
McConnell and colleagues revealed that the potential of NSCs is restricted 
over time (McConnell 1988).  With age NSCs become more defined in their 
fate, eventually losing the ability to generate deep layer neurons (Desai and 
McConnell 2000, Han and Sestan 2013).  Supporting the common progenitor 
model clonal analyses showed that neocortical NSCs generate deep and 
upper layer neurons in vitro in a sequential and temporal manner (Shen, 
Wang et al. 2006).  Fezf2, a transcription factor enriched in cortical layer 5 
and important in fate specification, was shown to exist throughout cortical 
neurogenesis in NSCs (Chen, Schaevitz et al. 2005, Molyneaux, Arlotta et al. 
2007, Guo, Eckler et al. 2013).  It was demonstrated that Fezf2+ NSCs could 
sequentially generate both deeper and upper layer neurons while becoming 
fate restricted over time (Guo, Eckler et al. 2013).  Moreover, Fezf2 is 
expressed by NSCs as early as E8.5 in the pallial neuroepithelium, 
suggesting its impact on fate determination (Leone, Srinivasan et al. 2008, 
Kwan, Sestan et al. 2012, Greig, Woodworth et al. 2013). 
The multiple progenitor model proposes different subsets of progenitors, 
which are pre-determined and committed to generate specific neuronal 
subtypes (Greig, Woodworth et al. 2013). These fate restricted NSCs express 
the transcription factors Cux1 and Cux2 in the VZ and SVZ abundantly during 
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upper-layer neurogenesis, specifying them to become callosal projection 
neurons (Franco, Gil-Sanz et al. 2012). However, it was shown that during 
early development Cux2+ NSCs proliferate and expand without differentiating. 
Later when neurons of the superficial cortical layers are being generated, 
these NSCs and progenitors switch to a neurogenic mode and generate 
Cux2+ upper-layer neurons (Franco and Muller 2013). These findings 
challenged the existing ‘common progenitor model’ but left many questions 
unanswered.  Subsequent lineage tracing experiments confirmed the 
presence of Cux2+ NSCs but suggested they generate both upper and deep-
layer neurons as well as interneurons derived from the ventral telencephalon 
(Guo, Eckler et al. 2013).  The presence of multi-potent Fezf2+Cux2+ NSCs 
does not negate the possibility of the existence of fate-restricted progenitors.   
Further investigations at the single cell level are crucial in understanding the 
mechanisms underlying NSC regulation (Guo, Eckler et al. 2013, Han and 
Sestan 2013).  
Other models in the field emphasize the presence of stem cells that are 
multipotent and switch their fate over the course of sequential rounds of 
cortical neurogenesis.  This suggests that NSCs would be initially committed 
to one fate during development and then switch to an alternate fate as 
corticogenesis proceeds.  Multipotent NSCs could then generate multiple 
neuronal subtypes while still restricting their potential and eventually 
becoming unipotent.  Further investigation of the mechanisms driving 
neurogenesis is crucial to understand NSC cell regulation (Greig, Woodworth 
et al. 2013). 
2.2.7 The	  role	  of	  Wnt	  Signalling	  in	  embryonic	  neurogenesis	  and	  NSC	  proliferation	  
The Wnt family consists of secreted ligand glycoprotein signaling molecules 
that regulate cell proliferation, specification, differentiation, and migration 
throughout development (Clevers and Nusse 2012).  There are three 
characterized pathways of Wnt signaling; canonical Wnt signaling, non-
canonical Wnt planar cell polarity pathway, and the non-canonical 
Wnt/calcium signaling pathway (Fig. 6a) (Clevers and Nusse 2012).  In all 
three pathways signaling is activated when a Frizzled family receptor is bound 
by secreted Wnt.  In canonical Wnt signaling activation of Frizzled recruits the 
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co-receptor LRP5/6 leading to the phosphorylation and activation of 
disheveled (Dvl) (Clevers and Nusse 2012).  This results in the 
phosphorylation of LRP6 by GSK-3β kinase permitting the recruitment of Axin.  
Axin is part of the destruction complex responsible for sequentially binding, 
phosphorylating and ubiquinating β-catenin (Ctnnb1), eventually resulting its 
degradation by the proteasome (Clevers and Nusse 2012). However, when 
the Axin complex is bound to an activated LRP6 co-receptor it loses its ability 
to ubiquinate β-catenin and therefore can only bind and phosphorylate (Li, Ng 
et al. 2012).  Eventually there is a saturation of phosphorylated β-catenin and 
any newly generated β-catenin accumulates in the cytoplasm, eventually 
translocating to the nucleus (Li, Ng et al. 2012).  Nuclear β-catenin can 
displace the transcriptional repressor Groucho and interact with the 
transcription factors TCF and LEF (Behrens, von Kries et al. 1996).  Further 
transcriptional coactivators and histone modifiers such as Brg1, CBP, Cdc47, 
Bcl9 are recruited, driving the transcription of target genes (Fig. 6b) (Clevers 
and Nusse 2012).  When the Frizzled receptor is inactive the β-cantein 
destruction complex is activated and β–catenin does not accumulate in the 
cytoplasm, and evidently does not activate target genes (Clevers and Nusse 
2012). 
 
Figure 6. Canonical Wnt 
signaling. 
a) The recently revised 
model of canonical Wnt 
signaling where, upon 
activation of the frizzled 
receptor by Wnt, the 
coreceptor LRP becomes 
phosphorylated.  Although 
β-catenin can still be 
phosphorylated, it can no 
longer be ubiquinated, and 
therefore it begins to 
accumulate in the cytoplasm.  Eventually β-catenin is transported to the nucleus, where b) it 
interacts with and displaces the repressor Grucho. Continued on next page. 
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Figure 6: Continued from previous page.  It can then bind and interact with the transcription 
factors TCF and LEF to modulate target gene expression. (Directly from (Clevers and Nusse 
2012)) 
2.2.8 The	  direct	  regulation	  of	  target	  genes	  by	  Wnt	  signaling	  in	  Neurogenesis	  
In neural tube formation Wnt gradients are important in establishing 
anterioposterior polarity.  Additionally, during embryonic neurogenesis, Wnts 
play a crucial role in controlling the switch between proliferation and 
differentiation in RGCs.  By expressing a stabilized form of β–catenin Chenn 
and Walsh demonstrated that cortical progenitors proliferate, expanding the 
cortical neuroepithelium (Chenn and Walsh 2002).  Conversely, in loss-of-
function experiments there was a measurable increase in RGC differentiation 
into both BPs and neurons (Woodhead, Mutch et al. 2006, Mutch, Schulte et 
al. 2010).  Interestingly, the downstream target of canonical Wnt signaling, N-
myc, can direct APs into BPs, as well as promote neocortical neuronal 
differentiation (Kuwahara, Hirabayashi et al. 2010).  Therefore, Wnt signaling 
through the activation of N-myc may be crucial in controlling the neuronal 
number in the developing neocortex.  In chick studies N-myc was also shown 
to influence non-vertical cleavage planes and suppress Notch signaling, both 
of which were shown to lead to neuronal differentiation (Zinin, Adameyko et 
al. 2014).  Other known targets of the β-catenin/TCF complex include the 
bHLH gene neurogenin 1 (Ngn1), Ngn1 together with Ngn2 is a key 
determinant in neuronal differentiation (Hirabayashi, Itoh et al. 2004). 
In line with previous studies Hirabayashi and colleagues showed that 
expression of Axin suppressed neuronal differentiation (Hirabayashi, Itoh et 
al. 2004).  More recent reports present data for Axin having an opposing role 
in the nucleus, instead promoting neuronal differentiation.  Fang and 
coworkers demonstrated that Axin can bind specifically to nuclear β-catenin, 
directly regulating BP neurogenic induction through modulation of 
downstream Wnt targets (Fang, Chen et al. 2013).  
Although not demonstrated in the developing neocortex, there is evidence 
for direct regulation of the Notch ligand Jag1 by Wnt signaling in other 
mammalian systems (Rodilla, Villanueva et al. 2009, Chen, Stoeck et al. 
2010, Jacques, Puligilla et al. 2012).  This regulation is mediated through the 
binding of the β-catenin/TCF complex to two known TCF sites in the promoter 
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region of Jag1 and was confirmed through chromatin immunoprecipitation 
(ChIP) (Rodilla, Villanueva et al. 2009, Chen, Stoeck et al. 2010).  In future 
studies it would be interesting to determine if this link between the Wnt and 
Notch signaling pathways is conserved in NSCs of the developing embryo. 
2.2.9 The	   dual	   role	   of	   bHLH	   transcription	   factors	   in	   maintenance	   of	   NSCs	   and	  
neuronal	  differentiation	  	  
bHLH transcription factors play key roles in maintenance of NSCs and 
differentiation.  There are two main types of bHLH genes in neurogenesis; 
those involved in gene repression and those involved in gene activation.  The 
repressor genes include the orthologues of Hairy/Enhancer of Split 
(HES/HEY), while the proneural bHLH activator genes are defined by 
homologues of the Drosophila achaete–scute complex (Mash) and atonal 
(Math, Ngn, NeuroD) (Ohtsuka and Kageyama 2010).  
Hes genes are critical for neural development and maintenance of NSCs 
including NEPs and RGCs (Fig. 7).  Hes1 and Hes3 are mostly required for 
maintenance of NEPs, while Hes1 and Hes5 are more prominent in RGCs 
(Ohtsuka and Kageyama 2010).  Hes genes are defined by their bHLH 
domain, an orange domain (helix 3-helix 4 domain), and a WRPW (Trp-Arg-
Pro-Trp) domain, which is critical for regulating transcriptional activity of target 
genes (Grbavec and Stifani 1996).    The WRPW repression domain can 
interact directly with the co-repressor TLE/Grg, which is a homolog of 
Drosophila Groucho.  This leads to a modification of the chromatin structure 
through recruitment of histone deacteylase Rpd3 resulting in target gene 
inactivation (Grbavec and Stifani 1996).  The Hes genes show varying binding 
affinities for different DNA sequences called the N Box (CACNAG), E box 
(CANNTG) or class C sites (CACGCG), with Hes1 preferentially binding N 
box (Sasai, Kageyama et al. 1992).  In order for binding to occur they must 
first form homo- or heterodimers through the helix-loop-helix domain (Sasai, 
Kageyama et al. 1992).  Hes1 and Hes5 directly repress transcription of 
proneural genes including Achaete-scute homolog 1 (Ascl1 or Mash1), Atonal 
Homolog 1 (Atoh1 or Math1) and Neurogenin2 (Neurog2 or Ngn2) thereby 
maintaining NSCs in a progenitor state (Hatakeyama, Bessho et al. 2004, 
Louvi and Artavanis-Tsakonas 2006). 
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The activator bHLH genes, including Mash1, Math, Ngn1/2 and NeuroD, 
are responsible for regulating neurogenesis and specifically defining neuronal 
subtype identity (Chien, Hsiao et al. 1996).  Activator bHLH factors not only 
induce neuronal-specific gene expression but, in parallel, inhibit other cell 
fates such as glia by blocking lineage specific gene expression (Sun, Nadal-
Vicens et al. 2001).  Glial fibrillary acidic protein (GFAP), a gene involved in 
astroglia cell fate, is inhibited by a sequestering of co-activators Stat1/3 and 
Smad1 by Ngn1 (Sun, Nadal-Vicens et al. 2001).  This reinforces the role of 
bHLHs genes as activators in neuronal state specification. 
 
Figure 7.  Role of the bHLH 
Hes factors in fate 
commitment of NSCs. 
Hes1 and Hes3 genes are 
important in the maintenance of 
neuralepithelial cells (NEPs), 
while Hes1 and Hes5 are 
required to maintain radial glial 
cells (RGCs).  Activating bHLHs 
such as Mash1, Math1, Ngn, 
NeuroD and Hes6 are are 
responsible for promoting 
neurogenesis. (Adapted from 
(Ohtsuka and Kageyama 2010)) 
2.2.10 Notch	  Signaling	  as	  a	  critical	  regulator	  in	  maintenance	  of	  NSCs	  
In order to maintain neurogenesis from embryonic development through to 
adulthood NSCs must be able to self-renew.  One of the best-studied 
signaling pathways shown to be involved in NSC maintenance, proliferation, 
quiescence, and survival is the Notch pathway (Ohtsuka, Ishibashi et al. 1999, 
Hitoshi, Alexson et al. 2002, Androutsellis-Theotokis, Leker et al. 2006, Louvi 
and Artavanis-Tsakonas 2006, Basak and Taylor 2007, Mizutani, Yoon et al. 
2007, Imayoshi, Sakamoto et al. 2010). Notch receptors are type-1, 
transmembrane proteins that can be activated through extracellular protein-
protein interactions with either Delta or Serrate (Delta-like and Jagged 
respectively in mammals) ligands on adjacent cells.  Upon activation 
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receptors undergo sequential cleavage, first by a disintegrin and 
metalloprotease (ADAM10 or 17) and then Presenilin (PS) containing γ-
secretases, releasing the intracellular domain of Notch (NICD) (Fig. 8) (Brou, 
Logeat et al. 2000, Mumm, Schroeter et al. 2000).  Throughout the animal 
kingdom the number of Notch receptors varies but in mammals there are four 
(Notch1-4) (Kopan and Ilagan 2009). 
2.2.10.1 Spatiotemporal	  expression	  domains	  of	  Notch1,	  2	  and	  3	   in	  the	  developing	  
CNS	  
During embryonic development components of the Notch signaling 
pathway, including its receptors and ligands, are expressed in regions where 
neurogenesis occurs rapidly (Hatakeyama and Kageyama 2006).  By in situ 
hybridization, it was first demonstrated that Notch1 expression correlates with 
neurogenesis in the developing brain, spinal cord and doral root ganglia 
(DRG) in E10 mice (Weinmaster, Roberts et al. 1991).  The highest Notch1 
expression levels occur between E12 - E14, mostly localized to the 
developing brain and the DRG, with levels decreasing rapidly thereafter 
(Weinmaster, Roberts et al. 1991). By postnatal day 4 (P4) in the mouse 
Notch1 expression is prominent within the ventricular zone (VZ) and the SVZ 
of the lateral ventricle as well as in the lateral ventricles over the hippocampus 
(Stump, Durrer et al. 2002).  Additionally Notch1 transcripts were detected in 
the internal granule cell layer (IGL) and Purkinje cells (PC) of the cerebellum, 
albeit at lower levels (Stump, Durrer et al. 2002).  In adults this expression is 
largely restricted to the SVZ and dentate gyrus (DG) germinal zones, with 
some scattered expression outside the SVZ and in the rostral migratory 
stream (RMS), (Stump, Durrer et al. 2002).  
The notch receptors Notch2 and Notch3 are expressed in distinct, 
overlapping domains during brain development where active neurogenesis is 
occurring.  Disruption or ablation of Notch2 results in embryonic lethality, with 
mice phenotypically different than Notch1 ablated mice (Lindsell, Boulter et al. 
1996, Hamada, Kadokawa et al. 1999, Irvin, Zurcher et al. 2001, McCright, 
Gao et al. 2001).  This implies that while Notch receptor expression domains 
may overlap, receptors are not functionally redundant and expression is 
carefully regulated spatially and temporally.  Differing from Notch1 and 
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Notch3, Notch2 is expressed in the forebrain germinal zones, is localized to 
the ventricular zone of the lateral ventricle and not present in the SVZ (Irvin, 
Zurcher et al. 2001).  Additionally, unlike other Notch receptors, Notch2 is 
expressed in the granule cells of the DG, the choroid plexus epithelium and 
the external granule cell layer of the cerebellum (Irvin, Zurcher et al. 2001).  
During development Notch3 is expressed in a similar pattern to Notch1, 
albeit at lower levels (Lindsell, Boulter et al. 1996, Irvin, Zurcher et al. 2001).  
It is present in the ventricular zones of the lateral ventricle but lowly expressed 
in the SVZ where Notch1 is more prevalent.  In the postnatal and adult brain, 
Notch3 almost exclusively localizes to blood vessels, which lacks Notch1 or 
Notch2 expression (Lindsell, Boulter et al. 1996, Irvin, Zurcher et al. 2001). 
The reason for these distinct expression patterns of Notch ligands is not 
clear.  Notch receptors have a known role in regulating stem cell 
maintenance, as well as regulating cell fate ((Kopan and Ilagan 2009)).  
Potentially differences in downstream effectors regulated by activation and 
processing of the Notch receptors results in different commitment of cell fate.  
Notch1 and Notch3 activation were shown to induce neural progenitor cells to 
an astroglial fate (Tanigaki, Nogaki et al. 2001).  A loss of Notch signaling 
through conditional deletion of Rbpj results in NSCs differentiating into 
neurons in both the SVZ and SGZ of the hippocampal DG, underlying the 
importance of Notch signaling in both maintenance and regulating cell fate 
(Imayoshi, Sakamoto et al. 2010).   
Furthermore, receptors may be differentially activated through distinct 
Notch ligands (Lindsell, Boulter et al. 1996). Proteins such as Lunatic fringe 
(Lfng) can modulate Jag1 and Deltalike-1 (Dll-1) signaling by directly binding 
each ligand, resulting in differential activation of Notch1 and Notch2 (Hicks, 
Johnston et al. 2000).  Domains expressing Dll1 and Jag1 ligands are clearly 
defined with many cells in the germinal regions specific for only one Notch 
ligand (Lindsell, Boulter et al. 1996) and see 2.2.11.3).  Additionally, variations 
in Notch ligand glycosylation fine tunes its binding affinity and ability to 
activate Notch receptors and may be key to regulating differences in cell fate 
commitment (Kopan and Ilagan 2009). 
Another plausible explanation for multiple receptors is that they negatively 
regulate the cell autonomous signal of other Notch receptors (Irvin, Zurcher et 
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al. 2001).  Notch1 and Notch3 both share overlapping domains and are co-
expressed by some cells in the SVZ germinal niche.  One hypothesis is that 
Notch3 activation leads to an inhibition of the NICD, resulting in diminished 
Notch1 signaling (Irvin, Zurcher et al. 2001).   
Figure 8. Canonical Notch receptor signaling in the control of neurogenesis. 
Notch receptor activation is triggered when either Dll or Jag presented by neighboring cells 
binds to the ectodomain resulting in regulated intramembrane proteolysis (RIP) in which first a 
disintegrin and metalloprotease (ADAM10 or 17), and then Presenilin containing gamma 
secretase (γ-secretase) cleave the receptor releasing a soluble intracellular domain (NICD).  
The NICD translocates to the nucleus where it interacts with the CSL (CBF1, Su(H), and Lag1 
– RBP-J in mice)  protein complex including the DNA binding protein recombining binding 
protein suppressor of hairless (RBP-J). The binding of NICD releases the nuclear receptor co-
repressor complex (N-CoR), which includes silencing mediator of retinoid and thyroid 
receptors (SMRT) and histone deacetylases (HDACs). The NICD-bound CSL complex is a 
positive regulator of Notch target genes including Hes1 and Hes5.  Hes5 is a bHLH 
transcription factor that, together with a zinc finger protein of the transducing-like enhancer of 
split (TLE) family, represses the proneural genes (Atoh1, Ascl1 and Ngn1/2) in NSCs and 
thereby inhibits neuronal differentiation.  The NICD complex also interacts with histone 
acetyltransferase (HATs) leading to epigenetic marking of target genes and transcriptional 
activation. 
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2.2.10.2 Notch	   acts	   through	   the	   CSL	   transcriptional	   complex	   to	   directly	   regulate	  
effector	  genes	  in	  the	  CNS	  	  	  
Canonical Notch signaling is mediated by the interaction of nuclear 
translocated NICD with the CSL (CBF1/RBP-J/Su(H)/Lag-1) transcriptional 
complex (RBP-J in mice) (Fig. 8). This interaction occurs through a conserved 
WxP motif in its RAM domain, disrupting the preformed repressor complex, 
and subsequently converting it to an activator complex.  Factors such as the 
co-activator Mastermind (Maml1), histone acetyltransferases (HATs), 
chromatin remodeling factors, and the Mediator complex are recruited by the 
activator complex to mediate target gene expression (Dou, Zeng et al. 1994, 
Hsieh and Hayward 1995, Tamura, Taniguchi et al. 1995, Kato, Taniguchi et 
al. 1997, Kurooka, Kuroda et al. 1998, Fiuza and Arias 2007).  When NICD 
levels decrease in the nucleus the repressor complex is eventually reformed.  
RBP-J recruits the transcriptional co-repressor proteins SKIP, hairless/CtBP, 
and Groucho/TLE and the histone chaperone Asf1 (Kopan and Ilagan 2009).  
Asf1 specifically suppresses the Notch signaling pathway, remaining 
associated with the promoters of target genes.  Additionally, RBP-J can bind 
with numerous co-repressor proteins including the NCoR/SMRT complex and 
SHARP/MINT/SPEN complex which now is recognized as the key repressor 
of Notch genes (Oswald, Winkler et al. 2005, Tsuji, Shinkura et al. 2007, 
Kopan and Ilagan 2009).  
The best-studied targets of the Notch pathway in mammals are the 
HES/HEY family of bHLH (see 2.2.9), in particular Hes1 and Hes5.  Activation 
of Notch results in maintenance of the cell in a progenitor state, while 
conversely, inactivation of Notch results in upregulation of the proneural 
genes and neural progenitor differentiation (Pompa de la, Wakeham et al. 
1997, Gaiano, Nye et al. 2000, Lütolf, Radtke et al. 2002, Imayoshi, Sakamoto 
et al. 2010). Manipulating the Notch signaling pathway using either PS/γ-
secretase inhibitors, by ablating RBP-J, knocking-out individual members of 
the Notch family or expressing an activated NICD showed that Notch is key in 
modulating progenitor cell proliferation and neurogenesis during embryonic 
development (Pompa de la, Wakeham et al. 1997, Gaiano, Nye et al. 2000, 
Lütolf, Radtke et al. 2002, Imayoshi, Sakamoto et al. 2010). 
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Interestingly Notch can interact with other pathways through parallel 
crosstalk with its effector proteins.  For example, Hes1 and Hes5 can both 
physically interact with and modulate the JAK2-STAT3 signaling pathway by 
mediating the phosphorylation of STAT3 by JAK2 (Kamakura, Oishi et al. 
2004).   
2.2.10.3 Oscillatory	   expression	   of	   downstream	   Notch	   target	   genes	   leads	   to	   fate	  
determination	  of	  neighboring	  cells	  
The classic “lateral inhibition” model of Notch signaling in NSCs proposes 
that all early progenitors express similar levels of pro-neural genes and Notch 
ligands.  Stochastic variations in the levels of receptors, ligands and pro-
neural genes between adjacent cells results in a “salt-and-pepper” pattern of 
Notch component gene expression.  Cells with slightly higher ligand levels 
activate receptors in neighboring cells causing an inhibition of pro-neural 
genes in those cells.  The differences between neighboring cell gene 
expression levels continues to be exacerbated by positive and negative 
feedback loops resulting in exaggerated differences, and eventually leading to 
the lineage commitment of the high pro-neural gene expressing cells (Fig. 9).  
Real-time imaging in Hes-reporter mice showed that negative feed-forward 
and feedback loops exist, resulting in oscillatory expression of downstream 
Notch signaling components and their targets over time (Shimojo, Ohtsuka et 
al. , Basak and Taylor 2007, Kageyama, Ohtsuka et al. 2007).  Therefore, a 
cell with high pro-neural gene expression at one time point may revert to a low 
pro-neural gene expressing state shortly thereafter.  These oscillations of 
Notch signaling in progenitors of the CNS is analogous but not identical to the 
waves of Notch activity see during somite formation (Dequéant, Glynn et al. 
2006). Oscillations in Notch components may further alter the ability of NSCs 
to respond to external differentiation cues and be critical for regulating NSC 
potential (Kageyama, Ohtsuka et al. 2008). 
 
 
 
Introduction 
33 
Figure 9.  Oscillations 
of proteins leads to 
altered NSC potential. 
Hes1 and Ascl1 proteins 
in neural progenitor cells 
(NPCs) oscillate at a 
frequency of 
approximately 2 to 3 
hours and are likely 
dependent upon each 
other’s expression, while 
Olig2 has a frequency of 
5 to 8 hours and is likely 
independent of Hes1 
and Ascl1.  Together 
their relative expression levels are important determinants in the fate of NPCs. (Directly from 
(Imayoshi and Kageyama 2014)). 
2.2.11 The	  essential	  role	  of	  canonical	  DSL	  Notch	  ligands	  in	  the	  CNS	  
Canonical DSL (Delta, Serrate, Lag2) Notch ligands are largely responsible 
for activating the Notch receptors in the CNS, resulting in the receptors 
downstream processing by ADAM and PS/γ-secretase.  DSL ligands can 
therefore regulate cell type specification and progenitor cell maintenance 
through Notch.  In mammals, the canonical DSL ligand family is comprised of 
5 members; Jag1, Jag2, Dll-1, Dll-3, Dll-4 (Kopan and Ilagan 2009).   
2.2.11.1 The	  Jag1	  ligand	  structure	  and	  functional	  role	  in	  the	  CNS	  
The DSL domain characterizes canonical Notch ligands and is required for 
ligand-receptor interaction.  Additionally, receptor binding is mediated by two 
unique epidermal growth factor (EGF) repeats directly adjacent to the DSL 
domain termed DOS (Delta and OSM-11-like proteins) (Fig. 10) (Shimizu, 
Chiba et al. 1999, Kopan and Ilagan 2009).  Similar to Notch receptors all 
DSL ligands have extracellular domains consisting of EGF repeats (D'Souza, 
Miyamoto et al. 2008).  In vertebrates Jag1 and Jag2 have almost twice as 
many EGF repeats as Dll ligands.  Further, Jag1/2 ligands contain cysteine-
rich regions inserted close to the membrane that are absent in Dll ligands 
(Fiuza and Arias 2007).  The intracellular domains (ICD) of the Notch ligands 
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are highly conserved within each subfamily of ligand but lack sequence 
homology between subfamilies (D'Souza, Miyamoto et al. 2008).  It has been 
suggested that this is because the cytoplasmic tails of the ligands may be 
required for specific post-translational modifications and for specific protein-
protein interactions to occur (Pintar, De Biasio et al. 2007). The cytoplasmic 
tails of the ligands also contain a PDZ (PSD-95/Dl/ZO-1) ligand motif that 
allows for direct interaction with PDZ domain containing proteins (Pintar, De 
Biasio et al. 2007).  Additionally, Jag1 contains both ADAM and PS/γ-
secretase cleavage sites directly juxtaposed to the transmembrane region 
(TM).  Interestingly, Jag1 contains a nuclear localization signal on the N-
terminus of the Jag1 intracellular domain (JICD), implying that, if processed 
through regulated intramembrane proteolysis (RIP), the JICD could 
translocate and signal to the nucleus of the ligand-presenting cell. 
 
Figure 10.  Protein structure of the Notch ligand Jag1. 
a) Structure of full length Jag1 ligand.  The extracellular domain is composed of a 
Delta/Serrate/Lag-2 (DSL) and a DOS (Delta and OSM-11-like proteins) domain, which is 
responsible for interacting with the epidermal growth factor (EGF) repeats on Notch resulting 
in its activation.  Jag1 also contains EGF repeats similar to those found in Notch.  In contrast 
to Dll ligands Jag1 contains a cysteine rich (CR) region close to the transmembrane (TM) 
domain.  There are proteolytic cleavage sites that can be recognized and processed by 
ADAM17 and PS/γ-secretase directly adjacent to the TM domain.  The intracellular domain 
(ICD) contains a nuclear localization sequence, as well as a C-terminal PDZ ligand (amino 
acid sequence YIV) which can interact with PDZ domains. b) Jag1-C-terminal fragment (Jag1-
CTF1)  c) Jag1-intracellular domain (JICD).  
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2.2.11.2 The	  putative	  role	  of	  the	  PDZ-­‐ligand	  domain	  in	  Jag1	  
Jag1, Dll-1 and Dll-4 all have PDZ ligands at the C-temini of their ICD that 
are essential for mediating interactions with PDZ-containing scaffold/adapter 
proteins (Ascano, Beverly et al. 2003, D'Souza, Miyamoto et al. 2008).  
Experiments where Jag1 and Dll PDZ domains were abolished demonstrated 
that they are required for ligands to exert an effect on cell adhesion, migration 
and oncogenic transformation (Ascano, Beverly et al. 2003, Wright, Leslie et 
al. 2004, Mizuhara, Nakatani et al. 2005, Estrach, Legg et al. 2007).  It was 
demonstrated through yeast two hybrid (Y2H) experiments that the JICD-PDZ 
motif (MEYIV) could directly bind the PDZ domain protein afadin/AF6 (Pintar, 
De Biasio et al. 2007).  Downstream effectors of AF6 includes the superfamily 
of RAS signaling proteins, suggesting a potential mediation by Jag1 through 
AF6 (Ascano, Beverly et al. 2003).  Other proteins directly interacting with 
JICD-PDZ have yet to be elucidated. 
2.2.11.3 Domains	  expressing	  Jag1	  in	  the	  mammalian	  CNS	  
 Jag1 is widely expressed in the developing mammalian CNS (Lindsell, 
Boulter et al. 1996, Stump, Durrer et al. 2002, Irvin, Nakano et al. 2004) and 
Fig. 20a,b).  At E13.5 mRNA transcripts are found in the telencephalon, 
diencephalon, metencephalon, myelencephalon and the spinal cord VZ (Irvin, 
Nakano et al. 2004).  Interestingly it appears that the expression of the DSL 
ligands Jag1 and Dll-1 are complimentary, forming sharply demarcated 
boundaries within the hindbrain and spinal cord (Lindsell, Boulter et al. 1996).  
This may reflect the differing roles these ligands play in cell fate specification 
of the CNS.  By E17, Jag1 transcripts can be detected in the VZ of the 
developing forebrain although expression is more prominent in the hindbrain 
VZ (Irvin, Nakano et al. 2004).  Jag1 expressing cells reside directly adjacent 
to Notch1, Notch2 and Notch3 cells in the VZ and can functionally bind and 
activate all 3 Notch receptors.  This results in their processing through 
regulated intramembrane proteolysis (RIP) and the downstream Notch 
signaling cascade being activated (Shimizu, Chiba et al. 1999, Shimizu, Chiba 
et al. 2000).  Unlike Jag1, Jag2 does not localize specifically to the 
neurogenic regions (Irvin, Nakano et al. 2004).  Additionally, unlike Dll, Jag1 is 
found in the choroid plexus and meninges (Irvin, Nakano et al. 2004). 
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In perinatal mice (P4), Jag1 is highly associated with the developing 
forebrain and cerebellum, and most notably unlike other DSL ligands, is found 
expressed by cells lining the SVZ and by the granule cells of the DG (Stump, 
Durrer et al. 2002).  In the SVZ Jag1 mRNA expression is not evenly 
distributed, but instead there are a number of cells expressing Jag1 
transcripts in the dorsolateral corner and most rostral part of the SVZ (Irvin, 
Nakano et al. 2004).  At this time point, Jag1 is present on ependymal cells, 
Type B progenitors and some blood vessels in the SVZ in a salt and pepper 
pattern  (Fig. 13) (Stump, Durrer et al. 2002, Nyfeler, Kirch et al. 2005). 
Jag1 is expressed throughout the cerebellum and has been demonstrated 
to be critical for maintaining Bergmann glia in the early postnatal cerebellum 
(Weller, Krautler et al. 2006).  A loss of Jag1 leads to ectopic differentiation in 
the external germinal and molecular layers, with granule cell precursors 
undergoing apoptosis and an overall reduction in Bergmann glia numbers.  
Additionally, it was demonstrated that a loss of Jag1 results in defects in the 
migration of immature granule cells into the internal granule cell layer (Weller, 
Krautler et al. 2006). 
2.2.11.4 The	  putative	  mechanisms	  of	  cell-­‐autonomous	  Jag1	  signaling	  	  
The work by LaVoie and Selkoe on Jag1 and Dll ligand processing 
demonstrated that both ligands can be proteolytically cleaved in a similar 
manner to the Notch receptors.  Moreover, both Jag1 and Dll can release 
putative signaling ICD fragments into the cytoplasm, potentially implying bi-
directional signaling between neighboring cells (LaVoie and Selkoe 2003).  
Both ligands undergo RIP when they bind to the Notch receptor on adjacent 
cells in trans.  ADAM17 first processes Jag1 in a similar fashion to the Notch 
receptor, releasing its ectodomain fragment.  This finding was recently 
supported by the demonstration that the ADAM17 cleavage occurs in a lipid-
raft-independent manner (Parr-Sturgess, Rushton et al. 2010).  After 
processing by ADAM17 the remaining membrane-anchored fragment, Jag1-
CTF1, competes with Notch for PS/γ-secretase cleavage causing a decrease 
in Notch signaling.  This is due to the release of the ligand ectodomain 
resulting in a conformational change in the ligand CTF, allowing PS/γ-
secretase to cleave.  It was also shown that Jag1 and Dll CTF’s 
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coimmunoprecipitate with PS/γ-secretase, adding more strength to this 
hypothesis that PS/γ-secretase is involved in cleavage and release of the 
ligand ICD (LaVoie and Selkoe 2003). 
An intriguing finding was that after cleavage and release of the ligand ICD, 
the ICD is not only in the cytoplasm, but also nuclear.  This was previously 
shown for NICDs, but not for Notch ligands.  Using an AP1-mediated reporter 
system they demonstrated that the JICD was able to stimulate gene 
expression.  However, it may not be necessary for JICD to enter the nucleus 
to activate AP1 since a construct lacking the putative nuclear localization 
signal (NLS) was still able to increase activity, but this still raises the question 
of whether the JICD could play a role in transcriptional regulation.  Other 
evidence supporting this data showed that Jag1 expression causes an 
increase in Jag1, Dll-1 and Notch3 mRNA levels but not Notch1, -2, or -4 
(Ascano, Beverly et al. 2003).  Induction of specific genes shows that the 
JICD can have an effect on gene expression.  Furthermore, there is no 
published evidence that ligand ICD’s can bind DNA directly since they do not 
contain a recognizable DNA binding motif, but they may be involved in 
recruitment of other TFs (LaVoie and Selkoe 2003). 
Recently Duryagina, et al. 2013, confirmed that Jag1 in human 
mesenchymal stromal cells (MSCs), can undergo cleavage to release an 
intracellular domain that can translocate to the nucleus (Duryagina, Thieme et 
al. 2013).  They further showed through reporter assays that recombinant 
JICD could stimulate target gene stromal cell-derived factor-1 (SDF-1) but 
endogenous expression of JICD while overexpressing full-length Jag1 did not 
stimulate its expression.  They explain this contradictory role by showing that 
full-length Jag1 (Jag1FL) can actually block SDF-1 and inhibit it’s expression, 
negating the enhancing effects of the JICD (Duryagina, Thieme et al. 2013).  
2.2.11.5 Alternative	  regulation	  mechanisms	  of	  Jag1	  in	  Notch	  signaling	  
For correct activation of canonical Notch signaling to occur, ligand and 
receptor must interact with each other in trans (opposing cells).  If this 
interaction occurs in cis (same cell), Jag1 functions as a dominant negative 
repressor of the Notch receptor preventing activation (Fig. 11) (Celis de and 
Bray 1997, Klein, Brennan et al. 1997, Micchelli, Rulifson et al. 1997, 
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Sakamoto, Ohara et al. 2002, Li and Baker 2004, Cordle, Johnson et al. 
2008).  This model for cis-inhibition was clearly demonstrated in the 
Drosophila wing when Serrate (Jag1) was overexpressed, leading to a 
downregulation of Notch target genes (Micchelli, Rulifson et al. 1997).  The 
mechanism of how this inhibition occurs is unclear but it has been proposed 
that the interaction between DSL ligands and Notch receptor may be able to 
exist in a parallel and antiparallel binding formation (Cordle, Johnson et al. 
2008).  Binding of Notch in parallel (cis) would form a heterodimer complex 
preventing the receptor from transitioning to an active state.  This inactivation 
through titration model has recently gained support with studies using Dll to 
observe the effects of cis- versus trans- activation thresholds (Sprinzak, 
Lakhanpal et al. 2010).  The domains responsible for Jag1 cis-inhibition were 
recently identified as EGF repeats 4-6 (Fleming, Hori et al. 2013).  This would 
fit with the parallel/antiparallel binding hypothesis since EGF repeats 4-6 are 
dispensable for Notch transactivation, while EGF repeats 1-2 are required 
(Shimizu, Chiba et al. 1999, Fleming, Hori et al. 2013). 
Notch signaling also plays a pivotal role in the development of the inner ear 
and commitment of otic progenitors to a prosensory fate (Neves, Parada et al. 
2011).  Recently the competition of Jag1 and Dll in the inner ear hair cell 
development was modeled (Petrovic, Formosa-Jordan et al. 2014).  From that 
model Jag1 was predicted, and then confirmed, to induce a weaker Notch 
response than Dll in the opposing cell.  Additionally, they measured a 
competitive response between the two ligands, with Jag1 inhibiting Dll/Notch 
signaling.  This results in inhibition of Jag1 expression in the neighboring cell, 
and consequently hair cell patterning through lateral inhibition (Petrovic, 
Formosa-Jordan et al. 2014).  Potentially this mechanism of ligand 
competition is conserved and exists in other developmental systems where 
Notch signaling is a driving factor in fate commitment.  
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Figure 11.  Cis inhibition of Notch. 
Jag1 can interact with the Notch 
receptor through either trans- or cis- 
presentation, resulting in Notch 
activation or inhibition respectively.  
(Adapted from (Sprinzak, Lakhanpal 
et al. 2010)) 
 
2.2.11.6 Jag1	  in	  human	  disease:	  Tetralogy	  of	  Fallot	  and	  Alagille	  syndrome	  
Mutations in the JAG1 gene, which is located on human chromosome 20, 
are associated with two human diseases (Fig. 12).  The first, Tetralogy of 
Fallot (ToF), is the most common congenital heart defect occurring in 
approximately 1 in 3,000 live births (Eldadah, Hamosh et al. 2001).  Mutations 
directly result in ventricular septal defects that obstruct the right ventricular 
outflow and ultimately cause ventricular hypertrophy.  Missense mutations in 
ToF have been correlated with the 2 DOS domains that are responsible for 
aiding the interaction with Notch receptor (Eldadah, Hamosh et al. 2001, 
Kopan and Ilagan 2009). 
Alagille syndrome (AGS) is caused by heterozygous JAG1 mutations 
resulting in multi-system congenital defects affecting the heart, liver and 
kidneys (Li, Krantz et al. 1997, Oda, Elkahloun et al. 1997, Yuan, Kohsaka et 
al. 1998, Spinner, Colliton et al. 2001, Yuan, Kobayashi et al. 2006, Guegan, 
Stals et al. 2012).  Reflecting the multi-system nature of this disease, 
symptoms of AGS include mental retardation, spontaneous intracranial 
bleeding and stroke, the last being the main cause of lethality (Piccoli and 
Spinner 2001).  Missence mutations in JAG1 are associated with the disulfide 
bonds in the DOS Notch-binding domain.  A loss of DOS disulfide bonds may 
interfere with the overall structural integrity of this domain and therefore 
decrease its efficiency to activate the Notch receptor (Kopan and Ilagan 
2009). Additionally, JAG1 haploinsufficiency due to null mutations are 
commonly found in patients (Yuan, Kohsaka et al. 1998, Spinner, Colliton et 
al. 2001).   
Xue and colleagues studied the in vivo function of Jag1 by creating Jag1-
null mice (Xue, Gao et al. 1999). They removed a 5kb segment from the 5’ 
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end of the Jag1 gene, encoding the DSL and DOS domain responsible for 
interacting with the Notch receptor.  Mice heterozygous for the deletion could 
be identified through an eye dysmorphology.  Homozygous mutants however 
die at day E11.5 due to vascular defects.  This was the first direct evidence of 
Jag1s essential role in vascular development (Xue, Gao et al. 1999).  
Additionally, due to the lethality of Jag1 null embryos, future studies 
incorporated conditional deletion alleles with LoxP sequences flanking the first 
and second exons (Nyfeler, Kirch et al. 2005). 
 
Figure 12.  Human diseases directly correlated with Jag1 missence mutations. 
Jag1 mutations are responsible for the human diseases Tetralogy of Fallot and Alagille 
syndrome (ALGS1).  a) Missense mutations for both diseases have been associated with the 
extracellular DSL and DOS domains of Jag1, which are responsible for binding to and 
activating the Notch receptor.  b) Tetralogy of Fallot is the most common congenital heart 
birth defect, which causes a right ventricular hypertrophy.  (Adapted from CDC and 
Prevention and (Kopan and Ilagan 2009)). 
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2.3 Adult Neurogenesis 
2.3.1 The	  Neurogenic	  Regions	  in	  the	  Adult	  
Two germinal zones have been identified that continue to produce new 
neurons into adulthood in mice.  The first is the subgranular zone (SGZ) of the 
hippocampal DG and the second is the SVZ lining the lateral ventricle walls 
(Fig. 13) (reviewed in (Kriegstein and Alvarez-Buylla 2009)).  Continued 
neurogenesis has been shown to be key in brain homeostasis and reductions 
are associated with impaired learning, memory, and major depression (Zhao, 
Deng et al. 2008, Braun and Jessberger 2014).  Regulation of adult 
neurogenesis occurs through a complex network of extrinsic and intrinsic 
factors that modulate numerous signaling pathways and transcription factors 
(Basak and Taylor 2009, Faigle and Song 2013, Rolando and Taylor 2014).  
In both germinal niches, extrinsic factors such as cell-to-cell interactions, 
secreted factors, and neurotransmitters maintain the NSCs (Faigle and Song 
2013).  Further, both physiological and pathological activities including 
seizures, aging and exercise can influence stem cell proliferation and govern 
neurogenesis (Kuhn, Dickinson-Anson et al. 1996, Van Praag, Shubert et al. 
2005, Lugert, Basak et al. 2010).  
Neurons born in both adult germinal niches first migrate to their final 
destination before integrating and fully differentiating.  New born SGZ 
neurons, migrate to the granule cell layer and differentiate to become dentate 
granule cells (Zhao, Deng et al. 2008).  SVZ neurons migrate first along the 
rostral migratory stream (RMS), changing their migratory direction once they 
reach the olfactory bulb (OB).  In the OB they migrate radially, differentiating 
into granule cells or periglomular neurons (Zhao, Deng et al. 2008).  The 
Notch ligand, Jag1 has been shown to be crucial in the maintenance of NSCs 
in both the SGZ and the SVZ (Nyfeler, Kirch et al. 2005, Lugert, Basak et al. 
2010, Imayoshi 2012, Giachino, Basak et al. 2014, Lavado and Oliver 2014) . 
In recent years, other neurogenic regions have been identified including the 
α-Tanyctes of the adult hypothalamic third ventricle (Robins, Stewart et al. 
2013).  Further research will need to be done to determine whether additional 
neurogenic regions can be discovered in the adult mammalian brain. 
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Figure 13.  Stem cell niches in adult mammals. 
a) Adult neurogenesis in the subventricular zone (SVZ) and the subgranular zone (SGZ) of 
the hippocampal dentate gyrus (DG).  b) Neurons born in the SVZ, migrate along the rostral 
migratory stream (RMS) until they reach their final destination in the olfactory bulb (OB).  Here 
they migrate radially, differentiating into periglomular neurons. c) The SVZ is composed of 4 
main cell types.  Type B cells are the primary progenitors of the niche and give rise to the 
quickly dividing type C cells.  Type B cells are further classified into type B1 and B2, with B1 
cells remaining in contact with both the ventricle and niche blood vessels (BV).  Type C cells 
can divide asymmetrically to give rise to the migrating type A cells.  The ependymal (E) cells 
lining the ventricle are ciliated and can direct the flow of cerebral spinal fluid in the ventricle, 
which contains inductive cues for the niche.  d) Key determinants of the Notch signaling 
pathway are highly active in the SVZ niche, directly influencing cell maintenance, proliferation 
and fate.  Ascl1 (Mash1), which is high in type C cells, is inhibited through the Notch effector 
bHLH gene Hes1.  Jag1 is expressed by ependymal cells, type B cells and blood vessels of 
the SVZ niche.  (Adapted from (Tong and Alvarez-Buylla 2014, Vadodaria and Gage 2014)) 
Introduction 
43 
2.3.2 The	  SVZ	  neurogenic	  niche	  
The neurogenic ventricular-SVZ (V-SVZ) is composed of four cell-types, 
which are defined by their morphology, antigen expression, activity, and 
location in the neurogenic niche (Fig. 13b-d).  Each influences the local 
environment through direct cell-cell interactions and excreting extracellular 
signaling molecules.  Additionally, they can be defined by their marker 
expression pattern and location with respect to the ventricle and blood 
vessels.  The proliferative cells of the niche include the slowly dividing type B 
cells (primary progenitors) and the rapidly multiplying type C cells 
(intermediate progenitors).  Type B cells are believed to retain characteristics 
of both RGCs and astrocytes, and can be defined by marker expression of 
Nestin, Sox2, GFAP, GLAST, Lewis X (LeX) and CD133 (reviewed by (Ihrie 
and Alvarez-Buylla 2011)).  The multiciliated ependymal cells line the 
ventricle, forming pinwheel structures called rosettes (Ihrie and Alvarez-Buylla 
2011).  Type C cells proliferate rapidly to give rise to the fourth niche cell, type 
A, which are the immature neuroblasts that express Doublecortin (Dcx) and 
PSA-NCAM.  Type A cells are highly migratory and transverse along the RMS 
towards the OB (Ihrie and Alvarez-Buylla 2011).  There is a small number of a 
second type C cell in the V-SVZ which express the oligodendrocyte lineage 
transcription factor Olig2 and can give rise to immature oligodendrocyte 
precursors (OPC) and mature myelinating oligodendrocytes (Menn, Garcia-
Verdugo et al. 2006). 
The type B cells can be further categorized based on their morphology and 
location relative to the ventricle (type B1, B2, B3) (Doetsch, Garcia-Verdugo 
et al. 1997, Giachino, Basak et al. 2014).  The slowly dividing type B1 cells 
extend their primary cilium through the center of the ependymal rosette 
structures, allowing them direct access to the ventricular lumen (Mirzadeh, 
Merkle et al. 2008).  Additionally, the process forms symmetric adherens 
junctions joining type B1 cells with the surrounding ependymal cells.  
Increasing evidence suggests that this direct contact with the ventricle and the 
ependymal cells allows for signaling molecules in the cerebral spinal fluid or 
ependymal cells to influence the fate of type B1 cells directly (Mirzadeh, 
Merkle et al. 2008).  Type B1 cells share some familiar characteristics with 
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RGCs in the developing embryo.  They have an apical process contacting the 
ventricle, a basal process associated with blood vessels and proposed karyon 
movements that are reminiscent of interkinetic nuclear migration in the 
developing embryo (Ihrie and Alvarez-Buylla 2011). 
Careful lineage analysis of type B cells has identified mitotically active 
BLBP+ NSCs in the adult mouse V-SVZ (Giachino, Basak et al. 2014).  With 
age, active BLBP+ type B cells are lost, correlating with a decrease in active 
neurogenesis (Giachino, Basak et al. 2014).  Interestingly, BLBP expression 
also correlates mitotic activity in the adult human V-SVZ.  In contrast BLBP- 
type B cells are relatively quiescent and therefore it is thought that BLBP+ 
cells are the key drivers of neurogenesis during homeostasis.  It will be a 
matter of future experiments to analyze these populations in detail to 
determine the mechanisms involved in converting BLBP- type B cells to an 
active BLBP+ state, and potentially recapitulate a loss of neurogenesis in aged 
mammals (Giachino, Basak et al. 2014). 
Jag1 is an essential component of the SVZ niche (Nyfeler, Kirch et al. 
2005).  Jag1 is found on both ependymal and B cells in the niche as well as 
on endothelial cells of the blood vessels (Fig. 13d).  Understanding the dual 
role of Jag1 as a regulator of neural progenitor maintenance as well as a 
neural determinant factor in the ligand-presenting cell is crucial for discerning 
niche maintenance. 
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Figure 14.  Pathways and molecular factors involved in maintenance of the adult SVZ 
niche. 
The adult SVZ niche is maintained through a complicated network of signaling pathways, 
morphogens and growth factors.  As type B cells sequentially progress to type C, and 
eventually type A cells, they require signals to coordinate fate specification, migration, and 
eventually differentiation to develop into mature OB interneurons. Marker expression profiles 
differ amongst type B, C and A cells.  A few of the markers that B cells express include 
GFAP, Nestin and CD133.  Type A cells however express Dcx, Dlx2 and PSA-NCAM.  
(Adapted from (Faigle and Song 2013)).  
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2.3.3 Molecular	   factors	   and	   signaling	   pathways	   involved	   in	  maintenance	   of	   the	  
adult	  neurogenic	  niche	  
In recent decades an explosion of new technologies have allowed us to 
probe and study adult neurogenesis in ways that were not previously possible.  
Through these studies numerous novel growth factors and signaling pathways 
have been identified that directly control and maintain the adult germinal 
niches.  Some of these include the growth factors VEGF, EGF, FGF and 
BDNF, the Wnt, Shh, Notch signaling pathways, BMPs, neurotrophins and 
neurotransmitters (Fig. 14).  For a concise review of the role of these 
pathways and factors in the adult neurogenic niches please see (Faigle and 
Song 2013). 
2.3.3.1 Role	  of	  Wnt	  signaling	  in	  adult	  neurogenesis	  
While Wnt signaling plays an important role in the initial patterning and 
segmentation of the developing neural tube, it also appears to be crucial for 
adult neurogenesis (Faigle and Song 2013).  Of all the members in the Wnt 
family of signaling molecules, Wnt3 expressed in the DG hilar cells is the best 
studied in the context of adult neurogenesis (Faigle and Song 2013).  
Kuwabara and colleagues, demonstrated that positive regulation of NeuroD1 
through Wnt3a-activated canonical Wnt signaling was sufficient for neuronal 
differentiation in adult hippocampal neural progenitors (Kuwabara, Hsieh et al. 
2009).  Wnt signaling can increase adult neurogenesis by first expanding the 
progenitor pool, before they eventually differentiate, producing a greater 
number of neurons (Wexler, Paucer et al. 2009). 
Aging and neuronal activity has been shown to negatively and positively 
regulate adult neurogenesis in the DG, respectively (Zhao, Deng et al. 2008).  
Furthermore, two studies demonstrate that relative levels of Wnt signaling are 
at least partially responsible for this regulation (Jang, Bonaguidi et al. 2013, 
Seib, Corsini et al. 2013).  Exercise was shown to decrease the levels of 
secreted frizzled-related protein 3 (sFRP3).  sFRP3 is responsible for binding 
and sequestering Wnt proteins, resulting in a decrease of Wnt signaling.  
Therefore, by inhibiting sFRP3 through exercise, an increase in Wnt signaling 
occurs, resulting in an overall escalation of neurogenesis (Jang, Bonaguidi et 
al. 2013).  Conversely, with age there is a gradual accumulation of the 
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secreted glycoprotein Dickkopf 1 (Dkk1), which blocks neurogenesis at least 
in part by decreasing levels of Wnt signaling.  Upon deletion of Dkk1 adult 
mice exhibit expanded populations of neurons and increased levels of Wnt 
signaling (Seib, Corsini et al. 2013).  Interestingly, deletion of Dkk1 only 
resulted in expansion of neuronal populations, whereas in sFRP3 knockout 
(KO) expanded, neurons and glia, suggesting differing roles of Wnt dependent 
signaling regulation (Jang, Bonaguidi et al. 2013, Seib, Corsini et al. 2013).  
2.3.3.2 Role	  of	  Notch	  signaling	  in	  adult	  neurogenesis	  
It has been proposed that Notch1 plays a role in maintenance of the 
actively dividing NSCs in the adult niche (Nyfeler, Kirch et al. 2005, 
Androutsellis-Theotokis, Leker et al. 2006, Breunig, Silbereis et al. 2007, 
Ables, Decarolis et al. 2010, Aguirre, Rubio et al. 2010, Basak, Giachino et al. 
2012). In the DG and SVZ Notch activity promotes NSC survival, 
maintenance, and stem cell self-renewal (Stump, Durrer et al. 2002, Nyfeler, 
Kirch et al. 2005, Breunig, Silbereis et al. 2007, Basak and Taylor 2009, 
Ables, Decarolis et al. 2010, Aguirre, Rubio et al. 2010, Chapouton, Skupien 
et al. 2010, Ehm, Goritz et al. 2010, Lugert, Basak et al. 2010). However, both 
the preservation of, and the transition from a quiescent NSC state to, an 
activated one appear to be RBP-J dependent (Carlén, Meletis et al. 2009, 
Ehm, Goritz et al. 2010, Imayoshi, Sakamoto et al. 2010, Lugert, Basak et al. 
2010, Basak, Giachino et al. 2012).  Hence Notch1 may play a role in 
maintaining active NSCs, but not in switching from inactive to active states 
(Lugert, Basak et al. 2010, Basak, Giachino et al. 2012, Giachino, Basak et al. 
2014). 
Great efforts have been made over the years to identify molecular markers 
that discriminate populations of niche astrocytes from quiescent and activated 
NSCs (Pastrana, Cheng et al. 2009, Beckervordersandforth, Tripathi et al. 
2010, Mira, Andreu et al. 2010, Ferron, Charalambous et al. 2011, Codega, 
Silva-Vargas et al. 2014). EGF receptors have been associated with active 
SVZ NSCs that maintain astrocytic (BLBP) and glial (GFAP) markers 
(Pastrana, Cheng et al. 2009, Giachino, Basak et al. 2014).  Horizontal, non-
radial cell morphology identifies a population of actively dividing progenitors in 
the adult DG (Lugert, Basak et al. 2010).  However, there is also a population 
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of quiescent horizontal cells that currently cannot be discerned based on 
molecular marker alone (Suh, Consiglio et al. 2007, Lugert, Basak et al. 
2010).  New genetic tools are needed and markers identified that allow for 
independent and simultaneous lineage tracing of these two NSC populations.  
For an in depth analysis of the role of Notch in quiescence and active NSC 
populations see Giachino and Taylor, 2014 (Giachino and Taylor 2014). 
In the SVZ niche NSCs receive inductive cues directing them to specific 
fates, as well as restrictive signals which limit their potential and prevent 
differentiation (Doetsch 2003).  Some of these inductive cues most likely work 
in tandem with Notch (Shen, Goderie et al. 2004). Non-canonical activation of 
Notch through pigment epithelium–derived factor (PEDF), secreted by 
vascular endothelial cells within the SVZ, can bias cell fates towards radial 
glia.  By activating NF-κB PEDF exports nuclear receptor co-repressor 
(NCoR), which acts as a transcriptional inhibitor of the Notch target genes 
Hes1 and Egfr, allowing NSCs to undergo asymmetric, self-renewing divisions 
(Andreu-Agulló, Morante-Redolat et al. 2009). Other inductive cues include 
hypoxia-inducible factor 1α (HIF1α), that under hypoxic conditions is stabilized 
and cooperates with Notch signaling to promote expression of target genes in 
NSCs (Gustafsson, Zheng et al. 2005, Bar, Lin et al. 2010).   
To date, much of our knowledge about the Notch signaling pathway is 
derived from its role in NSC maintenance in the niche as a whole.  However, 
the role of Notch has not yet been addressed in detail at the single cell level, 
where levels of Notch signaling activity in NSCs may modulate response 
sensitivity to extrinsic signals.  New technologies allowing for precise single 
cell analysis may one day allow for identification and discrimination of NSC 
populations at the transcriptional level. 
2.4 Oligodendrogensis in mammals 
2.4.1 Signaling	  pathways	  involved	  in	  oligodendrocyte	  maturation	  
Glia cells carry out a diverse range of critical functions in the brain including 
ensuring adequate nutrient supplies to neurons, providing scaffolding and 
support, insulation of axons, removal of cellular debris and destruction of 
pathogens.  Oligodendrocytes are one of the major types of glia cells and 
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have the ability to not only provide support, but when mature also myelinate 
and insulate, axons thereby ensuring proper signal transduction (reviewed in 
(Pfeiffer, Warrington et al. 1993)).  Differentiation of oligodendrocytes from 
early oligodendrocytic precursor cells (OPCs) into mature myelinating cells is 
a process termed oligodendrogenesis.  Much like neurogenesis, 
oligodendrogenesis requires a complex network of morphogens, transcription 
factors, and signaling pathway crosstalk in order for maturation to occur 
correctly.  Some of the key signaling pathways involved include Wnt, Shh, 
BMP and Notch (Li, He et al. 2009). 
2.4.2 Origin	  of	  Oligodendrocytes	  in	  the	  SVZ	  
Oligodendrocytes in the developing forebrain are produced in three 
sequential and competitive phases beginning in the embryo and continuing 
into early postnatal development (Fig. 15) (Kessaris, Fogarty et al. 2006).  
The first wave begins ventrally at E11.5 in the Medial Ganglionic Eminence 
(MGE) - anterior entopeduncular region (AEP) and then moves more dorsally 
to the Lateral Ganglionic Eminence (LGE) - Caudal Ganglionic Eminence 
(CGE) from E15.5 onwards.  The third and final wave occurs even more 
dorsally in the postnatal cortex (Kessaris, Fogarty et al. 2006).  Interestingly, 
oligodendrocytes from the first wave of oligodendrogenesis in the forebrain 
are almost completely absent in the postnatal brain, potentially eliminated or 
are out competed by later waves (Kessaris, Fogarty et al. 2006).  
Oligodendrocytes begin in the developing neural tube as multipotent NEPs.  
Through sequential rounds of asymmetric cell divisions morphogen gradients 
of BMP and Shh restrict NEPs first to RGCs and then to OPCs (Fig. 4) (Li, He 
et al. 2009).  OPCs then proceed to receive chemo-attractant and mitogen 
signals, instructing them to proliferate and migrate from the SVZ into the 
developing forebrain (Li, He et al. 2009).  Once OPCs reach their destination, 
they proceed to integrate, differentiate, ensheath axons and form myelin.  
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Figure 15.  Waves of oligodendrogenesis in the developing forebrain 
a) As the forebrain develops the region of active oligodendrogenesis gradually moves more 
dorsally.  b) Oligodendrogenesis happens in three distinct waves, with the first two occurring 
during embryogenesis and the third postnatally.  The first wave (green) begins at 
approximately E11.5 in the Medial Ganglionic Eminence (MGE) - anterior entopeduncular 
region (AEP).  The second wave (blue) occurs after E15.5 in Lateral Ganglionic Eminence 
(LGE) - Caudal Ganglionic Eminence (CGE).  The third wave (red) takes place in the 
postnatal cortex, with OPCs able to distribute to all parts of the brain. (Directly from (Fancy, 
Chan et al. 2011)). 
 
2.4.3 Oligodendrocyte	  maturation	  in	  the	  developing	  forebrain	  
Oligodendrocyte maturation is a process requiring precise spatiotemporal 
coordination of both intrinsic factors, as well as direct contact with extrinsic 
factors such as active axons (Zuchero and Barres 2013).  During this process, 
oligodendrocytes undergo extensive chromatin reorganization resulting in 
transcriptional upregulation of maturation genes (Nielsen, Hudson et al. 2002, 
Yu, Chen et al. 2013).  One of the key transcription factors believed to 
regulate this remodeling is Olig2, and has been demonstrated to be critical in 
fate commitment to the oligodendrocyte lineage (Meijer, Kane et al. 2012, 
Zhu, Zuo et al. 2012).  Olig2 can act as a prepatterning factor by binding to 
the promoter of oligodendrocyte specific genes (Yu, Chen et al. 2013).  Olig2 
is then recognized by the ATP-dependent SWI/SNF chromatin-remodeling 
enzyme Smarca4/Brg1, resulting in it also localizing to these promoters.  
Smarca4/Brg1 then alters the chromatin structure and recruits additional 
proteins that actively transcribe target oligodendrocyte genes (Yu, Chen et al. 
2013).   
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In recent years Sox10 has emerged as a key fate determinant of early 
oligodendrocyte precursor specification (Fig. 16) (Kuhlbrodt, Herbarth et al. 
1998, Stolt, Rehberg et al. 2002, Li, Lu et al. 2007, Finzsch, Stolt et al. 2008, 
Rivers, Young et al. 2008). In precursor specification Olig2 binds through an 
evolutionary conserved distal enhancer to directly control the expression of 
Sox10 (Fig. 17) (Küspert, Hammer et al. 2011).  Sox10 is specifically 
expressed through the entire process of oligodendrogenesis, from OPCs to 
myelinating oligodendrocytes (Fancy, Chan et al. 2011).  Conditional genetic 
ablation studies have shown that Sox10 is essential for OPCs (Finzsch, Stolt 
et al. 2008).  Following the ablation of both Sox10 and Sox9, expression of 
platelet-derived growth factor receptor alpha (PDGFRα), which serves as both 
an important cue for migration and a survival factor for OPCs is lost (Finzsch, 
Stolt et al. 2008).  In the peripheral nervous system (PNS) Sox10 has been 
shown to interact with the transcription factor Krox20 (Egr2) (Ghislain and 
Charnay 2006).  Together, they bind to the promoters and directly regulate a 
cascade of genes involved in myelination (LeBlanc, Jang et al. 2006, 
Srinivasan, Sun et al. 2012).  Although Krox20 is not expressed in 
oligodendrocytes of the CNS a functionally similar protein called myelin 
regulatory factor (Myrf; also referred to as Mrf in the literature) has been 
identified.  Similar to what is seen with Krox20 expression in Schwann cells, 
Myrf is upregulated in myelinating oligodendrocytes of the CNS (Emery, 
Agalliu et al. 2009).   
 Upregulation of Sox10 does not immediately result in the expression of 
Myrf.  Data suggests that Sox10 binding sequences in the promoter of Myrf 
require chromatin remodeling from Smarca4/Brg1 and Olig2 before Sox10 
can bind (Hornig, Frob et al. 2013, Yu, Chen et al. 2013).  Interestingly, both 
Sox10 and Myrf can bind and act as a functional transcriptional complex 
(Hornig, Frob et al. 2013).  ChIP data also suggests that Myrf shares similar 
binding sites to Sox10, and can be found on the promoters of myelin specific 
genes including MBP (Bujalka, Koenning et al. 2013). 
Depending on the stage of oligodendrocyte maturation, oligodendrocytes 
express a range of unique markers (Fig. 16).  Key markers displayed by 
OPCs include PDGFRα, Nkx2.2, NG2, as well as the transcription factors 
Olig2 and Sox10 (Fancy, Chan et al. 2011).  However a variety of OPC 
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populations exist, with some having limited or no expression of PDGFRα 
(Spassky, Goujet-Zalc et al. 1998, Spassky, Heydon et al. 2001).   
Newly derived premyelinating oligodendrocytes have a distinct morphology 
that contains multiple processes extending both radially and symmetrically.  
They express the markers myelin-associated glycoprotein (MAG), 2’,3’-cyclic 
nucleotide 3’-phosphodiesterase (CNPase) and myelin basic protein (MBP) 
(Fig. 16) (Fancy, Chan et al. 2011).  Premyelinating oligodendrocytes can 
then either undergo apoptosis and be removed, or continue to mature and 
become myelinating oligodendrocytes (Barres, Hart et al. 1992, Barres, Hart 
et al. 1992). 
Similar to premyelinating oligodendrocytes, maturing oligodendrocytes 
express the markers MBP, CNPase and MAG however additional markers 
including proteolipid protein (PLP), myelin oligodendrocyte glycoprotein 
(MOG), peripheral myelin protein 22 (PMP22), myelin protein zero (P0) are 
also used to identify these cells (Fancy, Chan et al. 2011).  During maturation, 
these proteins are transported to the cell membrane with MAG targeted to the 
periaxonal membranes, CNPase to noncompact and PLP to compact myelin 
regions of the myelin internode (Martini and Schachner 1986, Sorg, Smith et 
al. 1987, Braun, Sandillon et al. 1988, Trapp, Bernier et al. 1988, Trapp, 
Andrews et al. 1989).  Additionally, contactin-associated protein (Caspr) can 
identify fully mature oligodendrocytes which have formed multiple ensheathing 
wraps of myelin around axons (Einheber, Zanazzi et al. 1997).  This is 
denotated by punctate Caspr expression at the paranodal junctions on 
myelinated axons (Rios, Melendez-Vasquez et al. 2000).  Interestingly the 
individual role of each protein seems to be quite complicated, with mutations 
resulting in a large range of phenotypes.  MBP ablated mice (shiverer mouse) 
are dysmyelinated but still form axons that are functional and intact 
(Readhead, Popko et al. 1987).  Conversely, PLP null mutations results in 
mature myelination but non-functional axons (Griffiths, Klugmann et al. 1998). 
While axons are not essential for oligodendrocyte production, they do act 
extrinsically on neighboring oligodendrocytes and regulate oligodendrocyte 
maturation and number (Nave and Trapp 2008).  Neurgulin-1 (Nrg1) is 
expressed by axons and can bind to ErbB receptor tyrosine kinases on 
oligodendrocytes and promote their development (Vartanian, Goodearl et al. 
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1997, Esper, Pankonin et al. 2006).  Nrg1 can also act as a chemoattractant 
for OPCs and direct their migration through embryonic development (Ortega, 
Bribián et al. 2012).  Furthermore, in spinal cord neural precursor cells, 
exogenous Nrg1 can enhance proliferation and differentiation into 
oligodendrocytes at the expense of astrocytes (Gauthier, Kosciuczyk et al. 
2013).  
As axons and oligodendrocytes mature, they signal to each other regulating 
their maturation spatially and temporally (Nave and Trapp 2008).  
Oligodendrocytes synthesize and release known neurotrophic factors such as 
Prostaglandin D that can act as a neuroprotective molecules for adjacent 
neurons, however the mechanism is not fully understood (Taniike, Mohri et al. 
2002, Nave and Trapp 2008).  Laminin-α2 and β1-integrin mediated signaling 
is also essential for correct axon selection and myelin thickness (Mitew, Hay 
et al. 2014).  Ablation of β1-integrin does not disrupt normal oligodendrocyte 
development however cells are unable to extend and form myelin sheaths or 
activate AKT, which is critical for axonal ensheathment (Lee, De Repentigny 
et al. 2006, Barros, Nguyen et al. 2009). 
It has long been known that axon diameter increases with the maturation 
and myelin expression of oligodendrocytes (Foster, Connors et al. 1982, 
Brady, Witt et al. 1999).  Oligodendrocytes that ensheath axons after a 
demyelinating injury form thinner myelin wraps than those during normal 
development, implying that axons and oligodendrocytes are providing 
feedback cues to each other (Lasiene, Shupe et al. 2008).  The biophysical 
properties of axonal diameter on oligodendrocyte maturation was addressed 
through studying engineered nanofibers in vitro (Lee, Leach et al. 2012).  
Oligodendrocytes not only show preference for axons of 0.5 µm in diameter or 
larger, but also initiate membrane ensheathment before they have begun to 
differentiate (Lee, Leach et al. 2012). 
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Figure 16.  Marker expression during lineages restriction of oligodendrocytes  
As oligodendrocytes progress from OPCs through to mature myelinating oligodendrocytes, 
they express a cascade of molecular markers and genes.  Transcriptional factors, Sox10, 
Nkx2.2, YY1, Myrf, and Zfp191 are delineated with solid black arrows and are essential for 
each stage of oligodendrogenesis to proceed.  Gradient bars define temporal expression of 
each factor, with green bars representing generally early expressed genes, orange being 
expressed by pre-myelinating oligodendrocytes, and red expressed in myelinating 
oligodendrocytes.  Other mechanisms including Wnt signaling and miRNA regulation play a 
role in both inhibiting and promoting maturation. (Adapted from (Back, Riddle et al. 2007, 
Silbereis, Huang et al. 2010, Fancy, Chan et al. 2011)).  
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2.4.4 The	  role	  of	  Wnt	  signaling	  in	  maturation	  of	  oligodendrocytes	  
Both Wnt and Notch signaling pathways act as repressors of 
oligodendrocyte maturation.  However, Wnt signaling has been shown to 
enhance proliferation of less fate restricted OPCs and careful regulation is 
required for myelinating oligodendrocytes to occur (Fancy, Baranzini et al. 
2009).  In line with this evidence, canonical Wnt negative regulators Axin2 and 
Adenomatous polyposis coli (APC) have been shown to be essential in 
ensuring correct OPC maturation (Fancy, Baranzini et al. 2009, Fancy, 
Harrington et al. 2011).  The negative role of Wnt in maturation is due in part 
to the Wnt downstream effector TCF4, which can bind to an activated form of 
β-catenin (Leung, Kolligs et al. 2002).  The β-catenin/TCF4 complex to the 
promoter region of MBP results in its expression being repressed, and 
consequently, a block in myelination (He, Dupree et al. 2007).  Disruption of 
TCF4 repression through HDAC1 and HDAC2 was found to alleviate some of 
these inhibitory effects by allowing expression of late stage maturation genes 
(Ye, Chen et al. 2009).  Other regulators of canonical Wnt signaling, including 
homeodomain interacting protein kinase 2 (HipK2) which phosphorylates 
TCF4 preventing it from binding to DNA, and therefore may play a role in 
modulating oligodengdrogenesis (Gao, Xiao et al. 2014). 
Precise regulation and fine tuning of oligodendrogenesis by Wnt signaling 
is crucial, resulting in it being both required for early development and 
repressed in later development.  In the adult dorsal SVZ, Wnt3a can induce 
the nuclear localization of β-catenin (Azim, Rivera et al. 2014).  Interestingly, it 
was shown that nuclear β-catenin accumulation was completely abolished 
through overexpression of BMP4, highlighting its potential role as an inhibitor 
of OPC development (Azim, Rivera et al. 2014).  However, constitutive 
expression of an active form of β-catenin results in the inhibition of OPC 
development and a loss of re-myelination in vivo (Fancy, Baranzini et al. 
2009, Ye, Chen et al. 2009).  Moreover, APC must be expressed in order to 
prevent OPCs from transitioning to high levels of Wnt signaling (Fancy, 
Harrington et al. 2014).  They went on to show that OPCs with high Wnt, do 
not express APC and could not fully mature or myelinate (Fancy, Harrington 
et al. 2014).  Therefore, the complicated dual role of Wnt signaling appears to 
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be required for correct spatial temporal timing of events in oligodendrogenesis 
(Fancy, Chan et al. 2011).   
2.4.5 The	  role	  of	  Notch	  signaling	  in	  maturation	  of	  oligodendrocytes	  
Activated Notch signaling is believed to play an inhibitory role in OPC 
maturation (Wang, Sdrulla et al. 1998, Jurynczyk, Jurewicz et al. 2008, 
Zhang, Argaw et al. 2009, Aparicio, Mathieu et al. 2013, Hammond, Gadea et 
al. 2014).  However, conflicting reports reveal that it is unclear how Notch may 
inhibit OPC development (Stidworthy, Genoud et al. 2004, Nakahara, 
Kanekura et al. 2009).  In remyelinating lesions activation of Notch receptor 
through Jag1 presenting reactive astrocytes leads to an overall decrease in 
remyelinated axons (Hammond, Gadea et al. 2014).  It was proposed that 
stimulation of Jag1 by endothelin-1 (ET-1) in reactive astrocytes leads to an 
over-activation of Notch1, and an increase in nuclear translocated NICD.  The 
NICD then potentially acts through Notch effector proteins such as Hes5 to 
inhibit OPCs (John, Shankar et al. 2002).  Conversely, it was demonstrated 
that active Notch signaling does not result in an inhibition of remyelination 
(Stidworthy, Genoud et al. 2004).  Additionally it was shown that inhibition of 
remyelination was not due to an activation of Notch but instead an 
upregulation and accumulation of TAT-interacting protein (Tip30) in OPCs, 
which inhibits the nuclear translocation of the NICD (Nakahara, Kanekura et 
al. 2009).  Although it is clear that Notch signaling plays a role in OPC 
maturation, what that role may be is still unclear. 
 
Figure 17.  Sox10 and Myrf are essential 
transcription factors required for 
oligodendrocyte terminal differentiation in 
the CNS. 
During OPC specification Olig2 positively 
regulates the expression of Sox10.  In order for 
oligodendrocytes to fully mature and express 
myelin, Sox10 and Olig2 must act in concert to 
induce Myrf expression.  Once expressed, 
Sox10 and Myrf can bind to similar sequences in 
promoters of essential myelin genes including 
PLP, MBP, MAG and MOG. (Directly from (Emery 2013)). 
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2.4.6 Multiple	  Sclerosis:	  The	  demyelinating	  disease	  
2.4.6.1 Fundamentals	  of	  MS	  
Multiple Sclerosis (MS) is a complicated autoimmune inflammatory 
demyelinating disease where the immune system targets and degrades 
myelinating oligodendrocytes, ultimately resulting in neuronal degeneration 
(Franklin, ffrench-Constant et al. 2012). Although the precise mechanisms 
involved are still unclear, it is believed to be the result of a cascade of cellular 
malfunctions.  Sites where inflammation and demyelination occur are referred 
to as lesions.  Axonal damage is a pathological condition of the disease, 
which can be contributed to oxidative damage, sodium accumulation and 
energy deprivation of the cells (for a full review please see (Franklin, ffrench-
Constant et al. 2012).   Unlike other neurodegenerative diseases, such as 
Parkinson’s or Huntingtons disease, the only cells that are lost in MS are 
myelinating oligodendrocytes.  Luckily the body can naturally regenerate 
these cells through a process termed “remyelination”, in which a natural 
reserve of OPCs (Fig. 18) can migrate to the site of the lesion, become 
activated, and undergo differentiation.  The precise mechanisms controlling 
this recruitment and differentiation are still unclear.  The key to curing MS lies 
in understanding why remyelination fails in patients with MS and how to 
recapitulate a healthy level of remyelination, while in parallel limiting the 
immune system degradation of newly generated myelin.  
 
Figure 18.  Regionalization 
of glia in the adult 
mammalian brain 
In the adult mouse OPCs 
expressing the marker NG2 
are scattered throughout the 
brain and can become 
activated and migrate large 
distances to the site of 
lesions.  Additionally, 
microglia, the resident 
immune cells of the adult brain, can migrate to the site of lesion and release mitogens to 
attract and activate OPCs.  (Adapted from (Morrens, Van Den Broeck et al. 2012))    
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2.4.6.2 The	  process	  of	  remyelination	  in	  MS	  lesions	  
In MS, although remyelination of lesions occurs naturally, relapse and new 
lesions form due to a continued autoimmune response against myelinating 
cells.  The process of remyelination is composed of three phases (Fig. 19a).  
The OPCs activation phase, the OPC recruitment phase, and finally the 
differentiation phase where OPCs mature and remyelinate the axonal 
processes (for a full review please see (Franklin and ffrench-Constant 2008)).  
After a lesion has occurred, the first cells to recognize and respond are 
astrocytes and the resident immune cells of the brain, the astrocytic microglia 
(Glezer, Lapointe et al. 2006, Rhodes, Raivich et al. 2006).  Together they 
release a cascade of mitogens and chemoattractants including platelet 
derived growth factor (PDGF) and fibroblast growth factor (FGF) that are 
involved in recruiting and activating migratory OPCs (Fig. 19b) (Scolding, 
Franklin et al. 1998, Sim, Zhao et al. 2002, Wilson, Scolding et al. 2006).  
During the recruitment phase the activated OPCs then proceed to invade the 
lesion site (Franklin 2002, Larsen, Wells et al. 2003).  Once at the site of the 
lesion they enter their final phase and begin to remyelinate the demyelinated 
axons.  This process is quite complex and not fully understood, but OPCs 
must begin by making physical contact with the cells it will ensheath.  Then 
the OPCs express myelin specific genes (Fig. 16) permitting them to continue 
the maturation process.  Finally, the processes of the myelinating 
oligodendrocyte ensheath neighboring axons forming a functional myelin 
membrane (Franklin and ffrench-Constant 2008). 
2.4.6.3 The	  role	  of	  inflammation	  in	  remyelination	  
A key inhibitor of remyelination in the mammalian brain is the T-cell 
mediated inflammation response.  In experimental autoimmune 
encephalomyelitis (EAE), a mouse model of MS, lesions are associated with 
elevated levels of Th1 and/or Th17 responsive T-cells (Balashov, Smith et al. 
1997, Crawford, Yan et al. 2004, Kebir, Kreymborg et al. 2007, Tzartos, 
Friese et al. 2008).  Even though myelin-specific T-cells exist in healthy 
individuals they do not become activated and induce MS under normal 
conditions.  Interestingly, both pro-inflammatory cytokines interleukin-1 (IL1) 
and tumour necrosis factor-α (TNFα) appear to be required in the process of 
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remyelination (Arnett, Mason et al. 2001, Mason, Suzuki et al. 2001).  
Contrary to the inflammatory Th1 induced cell response, a Th2 mediated 
response appears to have anti-inflammatory effects in lesions and promote 
remyelination (Aharoni, Teitelbaum et al. 1997, Park, Li et al. 2005, 
Bergamaschi, Villani et al. 2009, Pedotti, Farinotti et al. 2009, Guerau-de-
Arellano, Smith et al. 2011).  The Notch signaling pathway which plays a role 
in the remyelination of lesions (see 2.4.5), can differentially regulate either 
Th1 or Th2 T-cell responses depending on if it is activated by Dll or Jag1 
ligands respectively (Amsen, Blander et al. 2004, Amsen, Blander et al. 2004, 
Rutz, Mordmüller et al. 2005, Elyaman, Bradshaw et al. 2007).  Elyaman, et 
al. showed this by blocking Jag1 in vivo, which resulted in a Th2 specific 
decrease (Elyaman, Bradshaw et al. 2007).  When Dll was blocked, this 
decrease was specific for Th1 T-cell mediated response (Elyaman, Bradshaw 
et al. 2007).  Although it has been demonstrated in endothelial cells that Jag1 
can be positively regulated by TNFα it appears that in the CNS it has an 
inhibitory effect on the ligand (Elyaman, Bradshaw et al. 2007, Sainson, 
Johnston et al. 2008, Johnston, Dong et al. 2009).  Potentially through 
multiple levels of Jag1 regulation in active lesions, a finely-tuned Th2 T-cell 
anti-inflammatory response can be mediated through Notch signaling. 
2.4.7 Putative	  role	  of	  Jag1	  in	  remyelination	  
At present there are conflicting reports on the role of Jag1 in remyelination.  
The lab of Vittorio Gallo has put forth the hypothesis that through stimulation 
by ET-1, Jag1 is upregulated in reactive astrocytes, which in turn activates 
Notch signaling in active OPCs of the lesion (Hammond, Gadea et al. 2014).  
Other labs in recent years have also demonstrated that reactive astrocytes 
expressing Jag1 resulting in an inhibition of differentiating OPCs and 
remyelination, implying that activation through the Notch signaling pathway 
may exhibit an inhibitory role (Stidworthy, Genoud et al. 2004, Zhang, Argaw 
et al. 2009).  This, however, contradicts the findings of other labs that show 
Jag1 expression to be highest in astrocytes of MS lesions undergoing active 
remyelination (Elyaman, Bradshaw et al. 2007, Seifert, Bauer et al. 2007).  
Moreover, multiple studies have shown that astrocytes in remyelinating 
lesions express high levels of Jag1 and not Dll, implying that it is the key 
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ligand in regulating remyelination (Stidworthy, Genoud et al. 2004, Elyaman, 
Bradshaw et al. 2007).  Additonally it was shown that even within lesions 
containing OPCs with high levels of Notch and Jag1, remyelination can still 
occur (Stidworthy, Genoud et al. 2004).  Understanding the functional role of 
Jag1 at a molecular level is key to determining the potential mechanisms 
involved in its regulation of remyelination. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. Remyelination in the adult mammalian brain (next page) 
a) There are three phases in remyleination of the adult mammalian brain.  Activation, 
recruitment and differentiation.  These processes must be carefully regulated both temporally 
and spatially in order for functional remyelination to occur.  Key mitogens and signaling 
pathways have been denoted for each step.  b) A depiction of normal adult white matter (i) 
undergoing a demyelinating lesion (ii), resulting in the loss of oligodendrocytes ensheathing 
the axons.  This activates microglia and astrocytes, which attract and activate OPCs through 
excretion of mitogens.  Once at the lesion site (iii) OPCs begin to express markers for 
oligodendrocytic differentiation and start to ensheath the demyelinated axons (iv).  Careful 
timing of recruitment and differentiation factors is critical in order for myelination to occur 
(Adapted from (Franklin and ffrench-Constant 2008, Filipe Palavraa 2014)).
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Figure 19. Remyelination in the adult mammalian brain (legend on previous page). 
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3 Results 
3.1 Project 1: The role of Jag1 full length in maintaining the 
NSC niche 
3.1.1 Background 
Jag1 plays an important role in lateral activation of Notch, including during 
brain and ear development, vasculogenesis and cancer, (Xue, Gao et al. 
1999, Nyfeler, Kirch et al. 2005, Kiernan, Xu et al. 2006, Roca and Adams 
2007).  However, the molecular mechanisms controlling the transition from 
stem cell division, where Notch plays a maintenance role in most systems, to 
daughter cell differentiation, are not understood.  Our lab has previously 
shown by genetic ablation experiments that Jag1 provides niche signals for 
NSC maintenance during development of the mouse brain and in controlling 
adult neurogenesis (Nyfeler, Kirch et al. 2005, Weller, Krautler et al. 2006).  
An active secreted form of Jag1 was sufficient to compensate for the lost 
lateral signal in Jag1-ablated stem cell cultures and maintain wild type but not 
Notch1-/- NSCs in vitro (Nyfeler, Kirch et al. 2005). 
 The developing forebrain is highly organized and cell population identity 
determined based on topological position and marker expression (Fig. 3).  
Jag1 is expressed by progenitors in the developing forebrain, where it 
localizes to the apical domain and we postulate plays a role in lateral signaling 
in vivo (Fig. 20a-d).  In the first part of my thesis I will describe the results of 
experiments designed to address the functions of Jag1 in regulating NSC and 
progenitor differentiation. 
3.1.2 AAV-Jag1FL particles are able to package Jag1FL transcript and 
transduce cells in vitro 
 In an attempt to address the role of Jag1 in the developing SVZ niche, I 
adopted a gain-of-function approach, expressing Jag1FL from viral vectors.  
Type B1 cells of the SVZ can go through long periods of quiescence, and 
divide infrequently to give rise to intermediate progenitors which differentiate 
into neurons, astrocytes and oligodendrocytes.  To express Jag1 in NSCs of 
the niche I took two approaches.  First, with an adeno-associated virus (AAV) 
which can transduce mitotically active and inactive cells (Tenenbaum, Chtarto 
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et al. 2004) and secondly with a retrovirus for transduction of actively dividing 
cells (see below).   
 Jag1FL open-reading frame encoding mRNA was cloned between the 
inverted terminal repeats (ITRs) of the Strategene AAV-2 Helper Free System 
(Fig. 20e).  The total fragment size between the ITRs (red) was 5496 bp, 
which is near the theoretical maximum encapsulation capacity of AAVs (Wu, 
Yang et al. 2010). The vector AAV-Jag1FL was sequenced to confirm integrity 
and shown to express Jag1FL protein in vitro (Fig. 20I, g).  High transfection 
efficiency of viral plasmids ensured that co-transfection with pHelper and 
pAAV-RC plasmids occurred at a high frequency (Fig 20F).  AAV particles 
were purified and titered in collaboration with Jan Herb at the Max-Planck-
Institute for Medical Research in Heidelberg, Germany (20K).  Viral titers of 
AAV-Jag1FL were lower than control (3.33e9 capsides/ul), but the purified 
virus was still capable of transducing both HEK293 (Fig. 20J) and wild type 
(WT) C57BL/6 mouse NSC cultures (Fig. 20K,L).  This viral construct is a 
valuable tool for the expression of Jag1FL protein but has the limitation of 
relatively low viral titer and no reporter gene to monitor transduction and the 
fate of infected cells.  Therefore, in parallel I generated an additional viral 
construct based on the mouse Moloney leukemia virus (MMLV) retrovirus 
(RV). 
3.1.3 Retro-Jag1FL particles are highly efficient at transducing cells in 
vitro 
 The Jag1FL open-reading frame cDNA sequence was cloned into the pMIG 
RV expression vector (Fig. 21a).  pMIG contains an internal ribosome entry 
sequence (IRES) driving expression of a GFP reporter and due to the larger 
capacity of the RV, more sequence information can be packaged in each viral 
particle.  Expression of Jag1 from the pMIG vector was confirmed through 
transfection of HEK293 cells with the viral backbone plasmid and Jag1-
specific qRT-PCR and western blot analysis (Fig. 21b,c).  Viral particles were 
confirmed to be capable of transducing cells in vitro using a NIH3T3 fibroblast 
cell line (Fig. 21d-f).  Both control (IRES-GFP only) and Jag1FL-IRES-GFP 
RVs transduced NIH3T3 cells with a similar efficiency.  Notably, by 
immunohistochemistry (IHC) Jag1FL protein was detectable at the cell 
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membrane at higher levels in the Jag1FL-IRES-GFP expressing cells than the 
endogenous levels detected in the IRES-GFP transduced cells.  Jag1FL-
IRES-GFP NSCs were also confirmed to express elevated levels of Jag1 
protein (Fig. 21g,h). 
3.1.4 Jag1FL-IRES-GFP transduction into the postnatal SVZ niche 
results in a fate shift to Sox10+ oligodendrocytes 
  To address the role of Jag1 in the SVZ niche, RV was injected into the right 
lateral hemisphere of postnatal day (P) 2 wildtype C57BL/6 mice using 
predefined stereotactic coordinates (experimental outline Fig. 22a).  Since RV 
can only incorporate their genome into mitotically dividing cells, transduction 
in the SVZ likely targets actively dividing type B1 NSCs, and the proliferating 
type C (transient amplifying) cells.  Mice were analyzed at 3, 7, 15 and 30 
days post-infection (DPI) (Fig. 22a).  Jag1 was detectable by IHC in cells 
expressing the GFP reporter from the Jag1FL-IRES-GFP RV (Fig. 22b).  
Initial analysis of Jag1FL-IRES-GFP+ cells in 30 DPI animals, revealed a 
disproportionate number of Jag1FL-IRES-GFP+Sox10+ cells when compared 
to IRES-GFP+ control cells, particularly in the cerebral cortex (Fig. 22c).  IHC 
of 3 DPI mice demonstrated that RV infection occurred in the targeted 
progenitor cells lining the lateral ventricle (LV) (Fig. 23a).  Surprisingly, 
Jag1FL-IRES-GFP+ cells at 30 DPI exhibited an oligodendrocyte-like 
morphology more obvious than IRES-GFP+ cells at the same time-point (Fig. 
23a,b,d,e).  Analysis of cell migration demonstrated that there was a 
significant increase in Jag1FL-IRES-GFP+ cells in the cerebral cortex by 7 
and at 15 DPI compared to IRES-GFP+ cells (Fig. 23c). 
 High migration potential is characteristic of OPCs that are capable of 
traversing large distances during oligodendrogensis (Fancy, Chan et al. 
2011).  Based on the migration data and the oligodendrocyte-like morphology 
of the Jag1FL-IRES-GFP+ cells, I hypothesized that expression of Jag1FL 
could induce a fate switch of transduced cells to the OPC lineage.  To test 
this, I studied the expression of essential oligodendrocyte transcription factors 
Olig2 and Sox10 (Fig. 24), both of which are required for OPC commitment 
(Introduction Fig. 16).  In both the corpus callosum and the cerebral cortex of 
Jag1FL-IRES-GFP transduced animals there was a noticeable increase in 
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Jag1FL-IRES-GFP+Olig2+Sox10+ expressing cells when compared to control 
mice.  Since most Sox10+ cells were also Olig2+, future experiments used 
Sox10+ labeling to denote cells in the oligodendrocytic lineage.  By 30 DPI, 
there was a significant difference in the number of Jag1FL-IRES-GFP+ cells 
residing in the corpus callosum and striatum (Fig. 25a).  Surprisingly, 
compared to IRES-GFP+ controls there was almost double the number of 
Jag1FL-IRES-GFP+Sox10+ cells by 15 DPI, which was maintained through to 
30 DPI (Fig. 25b). 
 I asked if this shift in Sox10 expression amongst Jag1FL-IRES-GFP+ cells 
was brain region specific.  While there were slight increases in Sox10+ cells in 
all regions of the forebrain of Jag1FL-IRES-GFP transduced animals 
examined at 3 DPI, compared to IRES-GFP transduced controls there was 
only a significant shift in Sox10+ in the cerebral cortex (Fig. 25c, 26a,b).  
However, by 15 DPI there was a significant change in Jag1FL-IRES-
GFP+Sox10+ in all forebrain regions.  The most dramatic increase was seen in 
the cerebral cortex where almost 80% of Jag1FL-IRES-GFP+ cells at 15 DPI 
were Sox10+.  This trend was maintained in mice at 30 DPI (Illustrated in Fig. 
27b). 
3.1.5 Jag1FL-IRES-GFP+Sox10+ cells express the early OPC marker 
NG2 
 If Jag1FL causes a fate shift to the oligodendrocyte lineage, one would 
expect to see differences in early OPC marker expression in Jag1FL-IRES-
GFP+ cells.  To study this I examined the expression of the early OPC marker 
NG2.  NG2 (also known as Chondroitin Sulfate Proteoglycan, Cspg4) is an 
integral membrane proteoglycan (Nishiyama, Chang et al. 1999).   NG2 
expression is downregulated at later stages of OPC development and can 
only identify OPCs in their most primitive stages (Stallcup and Beasley 1987).  
At 7 DPI almost 40% of Jag1FL-IRES-GFP+ cells in the cerebral corticies of 
infected mice expressed NG2 compared to approximately 10% in IRES-GFP+ 
cells (Fig. 28a-c).  Interestingly, at this same time point the percent of total 
transduced cells that were Sox10+NG2+ decreased by approximately 15% in 
Jag1FL-IRES-GFP+ mice compared to control (Fig. 28c).  The cell-surface 
receptor PDGFRα, is another widely accepted marker for early OPC 
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development, although PDGFRα- OPC populations have been identified 
(Spassky, Goujet-Zalc et al. 1998, Nishiyama, Chang et al. 1999, Spassky, 
Heydon et al. 2001).  By 30 DPI, no Jag1FL-IRES-GFP+ cells had detectable 
levels of PDGFRα (Fig. 28d). 
 To confirm that Jag1FL-IRES-GFP+ cells progress to later stages of 
oligodendrocyte development, I addressed whether they expressed the 
mature myelination markers CNPase (Cnp) and MBP (Boulanger and Messier 
2014).  Although analysis is ongoing, Jag1FL-IRES-GFP+ cells appear to co-
express CNPase in the cerebral cortex as early as 15 DPI, which is not a 
common phenomenon seen for IRES-GFP+ cells (Fig. 29a).  This increased 
number of Jag1FL-IRES-GFP+CNPase+ cells compared to control appears to 
become more pronounced by 30 DPI (Fig. 29b).  Additionally, by 30 DPI 
Jag1FL-IRES-GFP+MBP+ cells were present in all forebrain regions (Fig. 29b, 
30a-c). 
 Potentially, the oligodendrocytic phenotype could be explained by a 
Jag1FL-induced increase in proliferation.  Using the active cell proliferation 
marker Ki67, I examined the corticies of mice 7 DPI (experimental outline Fig. 
30D) but observed no significant differences between Jag1FL-IRES-GFP+ and 
IRES-GFP+ cells (Fig. 30e). 
3.1.6 Jag1FL-IRES-GFP+ NSCs lose sphere-forming capacity but do not 
change rate of proliferation 
 To study the phenotype of Jag1FL-IRES-GFP+ NSCs in vitro, I used the 
neurosphere assay and measured the sphere-forming capacity of NSCs after 
transduction.  Data from Nyfeler and colleagues, demonstrated that Jag1 
could act as a stem cell regulator, maintaining sphere formation and 
differentiation capacity through lateral activation of Notch even in the absence 
of EGF in the media (Nyfeler, Kirch et al. 2005).  However, based on my in 
vivo findings, Jag1FL-IRES-GFP+ cells lose their ability to remain as 
multipotent progenitors and become more fate-restricted over time.  NSCs 
derived from postnatal pups were transduced with either Jag1FL-IRES-GFP 
or IRES-GFP RVs, sorted by fluorescent activated cell sorting (FACS) and 
then maintained at clonal densities in 24 well culture plates (experimental 
outline Fig. 31a,b).  After multiple passages, Jag1FL-IRES-GFP+ NSCs lost 
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the capacity to form spheres, suggesting a loss of progenitor cell maintenance 
(Fig. 31c).  This was most pronounced after passaging the NSCs 3-4 times.  
To examine if a loss of sphere formation was due to a change in the rate of 
cell proliferation, spheres were dissociated and pulsed with a thymidine 
analogue (EdU) before staining for the mitotic marker Ph3.  No significant 
differences in EdU incorporation or Ph3 labeling were seen when comparing 
Jag1FL-IRES-GFP+ cells to control (Fig. 31d). 
3.1.7 Under differentiating conditions, Jag1FL-IRES-GFP+ NSCs can 
upregulate essential genes involved in oligodendrocyte 
maturation 
 NSCs lose their ability to give rise to all neural cell lineages as they 
become fate restricted. NSC fate commitment was monitored using the 
neurosphere differentiation assay where spheres were grown on coverslips 
under differentiating conditions (experimental outline Fig. 32a).  Transduced 
NSCs were sorted for GFP expression by FACS before initiating 
differentiation.  Jag1FL-IRES-GFP+ and IRES-GFP+ transduced NSCs 
exhibited viral silencing under differentiating conditions, most notably at the 
peripheries of the colony (Fig. 32b).  qRT-PCR analysis of differentiated 
cultures showed an increase in relative expression of the oligodendrocyte 
genes Enpp6, MBP, PDGFRa, Sox10, Myrf and Olig2 in Jag1FL-IRES-GFP+ 
colonies (Fig. 32c).  In addition, Jag1FL-IRES-GFP+ colonies displayed an 
upregulation of Olig2 protein (Fig. 32e). 
3.1.8 Next generation RNA sequencing of the transcriptome profiles of 
Jag1FL-IRES-GFP+ NSCs 
 I hypothesized that the Jag1FL-IRES-GFP+ NSCs would have a change in 
transcription profile compared to IRES-GFP+ control cells.  I anticipated that a 
genome-wide analysis of Jag1FL-induced gene expression could present a 
plausible explanation for both the fundamental changes seen in the 
oligodendrocytic fate shift in vivo and the differentiation ability in vitro.  Hence, 
transduced spheres were cultured, sorted for GFP expression by FACS and 
RNA immediately isolated for sequencing (Fig. 33).  In parallel, RNA-Seq 
target genes were confirmed by qRT-PCR to eliminate false positives. 
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3.1.9 Jag1FL-IRES-GFP+ NSCs upregulate genes involved in 
oligodendrocyte maturation 
 RNA-Seq was performed in duplicate (referred to as rep1 and rep3) on 
control and Jag1FL-IRES-GFP+ NSCs.  Reads per 1 kB transcripts, per 1 mB 
library (RPKM) were used for normalization of the data, taking into account 
variances in sample library size.  Libraries were analyzed using empirical 
analysis of digital gene expression data in R (edgeR).  FastQC quality reports 
were generated to verify that sequencing of all samples worked correctly (Fig. 
34).  Replicates were then cross-analyzed using a 2x2 contingency table and 
hypergeometric tests and low expressing genes filtered out (Fig. 35).  A total 
of 13 469 expressed genes were observed, with 220 genes exhibiting a 
significant +/- log2 fold change of 1 (p<0.05) between Jag1FL-IRES-GFP+ 
NSCs and IRES-GFP+ control NSCs.  Analysis of differentially expressed 
genes with the gene ontology (GO) database identified enriched gene 
categories for central nervous system myelination (Odds ratio: 15.1), axon 
ensheathment in the CNS (Odds ratio: 15.1), oligodendrocyte development 
and differentiation (Odds ratio: 8.47 and 6.93 respectively) (Fig. 36a).  In 
depth analysis of gene expression profiles revealed an increase in 
oligodendrocyte differentiation genes and a slight decrease in Wnt signaling 
genes (Fig. 36b).  Target genes from the screen were confirmed through gene 
specific qRT-PCR, with 84.2% of the genes analyzed proving to be true 
positives (Fig. 37a).  Interestingly, among the top 15 upregulated genes in the 
Jag1FL-IRES-GFP+ cells were Erbb4, HipK2, Tnr, Enpp6, and Gpr17 all of 
which have known roles in promoting oligodendrocyte maturation (Fig. 37b) 
(Pesheva, Gloor et al. 1997, Park, Miller et al. 2001, Roy, Murtie et al. 2007, 
Czopka, Von Holst et al. 2009, Greiner-Tollersrud, Berg et al. 2013).  
Additionally, the oligodendrocyte specific genes Sox10, Myrf, NG2 and 
PDGFRα were all confirmed to be upregulated in Jag1FL-IRES-GFP+ cells 
compared to the control (Fig. 37a).  A list of transcriptome changes in Jag1FL-
IRES-GFP+ NSCs is shown in supplementary table 1. 
3.1.10 Current experiments studying	  the	  role	  of	  Jag1FL in the	  NSC	  Niche 
 Ongoing experiments performed by our collaborators Annalisa Buffo and 
Enrica Boda in Torino, Italy, are addressing the ability of Jag1FL-IRES-GFP+ 
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cells to remyelinate induced and congenital demyelinated lesions.  
Transduced cells are being grafted into both lysolecithin-induced focal 
demyelinating lesion animal models and Citron-kinase knockout (KO) mice 
(Cit-K KO) (experimental outline Fig. 38a).  The cells used in these 
experiments were transduced with Jag1FL-IRES-GFP or IRES-GFP RVs, 
sorted for GFP by FACS and delivered to the Buffo lab where the grafting 
experiments are being performed (Fig. 38b). 
 Although these are preliminary results, Jag1FL-IRES-GFP cells grafted in 
the lysolecithin experiments appear to have a better survival rate and migrate 
further to the site of the lesion based on analysis of transduced cells (Fig. 
39a,b).  Additionally, in the Jag1FL-IRES-GFP grafts, there are visually many 
more Sox10+ cells, however quantifications for this as well as migration and 
survival are still on going.  Transduced cells are densely grouped in the 
Jag1FL-IRES-GFP cell grafted animals and their processes overlapping, but 
there appears to be some CNPase co-localisation (Fig. 39d-e).  IHC for NG2 
expression is inconclusive and further optimization of stainings for early OPC 
markers will be needed (Fig. 39f-h). 
 Interestingly, analysis of the first two brains from Cit-K KO mice show  
grafted Jag1FL-IRES-GFP cells that are CNPase+ (Fig. 40a-c).  This has not 
been seen in control cell (IRES-GFP+) grafted mice, and was never observed 
in OPC grafting experiments from the Buffo lab (Fig. 40f,g).  There is still a 
large heterogeneity of cell populations, with some appearing astrocytic, and 
others early OPC (Fig. 40 d,e).  Some grafted Jag1FL-IRES-GFP cells 
expressed NG2, but quantifications are currently ongoing (Fig. 40h-k). 
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3.2 Project 2: Jag1 and the role of the JICD in bi-directional 
signaling  
3.2.1 Background 
 It has been proposed that Jag1 can signal bi-directionally as a ligand 
activating Notchs on adjacent cells and as a receptor that can be cleaved by 
secretases releasing an ICD that signals to the nucleus of the Jag1 presenting 
cell (see section 2.2.11.4) (LaVoie and Selkoe 2003, Duryagina, Thieme et al. 
2013) (unpublished lab data).  In my first project where I addressed the role of 
Jag1FL in the adult SVZ niche, it was not possible to distinguish between the 
autonomous or non-autonomous roles of Jag1.  Therefore, the aim of this 
project was to address the autonomous effects JICD may have on 
differentiation.  
 In previous experiments studying the role of Notch and Jag1 in NSCs, we 
found that Jag1 is an important ligand in the postnatal neurogenic SVZ for 
maintaining NSCs.  We found that a soluble form of Jag1 could rescue Jag1-/- 
neurospheres and expand NSCs.  In addition, soluble Jag1 not only rescued 
Jag1-/- NSCs but also increased maintenance of the stem cell state producing 
more colonies in clonal assays than Jag1-treated wild type stem cells.  This 
suggested that Jag1 has an autonomous signal in NSCs that negatively 
influences stem cell maintenance.  Interestingly, active secreted Jag1 was 
able to maintain NSCs in culture, even in the absence of EGF, the growth 
factor usually used as a mitogen in these cultures (Nyfeler, Kirch et al. 2005). 
Hence, this data suggested that Jag1 induces a signal, potentially in a cell-
autonomous fashion, that drives stem cell differentiation.  In the next part of 
my thesis I will describe experiments performed to address the cell 
autonomous role of Jag1 signaling by studying the JICD and its effect on the 
Jag1 presenting cell. 
3.2.2 JICD induces a cell autonomous loss of progenitor markers and 
stimulates differentiation genes in a PDZ dependent manner 
 Jag1-null (Jag1-/-) mice die in utero by E11.5 (Xue, Gao et al. 1999). 
Examination of the forebrain at E10 showed that Sox2+ progenitors remain but 
early neurogenesis is severely reduced in the Jag1 mutants (Fig. 41a), which 
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is in stark contrast to loss of Notch signaling where neurons differentiate 
prematurely (Yoon and Gaiano 2005). The Taylor lab previously 
demonstrated that in vitro rescue experiments with an active secreted form of 
Jag1 ectodomain was sufficient to compensate for the lost lateral signal and 
maintain wild type but not Notch1-/- NSCs in vitro (unpublished data).  More 
importantly, exogenous Jag1 could also rescue the Jag1-/- NSCs increasing 
the number of sphereogenic stem cells above that seen in controls.  
Combining the in vitro and in vivo loss-of-function data, we concluded that a 
cell-autonomous Jag1 signal mediated through the ICD could explain Jag1 
role in promoting differentiation in the forebrain. 
 Taking a gain-of-function approach I expressed the JICD in forebrain neural 
progenitors in vivo by in utero electroporation (IUE) at E13.5 (experimental 
outline Fig. 41b).  JICD expression induced a rapid and maintained exit of 
cells from the ventricular zone (Fig. 41c) and a cell-autonomous loss of 
progenitor cell markers compared to control (Sox2, Pax6 and Nestin; Fig. 41f-
h).  In contrast, JICD stimulated expression of genes associated with 
differentiation including the basal progenitor marker Tbr2 and the neuronal 
proteins β-TubulinIII and neurofilament (NF160) within 24 hours (Fig. 41i-j) but 
did not affect neuronal migration or differentiation in the cortical plate after 48 
hours (Fig. 42a-b).  The cell cycle in the nervous system is precisely 
controlled upon onset of differentiation (Gotz and Huttner 2005, Kriegstein 
and Alvarez-Buylla 2009).  JICD significantly reduced cell labeling with the S-
phase marker bromodeoxyuridine (Fig. 42c-e).  The expression of the cell 
cycle marker Ki67 was not affected suggesting prolongation of the cell cycle 
rather than exit consistent with initiation of differentiation (Fig. 42c-e).  I 
conclude from these data that JICD can promote neuronal differentiation in 
vivo. 
3.2.3 Molecular components of JICD identified through TAP and Y2H 
screens 
 In order to identify molecular components of Jag1 signaling, Antje 
Grabosch used JICD as bait and performed Tandem Affinity Purification 
(TAP) followed by mass spectroscopic proteome analysis for interacting 
proteins in a neuroblastoma cell line (N2A) and a yeast-2-hybrid screen (Y2H) 
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of a developing brain cDNA library (Fig. 43a).  Multiple clones encoding the 
Protein Interacting with C-Kinase (PICK1) were identified by Y2H and 
interaction with full-length Jag1 and the JICD was confirmed by co-
immunoprecipitation from N2A cells (Fig. 43b,c).  PICK1 binds active protein 
kinase C-alpha (PKCα) recruiting it to target proteins and the intracellular 
surface of membranes (Staudinger, Lu et al. 1997, Hanley 2008).  PKCα co-
immunoprecipitated with full-length Jag1 and JICD (Fig. 43b,c). PKCs can 
activate ADAM metalloproteases such as TACE to stimulate shedding of 
surface proteins (Merlos-Suarez, Ruiz-Paz et al. 2001). Treatment of Jag1 
expressing N2A cells with phorbol ester (PMA) to activate PKC stimulated 
translocation of PKCα to the plasmamembrane and colocalization with Jag1 
(Fig. 43d), RIP of Jag1 and generation of Jag1CTF1 (Fig. 43g,h).  Blockage of 
gamma-secretase with DAPT increased Jag1CTF1 formation (P<0.05) 
supporting the normal processing of the CTF1 fragment to release the ICD. 
Activation of PKC with PMA and concomitant DAPT treatment increased 
Jag1CTF1 levels above PMA or DAPT treatment alone (Fig. 22g,h; P<0.001).  
Surprisingly, although the ADAM inhibitor GM6001 slightly reduced Jag1CTF1 
levels, it did not completely block RIP (Fig. 43g,h).  Therefore, RIP of Jag1 is 
stimulated by PKC activation. We addressed whether PICK1 is required for 
RIP of Jag1.  We knocked-down PICK1 80% (P<0.001) with two independent 
shRNA vector constructs (Fig. 43i and not shown). In three independent 
knockdown cultures (shPICK1), PMA failed to induce JagCTF1 accumulation 
above vehicle-treated cultures (DMSO) (Fig. 43j,k; right graph) and compared 
to N2A cells expressing a control shRNA (Fig. 43j,k; left graph P<0.001).  We 
conclude that PICK1 regulates PKC-induced RIP of Jag1. 
 Interestingly, the Y2H screen also identified the binding targets Galectin-3 
and PMP2, both of which have been shown to play a role in oligodendrocyte 
maturation and myelination (Majava, Polverini et al. 2010, Pasquini, Millet et 
al. 2011).  Future co-immunoprecipitation experiments are required to confirm 
these targets. 
 Mass spectroscopic analysis of proteins associated with JICD identified the 
transcriptional regulators TBL1 and TBLR1 as well as core Histones H3, H4 
and H2A (Fig. 43a).  Antje confirmed association of TBLR1 and core Histones 
with JICD in co-purification assays (Fig. 43e,f).  She was unable to co-purify 
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TBL1 directly with JICD suggesting that TBL1 may not directly associate with 
JICD but be in a tertiary complex with other proteins. 
 TBLR1 is a key component of the Notch and Wnt pathways (Perissi, 
Aggarwal et al. 2004, Perissi, Scafoglio et al. 2008).  Antje performed 
luciferase reporter assays in HEK293 cells using the TopFlash reporter to 
measure Wnt/β-Catenin signaling (Fig. 44a).  JICD did not stimulate the 
Wnt/β-Catenin TopFlash reporter but synergized with submaximal levels of 
stabilized β-Catenin to potentiate expression of Wnt/β-Catenin target genes 
(Fig. 44b).  TBLR1 has been shown previously to be able to potentiate β-
Catenin activation of TopFlash (Li and Wang 2008).  When both TBLR1 and 
β-catenin were expressed with JICD, we found that it dramatically enhanced 
reporter expression in a synergistic fashion (Fig. 44b).  We also assessed the 
effects of JICD on an endogenous Wnt/β-Catenin target promoter Axin-2.  
Although JICD and β-Catenin did not synergize in this assay, JICD, β-Catenin 
and TBLR1 together resulted in a synergistic potentiation of Axin-2 promoter 
expression (Fig. 44c).  To explain the transcriptional modulatory effect we 
addressed whether JICD interacts with p300 and CBP but were unable to co-
immunoprecipitate either with JICD (Fig. 44d).  Similarly, we did not observe 
an interaction of JICD with TLE proteins, other key components in the Notch 
and Wnt/β-Catenin pathways (Fig. 44e).  Therefore, JICD can modulate 
transcriptional regulation of the Wnt signaling pathway, which is critical for 
development, particularly of the nervous system and in some cancers (Radtke 
and Clevers 2005). 
 As TBLR1 displayed a synergistic effect on JICD-modulated Wnt/β-Catenin 
signaling, we generated mutant proteins to map the interaction domain on the 
JICD.  Sequential truncation of 25 amino acids at the C-terminus of Jag1 (F1-
F3) and co-affinity purification revealed reduced interaction when the last 75 
amino acids were removed suggesting that this region of TBLR1 is required 
for binding to JICD (Fig. 45a,b).  When tested in reporter assays, these 
truncated JICDs had all lost their transcriptional co-stimulatory activity (Fig. 
45c,d and not shown).  In addition, although the JICD-F1 fragment was still 
able to bind TBLR1, TBLR1 co-expression failed to rescue the function of this 
mutant (Fig. 45c).  Thus, the C-terminal 25 amino acids contain a functionally 
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important domain that mediates JICD effect in modulating Wnt/β-Catenin 
transcription independent of TBLR1 interaction.  
 We deleted the PDZ-ligand from the C-terminus of the JICD (JICDdelPDZ) 
to address whether this affected co-stimulatory function.  JICDdelPDZ 
localized to the nucleus (Fig. 46a) but failed to potentiate β-Catenin induced 
transcription (Fig. 46b) indicating that the synergistic activity of JICD on β-
Catenin mediated transcriptional regulation resides in the PDZ-ligand domain.  
We postulated that PDZ proteins are involved in JICD function.  We never 
observed a direct interaction of JICD with β-Catenin in co-immunoprecipitation 
assays (not shown).  Based on our link between PICK1/PKCα and JICD, we 
addressed whether the function of JICD in transcriptional modulation requires 
PKC activity.  Inhibiting PKCα with RO 32-0432 in the TopFlash assay 
dramatically reduced the JICD/TBLR1 potentiated activity of β-Catenin (Fig. 
46c).  Surprisingly, inhibition of PKCα also reduced β-Catenin signaling, the 
mechanism of which remains to be elucidated but suggests that PKCα is a 
key regulator of β-Catenin transcriptional activity and that JICD functions as a 
co-regulator to increase this activity (Fig. 46c).  Thus, PKC promotes RIP of 
Jag1 but also cooperatively regulates JICD and β-Catenin activity. 
 Next, I addressed whether the phenotypic effect of JICD to promote 
differentiation in vivo is also dependent on the PDZ-ligand domain. 
JICDdelPDZ did not induce exit of NSCs from the ventricular zone or 
differentiation of neural progenitors when expressed in vivo (Fig. 46d-g) 
Therefore, the differentiation effect of JICD and the autonomous Jag1 signal 
was dependent upon PDZ-mediated protein interaction.  This supports 
previous observations that the transforming effect of Jag1 is PDZ-dependent 
and suggests that this may be through activation of β-Catenin signaling 
(Ascano, Beverly et al. 2003). The PDZ adapter protein AF-6 was shown to 
bind to JICD in a Y2H screen where AF-6 was used as bait (Hock, Bohme et 
al. 1998).  AF-6 binds a number of proteins including Ras in a PDZ-
independent manner.  We did not identify AF-6 in our Y2H or TAP assays with 
JICD as bait.  However, it is possible that Jag1 could, in addition, signal 
through AF-6 to regulate other downstream pathways.  Further experiments 
will be required to address potential cross-talk between AF-6 and JICD and 
TBLR1 in the regulation of β-Catenin. 
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3.2.4 Basis for ChIP-Seq experiments  
 Taking together the in vitro and in vivo data, I proposed that the Jag1 
signaling pathway is a hub for the regulation of one or more signal 
transduction pathways involved in NSC differentiation.  I hypothesized that 
Jag1 is a signal integrator modulating neural progenitor fate and driving the 
onset of differentiation in the developing brain.  Previously we had shown that 
JICD could interact directly with histones (Fig. 43e,f).  As a follow up 
experiment, I performed a subcellular fractionation of N2A cells expressing 
either JICD-eGFP or eGFP as a control (experimental outline Fig. 47a) to 
observe where JICD was localized in the cell.  Although JICD was present in 
the cytoplasm of cells, most of the JICD was in the nucleus due to the basic 
nuclear localization sequence (Introduction Fig. 10) and the majority of the 
JICD was bound to chromatin providing direct support that JICD plays a role 
in transcriptional regulation (Fig. 47b). 
 Since JICD was chromatin bound, I hypothesized that it may be binding to 
the promoters of genes, resulting in the regulation of their expression.  To 
address transcriptional targets of the Jag1 signaling pathway in vitro, I 
performed chromatin immunoprecipitation (ChIP) followed by ChIP-
Sequencing (ChIP-Seq) (experimental outline Fig. 47c,d).  Although JICD has 
no known DNA binding domain, it may act by forming a transcriptional 
complex by binding to partners that bind DNA.  This would also support our 
data that shows JICD can bind through PDZ-mediated protein interactions.  
Due to a lack of JICD specific ChIP grade antibodies, I used a JICD construct 
with an N-terminal tandem affinity purification (TAP) tag.  This allows for 
efficient purification of bound protein using streptavidin resin.  Based on our 
previous Wnt signaling luciferase reporter data, I was curious to see if the 
binding affinity for promoter sequences would change or shift when JICD was 
expressed with either an active form of β-Catenin alone or when β-Catenin 
and TBLR1 were both present.  I established ChIP conditions by optimizing 
crosslinking, DNA sonication to ensure sheared DNA fragment sizes were 
200-300bp and reverse-crosslinking to release the ChIPed DNA fragments 
(Fig. 47h).  ChIPs were performed in parallel from N2A cells under four 
transfection conditions, empty N-TAP expression vector, JICD-NTAP 
expression vector alone, JICD-NTAP and an active form of β-Catenin 
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together, or JICD-NTAP, β-Catenin and TBLR1 transfected simultaneously.  
Sister plates of N2A cells were transfected in parallel to the ChIP experiments 
for RNA isolation to assess transcriptional expression profiles by qRT-PCR. 
 Since our luciferase data demonstrated that JICD in combination with β-
Catenin and TBLR1 could potentiate Axin2, transcript levels of Axin2 were 
verified from sister plates by qRT-PCR before performing JICD-NTAP ChIP 
(Fig.  47f).  When JICD and TBLR1 were expressed with submaximal levels of 
β-Catenin, Axin2 expression was potentiated in the N2A cells reconfirming the 
luciferase findings (Fig 44b,c).  Interestingly, western blot analysis on sister 
plate lysates showed an upregulation of Jag1 under both JICD-NTAP, β-
Catenin and JICD-NTAP, β-Catenin, TBLR1 conditions, hinting that the JICD 
may directly or indirectly regulate expression of the endogenous Jag1 gene 
(Fig. 47g).  In total, three individual ChIPs were sequenced by Illumina next 
generation sequencing, with samples summarized in Fig. 47i (see Fig 48 for 
Illumina HiSeq2000 workflow). 
3.2.5 Analysis of JICD ChIP experiments 
 ChIP-Seq was performed at the Quantitative Genomics Facility of the 
University of Basel, Switzerland.  Sequence alignment to the genome and 
model-based analysis of ChIP-Seq data (MACS) was performed by Robert 
Ivanek, at the bioinformatics service of the Department of Biomedicine at the 
University of Basel.  Cross-analysis of promoter peak enrichment amongst 
replicate samples was carried out to compare the similarity of samples (Fig. 
49).  Additionally, the number of mapped and unique reads per sequencing 
sample was measured (Fig. 50 and 51).  A high variability in the sequences 
from the samples replicates likely reflected the indirect binding of the JICD 
with chromatin and that the JICD most likely binds through an interaction 
partner.  Peaks were compiled using a union of peaks, which combines any 
replicates that have 1 or more base pair (bp) overlapping.  Peaks with a log2 
value of greater than 0.6 (compared to input) were then cross-compared to 
other ChIP samples, and peaks unique for each treatment were compiled 
(experimental outline Fig. 52a and summary of peaks supplementary table 2).  
Genes containing enrichment in their promoters were then screened using the 
GO database to organize targets by function and pathway significance (Fig. 
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52b).  qRT-PCR primers were designed for these specific gene targets to 
determine their relative expression levels in each treatment conditions.  
Finally, peak specific primers were designed and tested by ChIP-PCR on 
genes that exhibited a positive enrichment in JICD-NTAP/β-Catenin/TBLR1 
treatments (quantitative ChIP PCR). 
3.2.6 Confirmed targets identified by the JICD ChIP 
 Analysis of promoter specific peaks identified enrichment for the GO 
categories central nervous system myelination and Wnt targets (Fig. 52b).  
qRT-PCR of Wnt target genes containing peaks in their promoters revealed 
enrichment for Axin2, Lgr5, Lef1, and Id2 in the JICD-NTAP/β-Catenin/TBLR1 
treatment.  I hypothesized that potentially the affinity of DNA binding sites for 
JICD, shifted when co-expressed with β-Catenin and TBLR1.  Therefore I 
designed JICD treatment peak specific primers for the promoter region of 
Axin2 as well as peak specific primers for a peak only found in the JICD-
NTAP/β-Catenin/TBLR1 treatment  (see Fig 53 and 54a).  Primers were 
tested and validated based on their qRT-PCR melting curves and their 
specificity for only one PCR product.  Peak enrichment was quantified by 
quantitative ChIP PCR run on ChIP elutes from all four treatments and the 
input samples.  Although the JICD treatment specific peak was not enriched 
for, the JICD-NTAP/β-Catenin/TBLR1 treatment peak showed almost 5-fold 
enrichment over JICD treatment alone.  Taken together with the Axin2 
potentiation data, this would suggest that when JICD, β-Catenin, TBLR1 are 
expressed together, JICD can bind to the promoter region of Axin2, and 
directly upregulate its expression.  Similarly, using peak specific primers for 
the JICD-NTAP/β-Catenin/TBLR1 treatment, peaks in the promoters of Lgr5, 
Lef1 and Id2 were all confirmed (Fig. 54b-d).  This is clear evidence that 
together with β-Catenin and TBLR1, JICD can be enriched at the promoter 
sequences of Wnt target genes, resulting in their direct regulation. 
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3.2.7 Figures	  
 
 
 
 
 
 
 
 
 
 
Figure 20 
Results 
79 
  
Figure 21 
 80 
  
Figure 22 
Results 
81 
 
  
Figure 23 
 82 
 
  
Figure 23 Continued 
Results 
83 
 
  
Figure 24 
 84 
 
  
Figure 25 
Results 
85 
 
  
Figure 26 
 86 
 
  
Figure 27 
Results 
87 
 
  
Figure 28 
 88 
 
  
Figure 29 
Results 
89 
 
  
Figure 30 
 90 
 
  
Figure 31 
Results 
91 
 
  
Figure 32 
 92 
 
  
Figure 33 
Results 
93 
 
  
Figure 34 
 94 
 
  
Figure 35 
Results 
95 
 
  
Figure 36 
 96 
 
  
Figure 37 
Results 
97 
 
Figure 38 
 98 
Figure 39 
Results 
99 
  
Figure 40 
 100 
 
 
 
  
Figure 41 
Results 
101 
 
  
Figure 42 
 102 
 
  
Figure 43 
Results 
103 
  
Figure 44 
 104 
  
Figure 45 
Results 
105 
  
Figure 46 
 106 
 
 
Figure 47 
Results 
107 
  
Figure 48 
Figure 49 
 108 
 
 
 
 
  
Figure 50 
Results 
109 
 
  
Figure 51 
 110 
 
  
Figure 52 
Results 
111 
 
  
Figure 53 
 112 
 
  
Figure 54 
Results 
113 
 
  
Supplementary table 1 
 114 
 
  
Supplementary Table 1: Continued 
Results 
115 
 
  
Supplementary Table 1: Continued 
 116 
 
  
Supplementary Table 1: Continued 
Results 
117 
 
  
Supplementary Table 2: 
 118 
 
  
Supplementary Table 2: Continued 
Results 
119 
3.2.8 Figure	  Legends	  
Figure 20: Design and establishment of the AAV-Jag1FL viral system.  (a) In 
situ RNA hybridization for Jag1 in E13.5 telencephalon demonstrating that 
Jag1 mRNA is broadly expressed in the embryonic mouse telencephalon 
including in the (VZ), subventricular zone (SVZ) and cortical plate (CP).  Along 
the telencephalic vesicle (tel v) and the lateral ganglionic eminence (LGE), 
Jag1 is expressed in a “salt and pepper” like distribution.  (b) At higher 
magnification Jag1 RNA is seen throughout the VZ and SVZ and also in cells 
within the cortical plate.  (c and d) Jag1 is localized to the apical side of 
neural progenitors in the developing telencephalon (tel) of the forebrain at 
embryonic day 13.5 (arrowheads).  This confirms the mRNA expression 
patterns seen within the cortical plate.  (e) Design of the pAAV-Jag1 full-
length (FL) construct, containing the entire Jag1 coding sequence between 
both LTR sites.  (f-h) pAAV-Jag1FL was transfected and grown in HEK-293 
cells and then quantified after purification. (i) IHC for Jag1 in transfected HEK-
293 cells using two different Jag1 antibodies.  (j) IHC for Jag1 in transduced 
HEK-293 cells (k) Transduced NSCs with control neurospheres expressing an 
endogenous GFP reporter.  (l) IHC for Jag1 in transduced neurospheres. 
Scale bars = 20µm. 
 
Figure 21: Design and establishment of the pMIG-Jag1FL retroviral system.  
(a) pMIG-Jag1FL construct was cloned containing the entire coding sequence 
of Jag1 and includes an IRES-GFP reporter. (b and c) Relative expression 
levels of Jag1 transcript and protein levels in transduced NIH3T3 and N2A cell 
lines respectively.  (d) Experimental overview for transduction experiments.  
First establish in vitro transduction is working efficiently and then test to 
ensure it can transduce NSCs.  Then go to in vivo models to study the role of 
Jag1FL on the stem cell niche.  (e and f) Transduction of NIH3T3 fibroblasts 
with both control IRES-GFP and Jag1FL-IRES-GFP viruses and stained for 
Jag1.  (g and h) Transduced NSCs with both control IRES-GFP and Jag1FL-
IRES-GFP viruses and stained for Jag1.  Scale bars = 20µm 
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Figure 22: Initial transductions of postnatal mice.  (a) Experimental outline of 
the time-course used in the stereotactic viral injection experiments.  Using 
predefined coordinates, stereotactic injections were performed in P2 mice and 
then chased for 3, 7, 15 or 30 days post infection (DPI). (b) Initial images from 
the cortex of a Jag1FL 30 DPI mouse, stained for Jag1 and Olig2. (c) Jag1FL 
transduced cortical cells express Sox10 by 30 DPI.  Scale bars = 20µm 
 
Figure 23: Time-course of Jag1FL transduced mice at  (a) 3 DPI, (b) 7 DPI, 
(d) 15 DPI, and (e) 30 DPI.  (c) Quantification of average migration distance 
of transduced cells in the corticies of 7 and 15 mice.  p=0.02;  Scale bars = 
200µm 
 
Figure 24: 30 DPI Jag1FL transduced cells upregulate the oligodendocyte 
markers Olig2 and Sox10 in all regions analyzed (a) Cortex (b) Striatum (c) 
Corpus Callosum. (d) Quantifications of the number of transduced cells by 
region which are Olig2+/Sox10+. n = 2; Scale bars = 20µm 
 
Figure 25: in vivo Jag1FL expression results in the significant upregulation of 
Sox10.  (a) By 30 DPI, Sox10 is upregulated in all regions brain regions 
containing Jag1FL-IRES-GFP+ cells (CC = Corpus callosum, Ctx = Cortex, Str 
= Striatum).  (b) This change in Sox10 expression is already significant by 15 
DPI with almost twice as many Jag1FL-IRES-GFP+Sox10+.  (c) Jag1FL-IRES-
GFP+Sox10+ cells analyzed by neural region, over the course of a 30 day 
time-chase. n=3 
 
Figure 26: Largest shift in Jag1FL-IRES-GFP+Sox10+ populations seen in the 
cortex.  (a and b) Jag1FL-IRES-GFP+Sox10+ expression plotted by region 
over time.  Significant shifts from control treated mice are demonstrated in 
corticies from as early as 3 DPI, and becomes more pronounced until 15 DPI 
where it eventually plateaus at just below 80% Jag1FL-IRES-GFP+Sox10+. 
n=3 
 
Figure 27: Summary of shift in Jag1FL-IRES-GFP+Sox10+ populations.  (a) 
Representative images of counts used in quantifying transduced cells from 
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figures 5 and 6.  (b) Shift of Jag1FL-IRES-GFP+Sox10+ are summarized in 
this diagram  with dark blue containing low densities of Sox10+ transduced 
cells and red representing high densities. Scale bars = 200µm 
 
Figure 28: Jag1FL-IRES-GFP+Sox10+ cells express the early oligodendrocyte 
marker NG2 but not PDGFRα or the neuronal marker Dcx.  (a) Representative 
images of Jag1FL-IRES-GFP+Sox10+NG2+ cells in the cortex.  (b) 
Quantifications were performed in the corticies of 7 DPI mice and (c) showed 
a significant increase in Jag1FL-IRES-GFP+Sox10+NG2+ cells.  (d) However 
another early oligodendrocyte marker PDGFRα, (e) or the neuronal marker 
Dcx could not be detected by 30 DPI.  Arrows in D and E point to Jag1FL-
IRES-GFP- and IRES-GFP- cells but positive for PDGFRα and Dcx 
respectively.  n=3, Scale bars = 20µm 
 
Figure 29: Mature oligodendrocyte markers are expressed by Jag1FL-IRES-
GFP+ cells.  (a) Jag1FL-IRES-GFP+Sox10+CNPase+ cells are found 
frequently in the cortex of 15 DPI mice (white arrow heads) and very rarely in 
control treated mice.  (b) They are prevalent still in 30 DPI corticies.  By 30 
DPI, many are co-positive for MBP in the striatum. Ctx – Cortex; Str – 
Striatum; CC – Corpus callosum. Scale bars = 20µm 
 
Figure 30: Mature oligodendrocyte marker MBP is expressed by Jag1FL-
IRES-GFP+ cells. (a-c) Representative images of transduced cells in each 
neural region.  (d) Overview of Ki67 analysis done in the corpus callosum of 7 
DPI corticies.  (e) No change was seen in proliferation as measured by the 
expression of the cell cycle marker Ki67. Scale bars = 20µm 
 
Figure 31: Jag1FL expression results in a loss of NSC maintenance.  (a) 
Outline of proliferation assay performed in NSCs (b) Representative images 
of the variety of transduction levels seen in neurospheres.  (c) Sphere forming 
capacity as measured by percentage of spheres formed from the cells plated.  
(d) Thymidine labeling experiments showed no noticeable differences in 
Jag1FL treated NSCs compared to control.  Percentages converted to arcsin 
values for student t-test calculations.  n=3, Scale bars = 20µm 
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Figure 32: Jag1FL expression results in an upregulation of oligodendrocyte 
lineage genes.  (a) Outline of NSC differentiation assay. (b) Representative 
colonies after being grown for 7 days under differentiating conditions. (c) qRT-
PCR confirmed that colonies upregulate genes associated with differentiating 
oligodendrocytes, including the essential transcription factors Olig2, Sox10 
and Myrf.  (d) Colonies were quantified by if they expressed a marker or not.  
Although both colonies express the marker O4 at the same frequency, there 
was a loss of colonies expressing GFAP and β-TubIII (β-TubulinIII). (e) 
Representative images of differentiated NSC colonies stained for Jag1, O4, 
BTubIII and Olig2.  Small white circles represent location in the differentiating 
colony where image was photographed.  n=3, Scale bars = 20µm 
 
Figure 33: Sequencing of Jag1FL transduced NSC transcriptomes.  (a) 
Outline of Jag1FL RNA-Seq experiment. (b) NSCs were sorted based on GFP 
from the IRES-GFP in both the control and Jag1FL viruses.  Shown are 
representative FACS sorting gates and (c) a report of total cells sorted for 
RNA sequencing. n=2 
 
Figure 34: FastQC reports confirm that RNA sequencing of samples went 
correctly. (a) Quality scores of reads across all base pairs in each sample.  (b) 
Report of total reads (millions), unique reads (%), Passed filters (%) and % of 
sequences aligned per sample.  
 
Figure 35: Cross-analysis of RNA-Seq replicates. (a) Comparison of % 
similarity of RNA-Seq replicates to one another. (b) Transcriptome 
comparison of Jag1FL treated NSCs to control NSCs.  Thresholds were set at 
+/- Log2 fold change of 1, with Log2counts per million reads plotted on the x-
axis. 
 
Figure 36: Jag1FL treated NSCs express genes associated with 
oligodendrocyte maturation and myelination. (a) Summary table of the top 10 
gene ontology (GO) categories upregulated in Jag1FL treated NSCs.  
Although not in the top 10, there were also significant odds ratios for both 
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oligodendrocyte development and differentiation. (b) Changes in genes 
involved in oligodendrocyte differentiation, maturation and myelination are 
grouped based on early, intermediate, or late expression (Introduction Fig. 16) 
(c) Wnt signaling genes were largely unchanged, however a notable decrease 
was seen in Wnt3.  
 
Figure 37: Summary of target genes identified in RNA-Seq.  (a) Lysates from 
NSCs prepared in parallel to the RNA-Seq samples were used to confirm 
targets by qRT-PCR.  Although expression levels of Olig2 did not change 
significantly (data not shown) interestingly Sox10 levels increased nearly 3 
fold. (b) New lysates prepared in a similar fashion to those used in the RNA-
Seq, but not in parallel, confirmed additional targets such as Myrf and 
PDGFRα, however the relative fold changes are far more exaggerated (n=3 
biological replicates).  (c) Table summarizing the top 15 genes upregulated in 
Jag1FL treated NSCs.  Genes with stars are of particular interest due to their 
reported positive roles in promoting oligodendrogenesis.  Through qRT-PCR 
analysis, 84.21% of genes identified in the screen were true positives. 
 
Figure 38: Summary of an on going collaboration examining the ability of 
grafted Jag1FL-IRES-GFP+ NSCs to remyelinate in vivo.  (a) Overview of 
current experiments using both lysolecithin lesion treated mice and citron-
kinase KO mice (For full summary see 0) (b) Representative images of NSCs 
used in grafting experiments, before and after FACS sorting.  Scale bars = 
20µm 
 
Figure 39: Initial results from the first lisolecithin treated mice.  (a) Overview 
images from a Jag1FL-IRES-GFP+ NSC grafted mouse (b) and an IRES-GFP 
control grafted mouse.  (c-e) Jag1FL-IRES-GFP+ express CNPase which is 
not seen in control grafted cells. (f-h) Jag1FL-IRES-GFP+NG2+ cells are 
present and not seen in control grafted cells. Scale bar = 20µm 
 
Figure 40: Initial results from the first Cit-K KO mice.  (a) Overview of 
Jag1FL-IRES-GFP+ grafted cells which (b-c) express the mature myelinating 
marker CNPase.  (d-e) Populations of cells in Jag1FL-IRES-GFP+ grafted 
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mice are quite heterogeneous and some appear more astrocytic.  (f-g) Control 
grafted cells do not express CNPase. (h-i) Jag1FL-IRES-GFP+ grafted cells 
express NG2 (j-k) which is not seen in control grafted cells. Scale bar = 20µm  
 
Figure 41: Jag1 signals through its ICD to regulate neurogenesis.  (a) 
Embryonic day 10 Jag1-/- mice show maintained neural progenitors (Sox2+) 
and reduced neurons (β-TubulinIII+) in the dorsal telencephalon compared to 
wild type littermates (wt). Note also the reduced β-Tub expression in the 
ventral telencephalon and in the hindbrain (hb) (data not shown). (Photo by 
Marion Rukavina) (b) Transfection of the lateral ventrical wall of E13.5 
embryos using IUE. (c and d) Expression of JICD or JICD-GFP fusion in 
neural progenitors in vivo causes a precocious exit from the VZ to the SVZ/IZ 
(P<0.05). (e-i) JICD expressing cells down regulate progenitor marker 
expression (P<0.05* and <0.001**) and activate basal progenitor (Tbr2) and 
neuronal gene expression (β-TubIII/NF160) (P<0.001). LV - lateral ventricle; 
LGE - lateral ganglionic eminence. Scale bars = 20µm.  
 
Figure 42: (a) Even though JICD induces precocious differentiation within 24 
hours, and this is maintained, JICD expressing cells progress and differentiate 
into Tbr1+ neurons. Tbr1 expression of transfected cells (green) 48 hours 
post-electroporation. (b). Quantification shows no difference in Tbr1 
expression between control and JICD expressing cells, indicating that JICD 
expressing cells are still able to go through a normal differentiation program.  
(c-f) JICD expression reduces the number of cells passing though S-phase 
22-24 hours post-electroporation but does not induce cell cycle exit. (c) 
Scheme showing the BrdU labeling paradigm after transfection. Twenty-two 
hours after IUE, a single dose of BrdU was given intraperitoneal to the 
mother. Embryos were isolated three hours later.  (d) Combined staining of 
cell cycle marker Ki67 (to mark cells in the cell cycle) and S-phase label BrdU 
in JICD (left) and GFP-only (right) transfected cells in the developing 
forebrain. (e) Quantification of BrdU incorporation revealed that less JICD 
expressing cells passed through S-Phase between 22-24 hours post-
electroporation. (f) Quantification of the transfected cells expressing the cell 
cycle marker Ki67 indicated that JICD expressing cells remain in the cell 
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cycle. However, combining Ki67 and BrdU revealed that the cell cycle length 
on divining JICD expressing cells is extended.  VZ - ventricular, SVZ- 
subventricular zone and CP - cortical plate. Scale bars =  20µm. P<<0.001. 
 
Figure 43: (a-c) Identification of JICD binding partners and JICD directly 
regulates the Wnt target Axin2. (a) A subset of JICD interacting proteins 
identified in the Yeast-2-Hybrid (Y2H) and Tandam Affinity Purification (TAP) 
screens. (b) Confirmation that full length Jag1 can interact directly with PICK1 
and PKCα by co-immunoprecipitation.  Both are critical in mediating regulated 
intramembrane proteolysis of Jag1.  (c) Both PICK1 and PKCα were 
confirmed to also bind JICD. (d) PKCα translocates to the plasma membrane 
and colocalizes with Jag1 upon stimulation with phorbolester (PMA). Full-
length (FL) Jag1 GFP fusion is expressed at the cell membrane of transfected 
HEK293 cells. Endogenous PKCα is distributed in the cytoplasm (mock) and 
translocates to the plasma membrane where it co-localizes with Jag1FL only 
upon activation with PMA. (e) JICD interacts with TBLR1 (f) and core 
Histones including H3. (g-k) Jag1 undergoes RIP in vivo, which is controlled 
by PICK1 and PKCa. (g and h) Jag1 is a substrate for RIP to generate Jag1-
CTF1 and JICD. Blockage of gamma-secretase increases CTF1 accumulation 
(P<0.05*) and phorbol ester (PMA) activation of PKC stimulates RIP of Jag1 
(P<0.001**). (i, j and k) An 80% shRNA knockdown of PICK1 (P<0.001**) 
abolishes PMA-induced RIP and accumulation of Jag1-CTF1 compared to 
control shRNA (ctrl sh) expressing cells (P<0.001**).  All data provided by 
Antje Grabosch. Scale bar = 5 µm. 
 
Figure 44: (a) Endogenous Axin2 and synthetic TopFlash luciferase reporters 
used in studying JICDs ability to potentiate of Wnt signaling (b) JICD 
potentiates stabilized β-Catenin activity on the TopFlash Luciferase reporter 
and (c) synergizes with TBLR1 and β-Catenin to potentiate activity of the 
Axin2 promoter (blue bar). (d) Neither p300 nor CBP copurified with JICD. (e) 
Tle1, Tle2 or Tle3 did not copurify with JICD. 
 
Figure 45: (a and b) The JICD contains a nuclear localization signal (RKRRK) 
downstream of the gamma-secretase cleavage site and a C-terminal PDZ-
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ligand (YIV). C-terminal truncations (F1-F3) revealed that the TBLR1 
interaction domain likely lies in the middle of the protein and deletion of the C-
terminus does not affect TBLR binding. (c) Although able to bind TBLR1, 
JICD-F1 has lost its ability to potentiate β-Catenin activity even in the 
presence of TBLR1 (blue bar). (d) The C-terminal 25 amino acids of JICD are 
required for the JICD-mediated potentiation of β-Catenin-mediated 
transcription.  HEK 293 cells were transfected with the Wnt-reporter TopFlash, 
pRL Renilla luciferase expression plasmid, sub maximal levels of constitutive 
active β-Catenin, TBLR1 expression vector, vectors expressing JICD or JICD 
truncation mutants (F1-F3). Truncation of JICD at the C-terminus blocked 
transcriptional potentiation even in the presence of TBLR1 although the 
truncated JICD proteins are able to bind TBLR1. Luciferase activity was 
determined 48 hours post-transfection. The graphs show representative mean 
values from three independent experiments performed in triplicate. All values 
are normalized to the transfection control Renilla luciferase values. 
 
Figure 46: The PDZ-ligand domain of Jag1 and the PDZ domain of PICK1 
are critical for their induction of neurogenesis. (a) JICD PDZ-ligand deletion 
mutant (JICDdelPDZ) still localizes to the nucleus of transfected cells. (b) 
JICDdelPDZ does not potentiate Wnt/β-Catenin dependent transcription. (c) 
Blockage of PKCα activity (RO 32-0432) severely reduces the effect of JICD 
on Wnt/β-Catenin signaling. (d-g) JICDdelPDZ does not induce loss of 
progenitor marker expression, exit from the ventricular zone (VZ), or induction 
of basal progenitor (Tbr2) or neuronal genes (Tbr1) and over expressing cells 
mature normally. 
 
Figure 47: JICD is directly bound to chromatin. (a) Subcellular fractionation of 
N2A cells transfected with JagICD-eGFP or the eGFP control plasmid.  (b) 
Provides direct evidence that JICD is bound to chromatin.  Therefore to 
determine binding locations a (c) Chromatin immunoprecipitation (ChIP) 
followed by deep sequencing was performed. (d) Experimental outline of the 
ChIP protocol. (e) In parallel, sister plates of N2A cells were transfected to 
analyse gene transcripts by qRT-PCR. (f) Axin2 potentiation by JICD, 
stabilized β-Catenin, and TBLR1 was confirmed in transfected N2As. (g) JICD 
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expression was confirmed at the protein level.  (h) ChIP settings were 
optimized, including Covaris sonication shearing times. (i) A summary of ChIP 
samples sent for sequencing.  Samples from three independent ChIPs were 
sequenced.   
 
Figure 48: Workflow for Illumina HiSeq2000 sequencer. (Image from (Illumina 
2011)) 
 
Figure 49: Heat map comparison of promoter enrichment in all ChIP samples 
sequenced.  Although low levels of similarity was seen amongst ChIP 
replicates, there were still peaks shared amongst multiple replicates. 
 
Figure 50: A summary of all reads that mapped to the mouse genome in 
ChIP samples. 
 
Figure 51: A summary of unique reads per ChIP sample. 
 
Figure 52: The process of target discovery in JICD ChIP-Sequencing. (a) 
Outline of how ChIP-Seq analysis was performed. (b) Gene ontology (GO) 
category analysis showed an enrichment for both the promoter of Wnt target 
genes and genes involved in myelination. (c) Targets were chosen and 
relative expression levels screened by qRT-PCR of cDNA generated from 
sister transfected plates.  In the treatment where JICD-NTAP/β-
Catenin/TBLR1 were co-expressed, upregulation of Axin2, Lgr5, Lef1 and Id2 
was measured. 
 
Figure 53: Analysis of peaks using UCSC and Washington genome 
browsers.  (a) Peaks specific for both JICD alone and JICD-NTAP/β-
Catenin/TBLR1 co-expressed were identified for Axin2 in the immediate 
promoter region.  (b) Peaks specific for JICD-NTAP/β-Catenin/TBLR1 co-
expression identified in Lgr5. 
 
Figure 54: JICD can be enriched at the promoters of Wnt target genes in the 
presence of β-Catenin and TBLR1. Peak specific primers were designed and 
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tested on genomic DNA before performing quantitative ChIP PCR on ChIP 
elutes.  In (a) Axin2 (b) Id2 (c) Lef1 and (d) Lgr5, peak specific enrichment 
could be detected in JICD-NTAP/β-Catenin/TBLR1 ChIP samples, suggesting 
that JICD is bound and contributing to regulation of these genes. 
 
Supplementary Table 1: Summary of findings in RNA-Seq, grouped by 
signaling pathway and function.  For genes that have verified, the qRT-PCR 
result is listed next to the predicted relative expression. 
 
Supplementary Table 2: Summary of ChIP-Seq peaks identified by the 
screen outlined in Fig. 31.  Peaks are organized by treatment, with the 
number of times the peak occurs in the promoter of each gene.  Additionally, 
inter-comparison of ChIP treatments shows if the peak is present in other 
sample (true) or not (false).  J – JICD; JB - JICD-NTAP/β-Catenin, JBT - 
JICD-NTAP/β-Catenin/TBLR1. 
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4 Discussion 
4.1 Jag1FL in the role of NSC niche maintenance 
4.1.1 Jag1FL	  as	  a	  key	  regulator	  of	  stem	  cell	  fate	  
 In this project, AAV and RV were engineered to study the gain-of-function 
effects of Jag1FL in the NSC niche.  AAVs are well suited for gene delivery 
because they can transduce both dividing and non-dividing cells, making them 
an optimal candidate for targeting quiescent stem cell populations in the 
niche.  Live virus production requires a high transfection efficiency of AAV-293 
packaging cells (Fig. 20F) since cells must be simultaneously transfected with 
the pAAV-RC and the pHelper plasmids.  Although high tranfection efficiency 
was achieved, low titers of AAV-Jag1FL virus were obtained, which could be 
due to difficulties in packaging the long viral DNA transcript.  Additionally, it 
has be shown that AAV viruses can stably incorporate into the genome of 
host cells in approximately 15% of the infection events, resulting in a high 
transient but relatively low stable transduction rate.  RVs however can only 
transduce and incorporate their genome into proliferating cells and integration 
is a prerequisite for expression, but they can accommodate longer DNA 
fragments (Deregowski and Canalis 2008).  Due to this, I was able to 
integrate an internal ribosome entry site (IRES) and reporter protein (GFP) for 
monitoring viral infected cells.  In vivo, this allowed for RV transduced cells to 
be lineage traced based on GFP expression. 
 Once established, these tools allowed me to study the effects of a Jag1FL 
gain-of-function in the NSC niche.  Surprisingly, expression of Jag1FL-IRES-
GFP resulted in a fate shift of transduced cells to the oligodendrocyte lineage 
as measured by Sox10 expression (Fig. 25,26).  Sox10 was used in this study 
as a marker for oligodendrocytes since there are no known Sox10- 
oligodendrocyte lineages (Kessaris, Fogarty et al. 2006).  Additionally, initial 
analysis demonstrated that all Sox10+ transduced cells were also Olig2+, 
which is another key transcription factor in oligodendrogenesis (Results Fig. 
24, Introduction Fig. 14).  To determine where this fate shift may be occurring, 
I performed a time course analysis for 30 DPI.  By 15 DPI mice exhibited 
almost twice as many Jag1FL-IRES-GFP+Sox10+ cells in the cortex as 
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compared to controls.  This increase was mirrored in the striatum and corpus 
callosum.  This fate shift was reproduced in vitro with NSC cultures where 
both a decrease in sphere forming capacity (a sign of differentiation), and an 
increase in oligodendocyte markers was demonstrated for Jag1FL-IRES-
GFP+ NSCs.  Taken together this would imply that Jag1FL expression results 
in a fate switch to differentiated oligodendrocytes.   
 Approximately 40% of Jag1FL-IRES-GFP+Sox10+ cells in the cerebral 
cortex at 7 DPI expressed the early OPC marker NG2.  A difference of 
approximately 15% seen in the total percentage of Sox10+ transduced cells 
that were NG2+ when compared to the control may hint that these cells have 
already downregulated NG2 and progressed to a more mature state.  
Furthermore, no Jag1FL-IRES-GFP+ cells were identified with the OPC 
marker PDGFRα 30 DPI in vivo, supporting that they had progressed to a 
later stage of maturation or suggesting that they were derived from a 
PDGFRα- lineage of oligodendrocytes (Spassky, Goujet-Zalc et al. 1998, 
Spassky, Heydon et al. 2001).  However, approximately 30% of Jag1FL-
IRES-GFP+ cells at 15 DPI were not Sox10+, which leads me to ask what 
these remaining cells are?  Analysis is ongoing but in the cerebral cortex 
many of these cells have astrocytic morphologies.  
 Oligodendrocyte maturation can be measured through temporally 
expressed cell markers (Fig. 16).  The myelinating oligodendrocyte markers 
MBP and CNPase were both used to address if transduced cells progress to 
later stages of maturation.  Both MBP+ and CNPase+ Jag1FL-IRES-GFP+ 
cells were identified throughout the cerebral cortex, corpus callosum and 
striatum suggesting that they were actively myelinating.  Quantifications are 
currently ongoing, however this myelinating phenotype was not observed so 
frequently in control transduced cells at 15 DPI, particularly in the cortex. 
 Although there was a striking phenotypic increase in myelinating 
oligodendrocytes (based on morphology and IHC) induced by Jag1FL-IRES-
GFP+ 30 DPI, this is not the first study that proposed Jag1 might play a role in 
promoting remyelination (Seifert, Bauer et al. 2007).  Seifert and colleagues 
identified that astrocytes present Jag1 at the site of both actively 
demyelinating and remyelinating lesions in mice (Seifert, Bauer et al. 2007).  
However, they showed that remyelinating lesions contain far more Jag1+ 
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astrocytes than demyelinating lesions.  Additionally, Notch receptor 
expression was present in lesions that were remyelinating and not in non-
remyelinating lesions (Seifert, Bauer et al. 2007).  
 Contrary to these findings there has been a long-held belief that Jag1+ 
reactive astrocytes play a negative role in remyelination.  A recent publication 
from Hammond and colleagues demonstrates that through induction of Jag1 
by the soluble Endothelin-1, Notch activity increases in OPCs at the site of 
lesions and results in a decrease of remyelination (Hammond, Gadea et al. 
2014).  Interestingly, in OPCs with the Notch1 receptor specifically KO in adult 
mice, no noticeable differences were seen in remyelination efficiency, 
suggesting that Notch or other members of the Notch family are not a rate-
limiting determinant of remyelination (Stidworthy, Genoud et al. 2004).  These 
conflicting results raise the interesting possibility that the role of Notch 
signaling is much more complicated in OPC development than previously 
thought. 
 On going experiments hope to address the role of Jag1 in remyelination in 
vivo (experimental outline Fig. 38a).  Firstly, I am curious if Jag1FL-IRES-
GFP+ NSCs can remyelinate an actively demyelinating lesion.  Using 
lysolecithin, a drug known for its ability to induce demyelinating lesions, 
Jag1FL-IRES-GFP+ NSCs are being grafted into either the contra- or 
ipsilateral hemispheres and compared to IRES-GFP+ cells (experimental 
method from (Binder, Rukavina et al. 2011)).  Contralaterally grafted cells will 
address whether or not Jag1FL-IRES-GFP+ cells can migrate to the site of 
lesion, and furthermore if they can begin to express markers of OPCs.  These 
experiments will possibly determine if Jag1FL-IRES-GFP can also induce the 
same fate in actively demyelinating lesions. 
 Initial analysis of these mice show a notable increase in survival of Jag1FL-
IRES-GFP grafted cells, which also appear to migrate further towards the 
lesion.  Many of the Jag1FL-IRES-GFP+ cells are also Sox10+, but 
interestingly there are also many surrounding cells that express Sox10 but are 
negative for the reporter.  Either these are native cells that have migrated to 
the lesion or transduced cells that silenced the virus.  Virus silencing is a 
phenomenon we have experienced before in vitro, so this would not be 
completely unexpected.  Jag1FL-IRES-GFP+ grafted cells also appear to 
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express CNPase to a certain degree, although due to the high density and 
overlapping processes of grafted cells, it is difficult to clearly discern.  Further 
analysis and quantifications will be needed in order to determine what these 
cells may be.  Additionally, it will be interesting to see if this phenotype 
becomes more pronounced by 30 DPI, with all Jag1FL-IRES-GFP+ grafted 
cells maturing to myelinating oligodendrocytes. 
 Secondly, I asked if Jag1FL-IRES-GFP+ NSCs can still become OPCs or 
furthermore, myelinate in a non-OPC-permitting environment?  To address 
this, we are using Cit-K KO mice.  Cit-K is a crucial regulator of cytokinesis in 
neuronal precursors and Boda and colleagues have demonstrated that these 
mice display a limited number of OPCs in both the cortical grey and white 
matter (E. Boda 2013).  Grafting GFP expressing OPCs showed that they 
were capable of migrating and invading the entire brain, but never gave-rise to 
mature oligodendrocytes.  They also demonstrated that Cit-K is involved in 
glial cell divisions and OPCs lacking Cit-K are prone to undergo apoptosis.  
Due to fewer myelinating oligodendrocytes in the brains of Cit-K KO mice, 
Jag1FL-IRES-GFP+ NSCs may exhibit an exaggerated OPC migration 
phenotype.  
 Surprisingly, initial analysis of Jag1FL-IRES-GFP+ grafted mice found 
multiple CNPase+ transduced cells which is a marker for mature myelinating 
oligodendrocytes.  This will need to be analyzed further to determine if 
transduced NSCs already express CNPase at the time of grafting, or if this is 
upregulated post-grafting.  Jag1FL-IRES-GFP+ grafted cells also exhibit other 
oligodendrocyte markers including the early OPC marker NG2.  Further 
quantifications of both early and late oligodendrocyte markers are currently 
ongoing. 
4.1.2 Regulation	   of	   genes	   involved	   in	   oligodendrocyte	  maturation	   identified	   by	  
the	  Jag1FL-­‐IRES-­‐GFP+	  NSC	  RNA-­‐Seq	  
 One of the plausible explanations for why Jag1FL induces a shift to an 
OPC fate in vivo could be that Jag1 directly regulates genes involved in 
oligodendrogenesis.  Both Sox10 and Myrf have been reported extensively as 
key determinants of oligodendrocyte maturation (Introduction Fig. 17), with 
Sox10 being expressed throughout the oligodendrocyte lineage (Kuhlbrodt, 
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Herbarth et al. 1998, Stolt, Rehberg et al. 2002, Li, Lu et al. 2007, Finzsch, 
Stolt et al. 2008, Rivers, Young et al. 2008, Breuskin, Bodson et al. 2009, 
Emery, Agalliu et al. 2009, Koenning, Jackson et al. 2012).  Sox10 can 
stimulate expression of Myrf, which together can act as a transcriptional 
complex regulating downstream genes involved in myelination (Hornig, Frob 
et al. 2013).  Interestingly Sox10 and Myrf were confirmed through qRT-PCR 
to be upregulated in Jag1FL-IRES-GFP+ cells, and Jag1FL-IRES-
GFP+Sox10+ cells could be detected by IHC throughout all brain regions 
analyzed in transduced animals.  This suggests that potentially Sox10 is a 
downstream effector of Jag1 signaling. 
 Other genes known to be involved in oligodendrocyte maturation and 
myelination were upregulated in the Jag1FL-IRES-GFP+ NSC RNA-Seq 
including Tenascin-R (Tnr), Erbb4, Enpp6, Fatty acid 2-hydroxylase (Fa2H) 
and homeodomain interacting protein kinase 2 (HipK2).  These genes will 
need to be addressed in detail through gain- and loss-of-function experiments 
to help elucidate the regulatory role of Jag1.  The known roles of these genes 
and their effects on oligodendrogenesis are briefly covered below. 
 The first target gene that will be studied is Tnr, which is part of a family of 
extracellular matrix glycoproteins that are spatially and temporally controlled 
throughout development (Chiquet-Ehrismann, Orend et al. 2014).  Of the four 
members of the tenascin family, Tnr is the only one shown to be exclusively 
expressed in the developing and adult nervous system (Rathjen, Wolff et al. 
1991).  In the absence of PDGFRα, Tnr was shown to both enhance adhesion 
and maturation of oligodendrocytes by inducing myelin gene expression 
(Pesheva, Gloor et al. 1997).  Although recent studies have confirmed that 
Tnr promotes differentiation of oligodendrocytes in vitro, it was also shown 
that it could antagonize myelin membrane formation (Czopka, Von Holst et al. 
2009).  Tnr KO mice could be used to address the loss-of-function of Tnr in 
Jag1FL-IRES-GFP transduced animals (Weber, Bartsch et al. 1999). 
 The second target gene, is the neuregulin-1 (Nrg1) receptor Erbb4 which 
has been demonstrated to be an important mediator of oligodendrocyte 
survival and maturation (Park, Miller et al. 2001).  Although KO mice display 
normal myelin structure, their myelin sheaths are significantly thinner (Roy, 
Murtie et al. 2007).  Therefore, it is believed that Erbb4 may directly modulate 
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OPC responsiveness to Nrg1.  Although this was not looked at in this study, 
Erbb4 was the 8th most enriched target gene in the RNA-Seq screen when 
NSCs expressed Jag1FL-IRES-GFP (excluding Jag1).  Additionally, Nrg1 was 
slightly upregulated above control NSCs.  Taken together, increased signaling 
through the Erbb4 receptor may act as a positive signal for Jag1FL-mediated 
OPC survival and maturation. 
 A third target for future analysis is Fa2H.  Fa2H is an enzyme responsible 
for synthesizing precursor lipids which are later incorporated into the myelin 
sheath (Alderson, Rembiesa et al. 2004, Eckhardt, Yaghootfam et al. 2005).  
Fa2H KO mice display disrupted lipid membranes and severe axonal loss 
(Potter, Kern et al. 2011).  Therefore, a positive regulatory role by Jag1 might 
hypothetically result in increased myelin lipid membrane formation. 
 However, not all upregulated genes in the RNA-Seq have been reported to 
promote oligodendrocyte maturation, and in fact some are known inhibitors.  
When over expressed, Bmp4 has been shown to drive progenitor cells in vivo 
to an astrocytic lineage at the expense of oligodendrocytes (Gomes, Mehler et 
al. 2003, Samanta and Kessler 2004).  Bmp4 acts through activation of the 
Smad1/5/8 transcription factors, which translocate to the nucleus and regulate 
target genes (Massagué, Seoane et al. 2005).  Interestingly HipK2 was also 
elevated in the Jag1FL-IRES-GFP RNA-Seq and is a known inhibitor of Bmp 
signaling, acting by limiting the level of Smad activation (Chalazonitis, Tang et 
al. 2011).  Therefore, while Bmp4 may be expressed at high levels in Jag1FL-
IRES-GFP+ cells (Fig. 37c), it is possible that Bmp signaling is moderated by 
HipK2 in Jag1FL expressing cells.  In addition HipK2 has been shown to 
inhibit Wnt/β-catenin signaling through phosphorylation of TCF/LEF 
transcription factors, preventing their binding to DNA (Gao, Xiao et al. 2014).  
Since Wnt signaling is both a requirement in early OPC commitment and an 
inhibitor in later stages of oligodendrocyte differentiation, HipK2 may be an 
interesting target to address oligodendrocyte regulation at different stages and 
by modulating different signaling pathways (Fancy, Baranzini et al. 2009).  
Additional genes downregulated in Jag1FL-IRES-GFP+ cells included Lars2, 
CD68, and Lag3, which are all associated with psychiatric disorders or 
inflammatory MS lesions (Werner, Pitt et al. 2001, Tkachev, Mimmack et al. 
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2003, Munakata, Iwamoto et al. 2005, Chiu, Morimoto et al. 2013).  How Jag1 
regulates these genes is not clear, but could be the focus of future studies. 
4.1.3 Hypothesis:	  Wnt	  signal	  regulation	  by	  Jag1	  determines	  OPC	  specification	  
 Interestingly, the Jag1FL-IRES-GFP NSC RNA-Seq showed a general 
trend in Wnt signal reduction (Fig. 36c).  Supporting this data, the JICD 
experiments in the second half of my thesis also demonstrated a regulation of 
Wnt target genes in a cell autonomous manner.  However, the Jag1FL gain-
of-function experiments do not allow us to address whether this is due to a 
cell autonomous or non-autonomous effect.  Since Wnt signaling must be 
downregulated for OPCs to mature, Jag1 may play a role in mediating this 
transition.  The Wnt transcriptional target Axin2 is known to autoregulate and 
repress the Wnt pathway by promoting degradation of β-catenin (Behrens, 
Jerchow et al. 1998, Jho, Zhang et al. 2002, Lustig, Jerchow et al. 2002, Zeng 
and Nusse 2010).  Through inhibition of Wnt signaling, Axin2 is believed to be 
an essential regulator OPC progression (Fancy, Harrington et al. 2011).  
Sox5, a known stimulator of Axin2 expression, was upregulated at the mRNA 
level in Jag1FL-IRES-GFP NSCs (Martinez-Morales, Quiroga et al. 2010).  
However, no noticeable change was observed in Axin2 mRNA levels following 
expression of Jag1FL.  Another known inhibitor of the Wnt pathway is APC 
and deletion studies have shown to result in complete disregulation of Wnt/β-
catenin signaling (Lang, Maeda et al. 2013).  Therefore it is believed that OPC 
maturation requires APC expression to prevent transition to a high-Wnt 
signaling state (Fancy, Harrington et al. 2014).  Although the in vivo gain-of-
function experiments in this study did not address this, the role of Jag1FL and 
its regulation of Wnt signaling in OPCs would be an interesting avenue of 
future inquiry. 
 To address these questions in vivo transgenic Wnt reporter mice, such as 
the BAT-gal or Axin2-LacZ mouse, could be used (Lustig, Jerchow et al. 
2002, Maretto, Cordenonsi et al. 2003).  With the BAT-gal mouse, future 
experiments could measure the levels of Wnt activity in Jag1FL-IRES-GFP+ 
cells in vivo.  Similarly, the use of an Axin2 reporter mouse could characterize 
Jag1FL-IRES-GFP+ cells by Axin2 expression. 
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 A second approach to study Wnt signaling downstream of Jag1FL could be 
in vitro OPC differentiation studies that would allow for direct manipulation of 
Wnt target genes in Jag1FL-IRES-GFP+ cells.  It would be interesting to see if 
the ligand Wnt3, an activator of the canonical Wnt signaling pathway and 
downregulated in the Jag1FL-IRES-GFP RNA-Seq screen, could cause a 
loss-of-function when reintroduced into Jag1FL-IRES-GFP+ cells.  Additional 
targets could be identified and their impact on differentiation measured using 
both gain- and loss- of function studies. 
4.1.4 Interaction	  partners	  of	  JICD	  pertaining	  to	  the	  phenotype	  observed	  in	  Jag1FL	  
NSC	  niche	  gain-­‐of-­‐function	  experiments	  
 An interesting observation made when analyzing the Y2H screen for JICD 
interaction partners was that not only did the JICD interact with PICK1 and 
PKCα, but also with Galectin-3 and Pmp2, both of which have known roles in 
oligodendrocyte maturation and myelination (Majava, Polverini et al. 2010, 
Pasquini, Millet et al. 2011).  This is only a tentative link and has not yet been 
confirmed, but co-immunopreciptation studies should reveal if these 
interactions are true.  The implications of these interactions are however 
unclear.  Galectin-3 is highly expressed by activated microglia at the sites of 
MS lesions and was originally thought to play a negative role in remyelination 
by aiding myelin phagocytosis (Rotshenker, Reichert et al. 2008).  However, a 
study by Pasquini and colleagues demonstrated that Galectin-3 actually 
assists myelination through promoting OPCs to differentiate and favours 
oligodendrocytes following differentiation of NSCs (Pasquini, Millet et al. 
2011).  Direct interactions would not be unexpected with Jag1 since Galectins 
can interact with N-glycans on the surface of glycoproteins, however why an 
extracellular protein would interact with the cytoplasmic JICD is unclear.  A 
loss of N-glycans in Notch receptors has been hypothesized to increase 
endocytosis and potentially reduce Notch signaling (Stanley and Okajima 
2010).  Therefore interactions with Galectin-3 may stabilize Jag1 at the 
membrane, allowing for maintained activation of Notch.  
Discussion 
137 
4.1.5 Hypothesis:	  Regulation	  of	  CD4+	  T-­‐Cell	  development	  at	  the	  site	  of	  lesions	  by	  
competition	  between	  the	  Notch	  ligands	  Jag1	  and	  Dll	  
 Due to the complicated nature of demyelinating diseases such as MS (See 
2.4.6), the interplay between stem cell maintenance, autoimmune regulation 
and tissue homeostasis must all be addressed concurrently.  Although my 
work has only studied the effect of Jag1FL on the NSC niche, Notch ligands 
Jag1 and Dll both have a known competitive role in CD4+ T-cell development 
(Stidworthy, Genoud et al. 2004, Elyaman, Bradshaw et al. 2007, Seifert, 
Bauer et al. 2007, Reynolds, Lukacs et al. 2011).  In an animal model of MS 
termed experimental autoimmune encephalomyelitis (EAE), CD4+ Th1 T-cells 
induce inflammatory demyelinating lesions.  Competition at the site of EAE 
lesions between Dll and Jag1 influences the fate of T-cells to either an 
inflammatory Th1 or an anti-inflammatory Th2 cell, respectively (Fig. 56) 
(Stidworthy, Genoud et al. 2004, Elyaman, Bradshaw et al. 2007, Seifert, 
Bauer et al. 2007, Reynolds, Lukacs et al. 2011).  Further, proinflammatory 
cytokines IFN-γ, TNF-α and IL-17 all inhibit Jag1 expression at the site of 
actively demyelinating lesions.  Thus, through forced expression of Jag1 in a 
focal lesion there is the potential that a stimulated Th2 response will induce a 
faster recovery.  Understanding the molecular mechanisms and how Jag1 
moderates the Th2 T-cell response will be essential for future studies of MS. 
 
 
 
 
Figure 54: General theory in the literature regarding how Jag1 differentially affects T-cell 
development, resulting in recovery of lesions in EAE lesions.  (Interpreted from	   (Aharoni, 
Teitelbaum et al. 1997, Amsen, Blander et al. 2004, Amsen, Blander et al. 2004, Rutz, 
Mordmüller et al. 2005, Elyaman, Bradshaw et al. 2007))	  . Ag: Antigen. 
 
4.1.6 Conclusions	  
 This study has identified a novel oligodendocyte fate shift occurring in 
NSCs of the postnatal mouse mediated by Jag1FL-IRES-GFP.  Populations 
were identified by the oligodendrocyte lineage marker Sox10 and other known 
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markers of OPCs, and transcriptome profiles of Jag1FL-IRES-GFP+ NSCs 
compared to controls.  This revealed a global shift in mRNA transcription, 
expressing genes involved in differentiation of oligodendrocytes.  Although 
many potential molecular mechanisms could be acting simultaneously in 
Jag1FL-IRES-GFP+ treated NSCs, the end result is that Sox10 is upregulated, 
driving cells to early OPCs.  Since it has been demonstrated that Sox10 
directly regulates the expression of Myrf, which was also up at the transcript 
level in our studies, I believe these may both be downstream effectors of the 
Jag1 signaling pathway (Fig. 57).  Therefore studying this interplay between 
Sox10, Myrf and Jag1 will be fundamental to future studies of 
oligodendrogenesis and remyelination. 
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Figure 56: Summary of potential mechanisms driving the fate shift in Jag1FL-IRES-GFP+ 
NSCs. (a) Mature myelin genes are upregulated in the Jag1FL-IRES-GFP RNA-Seq, (b) 
Additionally, genes involved in oligodendrocyte dysfunction, including CD68, Lars2 and Lag3 
were all down in the Jag1FL-IRES-GFP RNA-Seq.  (c) Wnt signaling has a known role in 
inhibiting OPCs from maturing.  Through regulation of Wnt antagonists, Jag1FL may play 
direct role in moderating Wnt signaling.  (d) Jag1 and Dll compete with each other to regulate 
CD4+ T-cell development at the site of demyelinating MS lesions.  Jag1 promotes Th2 T-cell 
development, resulting in an anti-inflammatory response.  Dll promotes Th1 T-cell 
development, resulting in continued inflammation and degradation of myelin.  (e) Notch 
activation has been shown in some cases to inhibit remyelination.  Potentially through cis-
inhibition of Notch receptor by expressing Jag1FL, this inhibits the negative effects that Notch 
activation has on remyelination.  (f) miRNAs including miR-124, miR-34a and miR-200 have 
all been shown to regulate Jag1 expression in the literature.  These miRNAs have also been 
shown to regulate myelin formation, and potentially there is a link between the regulation of 
Jag1 and myelin formation by miRNA processing.  Solid lines denote data shown in my thesis 
that is also supported by the literature.  Dashed lines have not been shown in my thesis, but 
are hypothetical mechanisms that have been shown in the literature. 
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Figure 57: Summary of potential mechanisms driving Sox10 upregulation in Jag1FL-IRES-
GFP+ NSCs.  Although it is unclear what mechanism Jag1 is acting through, according to the 
literature, there are many potential candidates.  Each has been outlined in greater detail both 
in the discussion and in Fig. 56.  It may be that the phenotype observed in vivo is due to the 
result of multiple mechanisms outlined above, however this will need to be addressed in 
future studies.  Based on the in vivo phenotype observed in this study, it suggests that Jag1 
regulates Sox10 and Myrf, which are both known to promote OPC maturation in vivo.   
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5 The Cell autonomous role of JICD in NSC 
maintenance 
5.1.1 Significant	  findings	  of	  this	  project	  
 The significant finding of this project was the identification of the sequential 
proteolytic processing of Jag1, releasing the JICD that signals to the nucleus 
by binding to chromatin and regulating gene expression including Wnt target 
genes (Fig. 58).  Additional data from the Taylor lab showed that upon 
activation, Jag1 is bound by PICK1, which then recruits PKCα.  PKCα 
recruitment to the membrane activates ADAM17 by phosphorylation of its 
ICD, which proceeds to cleave the ectodomain of Jag1.  The remaining Jag1-
CTF1 is then rapidly processed by γ-secretase, releasing the JICD into the 
cytoplasm.  Due to its N-terminal NLS, JICD translocates to the nucleus 
where it can directly bind TBLR1 in a PDZ-dependent manner.  Through 
ChIP-Seq studies, the JICD was shown along with TBLR1 and β-catenin to 
bind gene promoters acting as a transcriptional regulator complex on Wnt 
genes including Axin2. 
5.1.2 JICD	  can	  directly	  regulate	  the	  transcription	  of	  known	  Wnt	  targets	  by	  binding	  
to	  the	  promoter	  regions	  
 The functional role of JICD in regulating differentiation was identified 
through KO and IUE gain-of-function experiments.  IUE allows for fast and 
efficient delivery of DNA constructs to NSCs lining the vesicles of the 
developing mouse telencephalon.  This not only eliminates the need for 
generating expensive and time consuming transgenic reporter mice, but it 
also allows for quick analysis of both gain- and loss- of gene function through 
the additional use of silencing shRNAs.  JICD gain-of-function induced a 
sustained exit of NSCs from the VZ and accompanied by a loss of progenitor 
markers and an increase in differentiation marker expression (Fig. 41).  When 
the JICD C-terminal PDZ domain was deleted this phenotype was lost, 
suggesting that the interaction of JICD with PDZ proteins plays a crucial role 
in mediating the cell autonomous effect of Jag1 signal activation (Fig. 45 & 
46).  Y2H and TAP screens identified direct protein interactions of JICD with 
targets including PICK1, PKCα and core histones H3, H4 andH2A, all of which 
were confirmed through co-immunoprecipitation.  Co-expression of TBLR1 
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and β-Catenin with JICD was shown to potentiate both synthetic Wnt 
luciferase reporters and endogenous Wnt target genes, implying that JICD 
could regulate Wnt signaling in vivo. 
 ChIP-Seq is an extremely powerful technique that can identify binding 
sequences of transcription factors, suggesting their possible direct regulation 
by the transcription factor being studied.  ChIP-Seq confirmed that Jag1 was 
directly bound to the promoter regions of known Wnt target genes, including 
Axin2, Lgr5, Id2 and Lef1.  Transcript levels from mRNA sister transfected 
plates demonstrated that when JICD was bound to the promoters of these 
genes in the presence of TBLR1 and β-Catenin, their expression was 
potentiated.  Taken together, JICD binding to these promoter sequences in 
combination with β-Catenin regulated the genes expression.  However, to 
properly confirm this claim additional experiments could identify putative 
consensus binding sequences and then mutate them.  
 Although there was significant background signal noise in many of the ChIP 
samples, enriched peaks could still be identified in the ChIP samples in which 
JICD-NTAP/β-Catenin/TBLR1 were co-expressed.  Analysis of target genes 
Axin2, Lgr5, Id2, and Lef1 reveals varying roles in Wnt signaling and 
development.  As discussed earlier, Axin2 is a known repressor of Wnt 
signaling.  Contradictory to this, Lgr5 plays a role in activating canonical Wnt 
signaling.  Therefore, JICD may play a role in fine-tuning downstream 
effectors of the Wnt pathway, exhibiting both a positive and negative 
regulation in a cell autonomous fashion. 
5.1.3 Future	  outlooks	  
 To address the cell autonomous effects JICD may have on global 
transciptome regulation, RNA-Seq experiments of NSCs expressing JICD are 
currently ongoing (experimental outline Fig. 59).  Through cross analysis of 
transcriptomes from both Jag1FL-IRES-GFP+ NSCs, where Jag1 could exhibit 
both a cell autonomous and non-autonomous effect on NSCs, and JICD 
NSCs where Jag1 acts autonomously, similarities and differences in transcript 
profiles can hopefully be identified.  Potentially, signaling regulation 
similarities might explain the effects on Wnt regulation and cellular 
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differentiation exhibited by both Jag1FL-IRES-GFP and JICD gain-of-function 
experiments (Outlined in Fig. 60). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 58: Working model of Jagged1 cell autonomous signaling.  Activation of Jag1 
results in recruitment of PICK1 and activated PKCα.  PKCα phosphorylates the ICD of 
ADAM17, which leads to the sequential proteolytic cleavage of Jag1 first by ADAM17, 
releasing the extracellular domain.  Jag1-CTF1 is then recognized and processed by γ-
secretase, releasing the JICD into the cytoplasm.  JICD translocates to the nucleus where it 
can directly bind TBLR1 in a PDZ-dependent manner.  Along with TBLR1 and β-catenin, the 
JICD can bind promoters of genes including Wnt genes, resulting in a transcriptional switch 
and target gene expression. 
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Figure 59: Outline of future RNA-Seq experiments to analyze the cell autonomous role of 
JICD.  Similar to the Jag1FL studies performed in the first half of my thesis, JICD will be 
transfected into NSCs and then maintained in culture as neurospheres.  On the 5th day, 
neurospheres will be dissociated and NSCs sorted for GFP expression by FACS.  RNA will 
then be immediately isolated and sent for RNA-Seq.  The transcriptome profiles of NSCs 
transfected with only the JICD will then be cross-analyzed with Jag1FL-IRES-GFP+ NSCs 
transcriptome profiles to determine which effects are due to Jag1 non-autonomous and 
autonomous signaling effects. 
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Figure 60: Illustration of the potential links seen in the autonomous role of JICD that may 
explain phenotypes expressed in Jag1FL-IRES-GFP+ NSCs. Based on both the Wnt 
luciferase reporter data and the JICD ChIP-Seq data, Wnt genes can be regulated by the 
JICD.  Similarly, in the Jag1FL gain-of-function experiments a regulation of Wnt targets was 
observed.  Additionally the JICD directly interacted with both Galectin-3 and Pmp2 both of 
which have known roles in oligodendrocyte maturation and myelination.  Potentially there is a 
link between the autonomous role of JICD and the in vivo Jag1FL phenotype.  Discerning if 
this is due to a cell autononomous or non-autonomous effect will be addressed with on going 
RNA-Seq experiments, which are outlined in Fig. 59.  Solid lines denote data shown in my 
thesis that is also supported by the literature.  Black dashed lines have not been shown in my 
thesis, but are hypothetical mechanisms that have been shown in the literature.  Grey dashed 
lines are potential links between the autonomous role of JICD and the in vivo phenotype 
based on data and observations presented in this thesis. 
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6 Materials and Methods 
6.1 Methods 
6.1.1 Animals	  and	  husbandry	  
Mice were maintained and housed in animal facilities with a 12-hour day/night 
cycle with adequate food and water under conditions according to DBM 
University of Basel institutional regulations and under license numbers and 
2462 2537, 2538 (Kantonales Veterinäramt, Basel). 
6.1.2 Preparation	  of	  tissue	  
Using a ketamine/xylazine/flunitrazepam solution (150 mg, 7.5 and 0.6 mg/kg 
body weight, respectively), mice were deeply anesthetized by injection and 
verified to be unresponsive through pinching the paw.  Perfusion was 
performed with ice-cold 0.1M phosphate buffer (PB) followed immediately by 
4% PFA prepared in 0.1M PB.  Additional fixation over night with 4% PFA was 
done to ensure full tissue fixation.  Next morning, brains were washed 4 times 
for approximately 10 minutes each, with 0.1M PB and cryopreserved with 
30% sucrose solution in 0.1M PB for 48 hours.  Brains were embedded in 
O.C.T. (Sysmex Digitana SA) and coronal sections of 20µm were collected in 
24 multiwell dishes (Corning) and stored at −20°C in antifreeze solution until 
use. 
6.1.3 Immunohistochemistry	  
Tissue sections were incubated for 30 minutes in a blocking buffer solution of 
2% normal donkey serum (Jackson ImmunoResearch) 1% Triton X-100 in 
phosphate-buffered saline (PBS) in a 24 multiwell dish (Corning).  Primary 
antibody was diluted (see table) in blocking buffer solution and incubated with 
the tissue overnight on a rocking table at 4°C.  Next morning sections were 
washed 4 times with PBS, and incubated for 1 hour with the corresponding 
secondary antibody diluted in blocking buffer solution.  For primary antibodies 
requiring antigen retrieval, tissue was first incubated in sodium citrate buffer 
(10mM Sodium Citrate, 0.05% Tween 20, pH 6.0) at 80°C for 10 minutes, and 
then allowed to cool to room temperature before washing with PBS and 
proceeding with the standard protocol.  For biotinylated secondary antibodies, 
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a) Primary antibodies 
b) Secondary antibodies 
sections were washed with PBS after secondary antibody incubation and then 
incubated for 1 hour with the corresponding peroxidase-conjugated 
streptavidin antibody (Jackson ImmunoResearch; 1:1000).  Sections were 
incubated with 0.015% 3,3’- diaminobenzidine, 0.0024% H2O2 in 0.05 M Tris-
HCl, pH 7.6.  Sections were mounted on glass slides (VWR), dehydrated and 
embedded in mounting medium containing 1,4-diazabicyclooctane (DABCO; 
Sigma) to prevent fading.  Sections were then visualized using either a Zeiss 
LSM510 confocal microscope or a Zeiss Observer microscope with apotome.  
 
Table 1: Antibodies 
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6.1.4 Stereotactic	  injection	  of	  RV	  into	  postnatal	  mice	  
Flaming/Brown micropipette puller (Sutter Instruments) was used to prepare 
borosilicate glass micro capillaries for viral delivery (Kwick-FilTM).  
Concentrated RV was prepared by mixing in a 10:1 ratio of virus:Fast Green 
(10%) (Sigma).  Micro capillaries were backfilled with viral suspension, loaded 
into a microinjector (Pneumatic Pico Pump, WPI Rnage) and secured onto the 
stereotaxic apparatus (David Kopf Instruments).  Postnatal (P2) wild type 
C57BL/6 mice were anesthetized by incubating on ice for approximately 5-10 
minutes before positioning into the stereotaxic apparatus.  A small incision 
using the tip of a needle was made halfway between the bregma line and the 
eye in the right hemisphere.  The capillary was positioned over the incision 
and the tip aided past the skull with the needle.  The capillary was lowered 1 
mm down to the lateral ventricle, and approximately 1 μl of virus injected.  The 
capillary was then removed and mouse returned under a heat lamp to 
recover.  Paws were tattooed to denote treatment and pups then returned to 
the cage with their mother.  Time-chases were done for 3, 7, 15 and 30 days 
post infection.  At the end of the experiment, mice were heavily anesthetized 
with ketamine/xylazine/ flunitrazepam solution (150 mg, 7.5 and 0.6 mg/kg 
body weight, respectively) and perfused as outlined in “Preparation of tissue.” 
6.1.5 Quantification	  of	  transduced	  mice	  
Immunostained brain sections of transduced mice were analyzed on a Zeiss 
Observer with apotome microscope.  3 images at 20x magnification were 
taken at random in the cortex, the striatum and the corpus callosum of each 
brain section, and 3 brain sections photographed from each animal.  Images 
were then imported into Fiji imaging software and cells counted manually 
based on marker expression.  Quantification of migration in the cortex was 
done using 20x magnification tiled images in Fiji imaging software.  The 
boundary of the corpus callosum was traced out and then individual 
measurements from the edge of the corpus callosum to approximately 75-100 
cells per mouse were taken.  Statistical comparisons was done by two-tailed 
unpaired Student’s t-test.  In the case where t-test was used on two sets of 
percentages, values were first converted to arcsin values.  Significance was 
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established at p<0.05.  In all graphs error bars represent standard error of the 
mean (s.e.m.). 
6.1.6 Maintenance	   of	   cell	   culture	   lines	   (N2A,	   NIH3T3,	   HEK293	   and	   Platinum-­‐E	  
HEK293	  cells)	  
Throughout this study, multiple cell lines were used that were all grown, 
maintained and passaged under similar conditions.  These include the mouse 
neuroblastoma (N2A), NIH3T3 fibroblasts, Human embryonic kidney 
(HEK293), and Platinum-E HEK293 cell lines.  Frozen aliquots of all cell lines 
were thawed quickly in a 37°C water bath and immediately transferred to a 15 
mL canonical tube containing 10 mL of DMEM culture medium (Gibco) and 
centrifuged at 80g for 5 minutes.  Pellets were resuspended in DMEM culture 
medium containing 10% fetal bovine serum (FBS) (PAA), and 1% Penicillin 
streptomycin (Life technologies) and plated in T75 culture flasks (Greiner).  
Cells were grown and maintained at 37°C in 5% CO2.  When cells became 
80-90% confluent (approximately two to three days after plating) cells were 
incubated with Trypsin diluted in Versene (Gibco) and incubated at 37°C for 2 
minutes.  Cells were then removed and resuspended in 10mL of cell culture 
PBS (Gibco) before centrifuging for 5 minutes at 80g.  Cells were 
resuspended in DMEM culture medium, counted using a neubauer chamber 
and replated in a T25 flask containing DMEM culture medium containing 10% 
FBS.  To store cells for length periods of time, cells were frozen down.  One 
T75 flask of cells was dissociated as described above and resuspended in 1 
mL of freezing solution (50% DMEM+Glutamax, 40% FBS, 10% DMSO, filter 
sterilized).  Cells were aliquoted into 500 μl/cryotube (Starlab) and placed in a 
Mr. Frosty cooling box at -80°C to ensure gradual cooling of cells at about -
1°C per minute.  For long-term storage, cells were then transferred to liquid 
nitrogen. 
 Uniquely, Platinum-E HEK293 cells contain a blasticidin/puromycin 
selection cassette allowing for selection and maintenance of retroviral 
packaging genes.  Cells were grown in selection medium (DMEM, 10% FBS, 
1 µg/mL puromycin, 10 µg/mL blasticidin, penicillin and streptomycin) for at 
least 24 hours and then allowed to recover in standard DMEM culture medium 
for approximately 24 hours prior to transfection with retroviral plasmids. 
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6.1.7 Transfection	  of	  cell	  culture	  lines	  by	  Calcium	  Phosphate	  
Calcium phosphate tranfection was performed according to manufactures 
instructions (ClonTech).  A 10 cm plate of cells was grown to approximately 
70% confluency.  Solution A was prepared by mixing 15-20 μg of plasmid 
DNA with 85 μl of 2M calcium solution and 680 μl of sterile H2O in a 15 mL 
canonical tube.  700	  μl of 2xHepes buffered saline (HBS) solution was added 
drop wise (approximately 1 drop every 2 seconds) to solution A while 
vortexing at 1400rpm.  The solution was then incubated for 10 minutes at 
room temperature before briefly vortexing and adding drop wise to the pre-
seeded cells.  Plates were then rocked to ensure even distribution of 
transfection mix and incubated overnight at 37°C in 5% CO2.  Medium was 
replaced 12 hours later with fresh DMEM 10% FBS. 
6.1.8 Transfection	  of	  Cell	  culture	  lines	  by	  TransFectin	  (BioRad)	  
TransFectin lipid reagent (BioRad) was used to transiently tranfect foreign 
plasmids into cell culture lines (approx. 70% confluent).  Transfection solution 
for a 24 well plate was prepared by mixing 50 μl of serum-free medium with 1 μg of plasmid DNA.  4 μl of TransFectin reagent was added to a second 50 μl 
volume of serum-free medium.  Both solutions were then mixed together and 
incubated at room temperature for 20 minutes.  The transfection solution was 
then directly applied to one well of cells in a 24 well plate and cells were 
incubated as outline in maintenance of cell culture lines. 
6.1.9 Subcellular	  fractionation	  of	  N2A	  cells	  
Cells were grown in a T25 flask and transfected with approximately 4ug of 
plasmid DNA when cells were approximately 70% confluent using TransFectin 
(BioRad).  Cells were then incubated for 48 hours at 37°C in 5% CO2.  Before 
harvesting, cells were washed twice with 5 mL of cold PBS (Gibco).  300 µL of 
Buffer A (10 mM Hepes pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M Sucrose, 
0.1% Triton, 1x complete protease inhibitor (Roche), 10% glycerol, 0.1 M 
PMSF, 1 mM DTT) was added directly to the cells, and then cells scraped 
from the flask with a cell scraper before being pipetted up and down to disrupt 
the cell membrane.  Lysates were then transferred to a fresh tube and 
centrifuged for 5 minutes, 1000 g at 4°C.  Supernatent was isolated (cytosolic 
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proteins, S1) and stored at -80°C until further analysis.  The pellet was 
washed in 400 µL of Buffer A and rotated on a rotating platform (Stuart) at 4°C 
for 5 minutes.  Lysate was centrifuged for 5 minutes, 1000 g at 4°C, and 
supernatant discarded.  The pellet was resuspended in 75 µL of Buffer B (10 
mM Hepes pH 7.9, 3 mM EDTA pH 8, 0.02 mM EGTA pH 8, 1x complete 
protease inhibitor, 0.1 mM PMSF, 1 mM DTT) and left to lyse on ice for 30 
minutes with no pipetting.  Nuclear lysate was centrifuged for 5 minutes, 1500 
g at 4°C, and the supernatant collected and stored at -80°C until further 
analysis (soluble nuclear lysis, S2).  Chromatin pellet was then washed with 
400 µL of Buffer B, and rotated at 4°C for 5 minutes.  Chromatin was 
centrifuged for 5 minutes, 1500 g at 4°C, and then resuspended in 150 µL of 
Buffer A without glycerol.  Chromatin bound proteins were released by adding 
1 µl/sample of Benzonase and incubating for 1 hour at room temperature with 
low (ie. 300 rpm) shaking.  Once complete, samples were stored until further 
analysis at -80C.  Samples were analyzed by SDS-Page western blot using 
approximately 10 ug of protein per lane and a loading control antibody specific 
for H2A was used to ensure that fractionation occurred cleanly. 
6.1.10 Cloning	  of	  retroviral	  and	  AAV	  and	  retroviral	  constructs	  
Full-length cDNA of Jag1 was subcloned into a modified pAAV vector 
containing the SV40 polyA sequence from pAAV-LacZ plasmid (pAAV-
Jag1FL).  The identical full-length Jag1 cDNA was subcloned into the pMIG 
vector, in frame with the IRES-GFP (pMIG-Jag1FL).  Both plasmids were 
confirmed to by sequencing.  
6.1.11 Purification	  of	  AAV	  via	  iodixanol	  centrifugation	  
A 50-60% confluent 10cm plate (Corning) of HEK293 cells was transfected 
with 10 μg of plasmid DNA (pHelper, pAAV-RC, and pAAV-GFP or pAAV-
Jag1FL) using the calcium phosphate transfection method.  72 hours later, 
cells were scraped from the plate in 37°C 3.5 ml PBS and transferred to a 50 
ml conical tube and centrifuged at 1000 rpm for 5 minutes at 4°C.  Pellets 
were resuspended in 8.5 mL of prechilled Tris/NaCl (50mM, 150mM, pH: 8) 
and 500	  μl of NaDOC (10%) /5µl Benzonase (Sigma) (ca. 1400U) added.  Cell 
pellet was incubated for 20 minutes at 37°C and then 584mg of NaCl was 
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dissolved in the buffer and incubated an additional 5 minutes at room 
temperature.  Virus was snap frozen in liquid nitrogen (N2) and thawed at 
37°C before centrifuging at 5000rpm for 20 minutes.  An iodixanol gradient 
was prepared by loading 6 mL of iodixanol in a Beckman centrifuge tube 
followed by first an underlaying layer of 4 ml 25% Iodixanol, then 3 mL 40% 
iodixanol and finally 3 ml 54% iodixanol, which remains separated as four 
visible phases.  Virus was loaded on the iodixanol gradient, keeping 100	  μl of 
lysate for future analysis.  Ultra centrifuge was then performed at 60 000rpm 
for 1.5 hours at 18°C. 40% iodixanol (3 mL) top phase was removed with a 
syringe and diluted 1:1 with PBS-MK (PBS, 1 mM MgCl2, 2.5 mM KCl), taking 
care not to disturb the cellular debris layer (white film) at the iodixanol 
boundary.  Virus was further concentrated in an Amicon Concentrator 
(Millipore) (100kDa) three times at 2000g by refilling with PBS-MK.  The final 
pellet was resuspended in 250	   μl PBS-MK and filtered through 0.2µm 
Acrodisc (Sigma), and immediately aliquoted in 25	  μl units and snap frozen in 
liquid nitrogen.  Analysis was confirmed by infecting HEK293 and titer 
determined through GelCode-Blue-Stain solution (Pierce) on a 10% SDS-
polyacrylamide gel. 
6.1.12 Purification	  of	  RV	  with	  Retro-­‐X	  concentrator	  (ClonTech)	  
A 10cm plate of 70% confluent Platinum-E HEK293 cells were transfected 
with 20 μg of pMIG viral plasmid DNA by the calcium phosphate method 
(ClonTech).  Supernatent was collected at 48 hours and 72 hours post 
transfection, and stored at 4°C.  Supernatent was pooled and filtered through 
a polyethersulfone (PES) low protein binding filter (Millipore) and clarified 
supernatant purified according to the standard Retro-X concentrator protocol 
(ClonTech).  Viral pellet was gently suspended in 200	   μl of PBS containing 
10% DMSO, and immediately snap frozen on dry ice and stored at -80°C.  
Viral titer was calculated by serial diluting the virus and transducing a NIH3T3 
fibroblast cell line and then 48 hours later quantifying the percentage of cells 
transduced. 
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6.1.13 Isolation	  of	  NSCs	  and	  maintenance	  of	  Neurospheres	  
Neurospheres were isolated and maintained in vitro as previously described 
(Giachino, Basak et al. 2009).  Brains were isolated from postnatal wild type 
C57BL/6 mice (P2-P5) and transferred to L15 medium (GIBCO).  The SVZ 
and cortices were micro-dissected using a binocular (Leica), and tissue 
digested with freshly prepared Papain based solution (L15 medium (Gibco), 
Papain (Sigma) 30 U/mL, Cysteine (Sigma) 0.24 mg/mL, DNAseI Type IV 
(Roche) 40 μg/mL, sterile filter) for 10 minutes at 37°C.  The reaction was 
terminated by adding an equal volume of Ovomucoid mix (stored at 4°C for a 
maximum of one week, Ovomucoid trypsin inhibitor (Sigma) 45 mg, BSA 
(Sigma) 21 mg, DNAseI Type IV (Roche) 40 μg/mL, L15 medium (Gibco) 39 
mL, sterile filter) and incubated for 5 minutes to ensure digestion has 
completed.  Spheres were then triturated with a fire polished Pasteur pipette 
by pipetting up and down at least 10-15x or until completely homogenous.  
Cells were resuspended in 9 mL of prewarmed DMEM/F12 culture medium 
(Gibco) and centrifuged for 5 minutes at 80g.  Pellets were resuspended in 
4.5 mL of NS culture medium  (DMEM/F12, Penicillin 10 U/mL, Streptomycin 
10 μg/mL, B27 supplement (1:50) (Gibco), FGF-2 20ng/mL (R&D), EGF 
10ng/mL (R&D)) and transferred to a T25 culture flask (Greiner).  Cells were 
incubated at 37°C, with 5% CO2.  2 mL of fresh NS culture medium was 
provided after 2 days in culture and neurospheres were passaged on day 5.  
 At day 5 neurospheres were transferred to a 15 mL conical tube and 
centrifuged at 80g for 5 minutes.  The pellet was resuspended in 500	   μl of 
0.05% Trypsin diluted in Versene (Gibco) and incubated at 37°C for 10 
minutes with agitation.  The trypsin reaction was stopped by adding 0.5 mL of 
Ovomucoid mix and incubating at room temperature for 5 minutes.  
Neurospheres were then triturated with a fire-polished Pasteur pipette and 
resuspended in 9 mL of DMEM/F12 medium in a 15 mL tube to wash them 
and centrifuged at 80g for 5 minutes.  Cells were resuspended in 1 mL of NS 
medium and gently triturated with a fire polished pipette before counting cell 
numbers using a neubauer chamber and replating in a T25 flask containing 
NS medium. 
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6.1.14 Transduction	  of	  NSC	  cultures	  
Low-passage neurospheres (passage 1-3) were dissociated with 0.05% 
Trypsin diluted in Versene (Gibco) and triturated with a fire polished pipette 
before counting cell numbers using a neubauer chamber.  Dissociated cells 
(approximately 7-10x107) were transferred to a 1.5 mL tube and resuspended 
in a minimal volume of approximately 200	   μl of NS medium (see NS 
maintenance) and 10	  μl of a previously prepared retroviral stock (see retroviral 
purification) was added directly to the cell suspension for an approximate MOI 
of 1.  Cells were then incubated at 37°C with 5% CO2, for 3 hours with the 
virus and then replated in a T25 flask with NS medium containing growth 
factors.  Cells were examined for reporter expression after 48 hours using a 
fluorescent binocular (Leica).   Neurospheres were maintained as outlined in 
the NS maintenance protocol. 
6.1.15 FACS	  sorting	  of	  transduced	  NSCs	  
NSCs were dissociated as single cells as outlined in the NS maintenance 
protocol.  Cells were resuspended in 500 μl of cell culture PBS (Gibco) and 
filtered through a 30 um cell sieve (Miltenyi Biotec) and sorted by forward and 
side-scatter for live cells and gated for GFP+.  Cells were then either directly 
used for RNA isolation or cultured in NS culture media (NS maintenance 
protocol). 
6.1.16 Differentiation	  of	  transduced	  NSCs	  
FACS sorted transduced neurospheres were plated on 30 mm coverslips 
(Biosystems) coated with poly-l-lysine (Sigma) and laminin (Sigma).  Cells 
were grown in differentiating medium containing reduced growth factors 
(DMEM/F12 (Gibco), B27 supplement (1:50) (Gibco), FGF-2 10ng/mL (R&D), 
EGF 5ng/mL (R&D)), with fresh medium provided every two days.  After 7 
days of differentiation, colonies were fixed by adding 12% PFA directly to the 
medium, for a final concentration of 4% PFA and incubated with rocking at 
room temperature.  Colonies were then washed 4 times with PBS and 
analyzed by immunohistochemistry. 
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6.1.17 Thymidine	  pulse	  chase	  assay	  of	  transduced	  NSCs	  
Thymidine pulse experiments of NSCs were performed using the Click-iT EdU 
kit (Invitrogen) as outlined by the manufacturers protocol.  NSCs were 
dissociated and plated on coverslips as outlined in the differentiation of 
transduced NSCs method, but instead grown in NS medium (DMEM/F12 + 
Glutamax (Gibco), B27 supplement (1:50) (Gibco), FGF-2 20ng/mL (R&D), 
EGF 10ng/mL (R&D)).  24 hours after plating, cells were incubated with EdU 
for a 3 hour pulse, and then immediately fixed with 4% PFA and 
permeabilized followed by immediate EdU detection.  Immunohistochemistry 
for Ph3 was performed in parallel. 
6.1.18 RNA	  Isolation	  
RNA isolation from cells was performed using TRIzol Reagent as outlined by 
the manufacturers protocol.  Adherent cells (ie. ChIP and NSC differentiation 
assays) and dissociated cells (ie. FACS sorted NSCs) were homogenized by 
adding 1 mL of TRIzol reagent directly to cells.  Cells were pipetted up and 
down several times and transferred to a clean 1.5 mL tube and left to sit for 5 
minutes at room temperature.  0.2 mL of chloroform was added and sample 
shaken for 15 seconds by hand, and then incubated for an additional 3 
minutes at room temperature.  Samples were then centrifuged at 12 000g for 
15 minutes at 4°C, separating out the aqueous phase, interphase, and 
organic phase.  The aqueous phases containing the RNA were carefully 
isolated, transferred to a new tube and Glycogen blue added to improve 
efficiency of RNA precipitation (Life Technologies).  0.5 mL of isopropanol 
was added to the aqueous phase, incubated at room temperature for 10 
minutes, and then centrifuged at 12 000g for 10 minutes at 4°C.  The RNA 
was then washed with 75% ethanol and centrifuged at 7 500g for 5 minutes at 
4°C.  Pellets were air dried and redissolved in 30	  μl of RNase-free water and 
incubated in a heating block at 55°C for 10 minutes. 
6.1.19 RNA-­‐Sequencing	  of	  NSCs	  
NSCs were derived from postnatal wild type C57BL/6 mice as outlined in 
Isolation of NSCs and maintenance of Neurospheres and were transduced as 
described in Transduction of NSC cultures.  At 5 days post-transduction, 
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neurospheres were dissociated and FACS sorted as explained in, FACS 
sorting of transduced NSCs, and RNA immediately isolated as described in, 
RNA Isolation.  Sample libraries were then assembled by the D-BSSE 
Quantitative genomics facility (Basel Switzerland) and analyzed using an 
Agilent Bioanalyzer 2100.  Multiplex sequencing was performed with Illumina 
Next Generation sequencing (HISeq2000).  Peak alignment and mapping to 
the genome of Mus musculus build NCBI37/mm9 was performed by Robert 
Ivanek of the DBM (University of Basel, Basel, Switzerland).  Intra-comparison 
of RNA-Seq replicates was performed to find reproducible gene profiles 
changes.  Jag1FL-IRES-GFP+ NSCs samples were then compared to control 
NSCs to determine fold change of transcripts.  Analysis  of sequencing 
datasets was done with GO and KEGG database software to identify gene 
targets that were later quantified through gene specific qRT-PCR as 
described in qRT-PCR analysis below.  
6.1.20 cDNA	   synthesis	   and	   quantitative	   reverse	   transcriptase	   PCR	   (qRT-­‐PCR)	  
analysis	  
Using 1-2 μg of starting RNA, first-strand cDNA synthesis was performed 
using SuperScriptIII (Invitrogen) exactly as outlined by the manufacturers 
protocol.  Gene specific qRT-PCR primers were both obtained and verified 
from previous publications, obtained from the verified primers in the Harvard 
PrimerBank (http://pga.mgh.harvard.edu/primerbank/) or designed using 
Primer3 software.  Criteria for primers included: a single PCR product as 
determined by analysis on agarose gel; a single peak in the melting curve of 
primer pairs; a PCR product of approximately 100-150 bp; and binding of both 
primers on different exons.  Primers that met these criteria were used to 
determine relative levels of transcripts, using the house-keeping gene β-actin 
as an internal sample standardization control.  10	  μl qRT-PCR reactions were 
performed in 0.1 mL strip tubes (Labgene Scientific Biolab) with SensiMix 
SYBR Kit (Labgene Scientific Biolab) and samples run on a RotorGene qPCR 
machine (Corbett).  cT values and melting curves were generated by 
RotorGene software, and statistics and follow-up analysis performed in Excel. 
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6.1.21 Production	  of	  endotoxin	  free	  plasmid	  DNA	  
Endotoxin free plasmid DNA was used for IUEs and purified according to 
manufacturers protocol (Qiagen). 
6.1.22 In	  Utero	  Electroporation	  
IUE was performed as previously described (De Pietri Tonelli, Calegari et al. 
2006).   Flaming/Brown micropipette puller (Sutter Instruments) was used to 
prepare borosilicate glass micro capillaries for plasmid DNA delivery (settings: 
heat = 540°C; pull = 50; velocity = 50; time = 200 sec) (Kwick-FilTM).  The tip 
of the capillary was sharpened using a capillary sharpener (Bachofer).  
Endotoxin free plasmid DNA was prepared with fast green (10%) (Sigma) in a 
10:1 ratio, for a final DNA concentration of 2 μg/μl.  Since all plasmids used in 
IUEs contained fluorescent tags, there was no need for co-electroporation of a 
second reporter plasmid.  Capillaries were backfilled with viral suspension and 
loaded into a microinjector (Pneumatic Pico Pump, WPI Rnage).  Pregnant 
mothers at day E13.5 of gestation were anesthetized with Isofluran (Baxter), 
diluted in O2 and carefully secured to the heated operating table.  The eyes 
were coated with Bepanthen cream to prevent drying and temgesic was 
delivered subcutaneously to relieve pain (0.1mg/kg).  Fur was removed from 
the stomach using depilation cream and then disinfected with 70% ethanol.  A 
small, 1 cm incision along the midline, was made beginning at the bottom of 
the abdomen and moving upwards.  This was done first by cutting through the 
skin, and then the muscle layer.  The uterine horns containing the embryos 
were gently removed from the abdominal cavity using pincets and rested on 
the skin.  Embryos were kept moist throughout the remainder of the 
experiment with HBSS/PenStrept (1:1000).  Beginning at one end of the 
uterine horn, embryos were injected into the left lateral ventricle with 1-2 μl of 
DNA solution.  To aid in visualization of the ventricle, a cold light source was 
used to backlight the embryo.  Electroporation paddles were held directly 
adjacent to the site of injection with the positive pole oriented towards the 
injection site.  Two consecutive rounds of pulses were delivered to each 
embryo (Electro Square Pavator™, BTX® Harvard Apparatus, 40V, pulse 
length: 50 ms, 5 pulses, interval: 950ms).  After all embryos had been 
electroporated, they were returned into the abdomen and the chest cavity 
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filled with HBSS/PenStrept to aid the recovery.  The muscle layer and then 
the skin were sutured with 3 stitches each and the animals placed under a 
heat lamp to recover.  Recovery was carefully monitored throughout the day. 
6.1.23 IUE	  tissue	  preparation	  and	  quantification	  	  
24 or 48 hours post-IUE, mothers were sacrificed and their embryos dissected 
in HBSS.  Brains were micro-dissected and electroporation efficiency 
measured using a fluorescent binocular (Leica).  Positive brains were fixed 
overnight in 4% PFA, and washed 4 times with PBS.  Brains were processed 
through sequential rounds of cryopreservation, first with 15% and then 30% 
PB-sucrose solution.  Brains were embedded in embryo molds with O.C.T. 
(Sysmex Digitana SA) and frozen on dry ice.  Brains were sectioned 
horizontally and mounted directly onto glass slides and stored in PBS at 4°C 
until analyzed by immunohistochemistry. 
6.1.24 SDS-­‐Page	  Western	  Blot	  	  
Media was removed and cells scraped into 300	   μl lysis buffer  (20 mM Tris-
HCl pH7.6, 150 mM NaCl, 2 mM MgCl2, 2 mM EDTA, 0.5% Triton-X-100, 
0.5% Nonidet P40, 10% Glycerol and Complete protease inhibitor 1x 
(Roche)).  Cells were lysed by pipetting up and down and vortexing for about 
2-3 minutes. Lysates were centrifuged at maximum speed (17 000g) for 5 
minutes and then transferred to a new tube to measure protein concentration 
with the BCA protein assay (Pierce) kit (followed manufacturers protocol 
exactly).  The volume of lysate required for 30 μg of protein per sample was 
prepared and β-mercaptoethanol added. 5x loading buffer was added to bring 
the total loading volume to 30	   μl.  Proteins were denatured for 10 minutes at 
95°C followed by immediately placing samples on ice.  Samples were then 
loaded on a 10% SDS-Page gel and run at 60V until samples reach the 
separating gel.  Once in the separation gel, voltage was then increased to 
120V and run as long as needed for correct protein band separation.  Proteins 
were then transferred to an activated PVDF membrane run at 150 mA for 50 
minutes and then ponceau stained to confirm that transfer worked 
successfully.  Ponceau was destained from the membrane with 3, 5 minute 
washes with PBS.  Membranes were then blocked with 5% milk powder in 
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0.05% Tween TBS (TTBS) for 30 minutes at room temperature.  Primary 
antibody in blocking buffer was then incubated over night at 4°C on rollers 
with the membrane.  Membranes were washed with 3 times for 15 minutes 
with TTBS.  Membranes were then incubated with secondary antibody in 
blocking buffer for 1 hour and again washed for 15 minutes 3 times with 
TTBS.  ECL detection (GE Healthcare, ECL Plus western blot detection 
reagents) was performed according to manufactures protocol and imaged 
using a ChemiDoc MP imager (BioRad). 
6.1.25 Yeast-­‐2-­‐Hybrid	  and	  TAP-­‐tag	  proteomics	  screen	  screening.	  
cDNA encoding JICD in the pGBT9 expression vector was used as a bait in 
the yeast two-hybrid screen. A Gal4-based system (Out-sourced: RZPD, 
Heidelberg, Germany) was used to screen in parallel a human fetal brain 
expression library and a human full-length clone library with three times 
genome coverage.  A positive two-hybrid interaction was determined based 
on fluorescent signal and screened for specificity and background interaction 
(RZPD). 
 Tandam affinity purification (TAP), was performed on N-terminal TAP-JICD 
and control plasmid transfected N2A cells  (>108 cells). The InterPlay N-
terminal Mammalian TAP system was used (according to manufactures 
protocols) to TAP protein complexes associated with JICD (Stratagene).  3 
freeze-thaw cycles were performed in lysis buffer to lyse N2As and lysates 
incubated with streptavidin resin.  TAP-tagged protein complexes bound to 
streptavidin resin were eluted from the beads after several washes with biotin 
solution.  Elute was incubated with calmodulin resin in the presence of Ca2+.  
Bound protein complexes were eluted by boiling the resin in SDS sample 
buffer.  Samples were separated by gradient denaturing SDS-PAGE and 
visualized with silver staining.  Protein bands were excised and enzymatically 
digested with trypsin. Before LC-mass spectroscopic analysis, tryptic peptide 
mixtures were desalted using STAGE tips.  Nanoscale LC (MDLC; GE 
Healthcare) was coupled to a 7-tesla linear ion-trap Fourier-transform ion 
cyclotron resonance mass spectrometer (LTQ-FT; Thermo Electron) equipped 
with a nanoelectrospray source (Proxeon). Peptides were eluted from an 
analytical column by a linear gradient running from 2 to 60% (vol/vol) 
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acetonitrile (in 0.5% acetic acid) with a flow rate of 250 nl/min in 35 min and 
sprayed directly into the aperture of the mass spectrometer. Information-
dependent acquisition of MS, MS/MS, and MS3 spectra was performed as 
described previously (Olsen, Blagoev et al. 2006).  Acquired spectra were 
then searched with Mascot (Matrix Science) against the human and mouse 
International Protein Index protein database (version 3.14, available at 
http://www.ebi.ac.uk/IPI/), to which we added frequently observed 
contaminants. Tryptic enzyme specificity with up to two missed cleavages was 
applied to all searches. Protein identifications were further analyzed and 
manually verified by the use of MSQuant (available at 
http://msquant.sourceforge.net). 
6.1.26 Luciferase	  reporter	  assays.	  	  
Luciferase reporter constructs TopFlash, Axin2-Luc (Aulehla, Wehrle et al. 
2003) were cotransfected with expression constructs (see supplementary 
table) for JICD, TBLR1, constitutive active β-catenin (S33A), and pCS2 into 
HEK 293 cells by calcium phosphate precipitation. Luciferase and Renilla 
luciferase (pRL; Promega) activity was assayed 48 hours after transfection.  
10µl of cell lysate was mixed with 100µl of Luciferase Assay Reagent 
(Promega) and the light produced was measured using a Berthold Tech 
Centro LB960.  To control for differences in transfection efficiency, the 
luciferase values were normalized to Renilla luciferase expression of the 
same sample. 
6.1.27 Chromatin	  immunoprecipitation	  (ChIP)	  and	  ChIP-­‐Sequencing	  
8, 10cm plates of 70% confluent N2As (approximately 7x106 cells/plate) were 
each transfected using Transfectin (BioRad) with 15 μg of plasmid DNA.  The 
four transfection conditions included, i) pNTAP-B only (empty control vector), 
ii) TAP-JICD with pNTAP-B, iii) TAP-JICD with active β-catenin (S33A) and 
pNTAP-B and, iv) TAP-JICD with β-catenin and TBLR1.  Cells were incubated 
for 48 hours and then 4 of the plates were cross-linked using 200	   μl of 37% 
formaldehyde per plate, and rocked gently for 10 minutes.  The other 4 plates 
were used for RNA extraction (see RNA isolation protocol).  Glycine was 
added to a final concentration of 125mM (for 10 mL of media, 500µL of 2.5M 
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solution) to the media to stop the cross-linking.  Cells were then rinsed twice 
with 10 mL of cold PBS and scraped into 5 mL cold PBS and transferred to a 
15 mL tube (Falcon) (approximately 1x107 cells).  Lysates were centrifuged 
for 5 minutes, 1000g at 4°C, and pellets resuspended in 1 mL of FA lysis 
buffer.  A covaris sonicator was used with the following settings, keeping 
samples on ice at all times when not being sonicated: Duty cycle: 5%, 
Intensity: 4, Peak incident power:  140 watts, Cycles per burst: 200, 
Processing time: 20 min, Temperature: 4°C, Power mode: Frequency 
sweeping, Degassing mode: continuous, Volume: 1 mL  in a TC12x12 AFA 
Tube. 50	   μl of washed streptavidin resin was added to the sonicated lysate 
and incubated while rotating for 16 hours at 4°C (InterPlay Mammalian TAP 
system).  Resin was collected by centrifugation at 1500g for 5 minutes and 
supernatant stored for future analysis.  Resin was resuspended and washed 
with Streptavadin binding buffer (SBB) by rotating the tube at 4°C,	   and	   then	  
recollected	   by	   centrifugation at 1500g for 5 minutes.  120µL of Streptavadin 
Elution Buffer (SEB) was added to resin and rotated at room temperature for 
30 minutes to elute the protein complexes.  Resin was collected by 
centrifugation at 1500g for 5 minutes and supernatant transferred to a new 
tube.  Reverse cross-linking of each sample was done by incubating at 65°C 
for 16 hours with RNaseA (24mg/ml, Sigma).  Purification of DNA done 
according to Qiagen QIAquick kit standard protocol, with 600	  μl of buffer PB is 
added to the 120	   μl of ChIP DNA.  DNA was eluted with 30	   μl of prewarmed 
Buffer EB, allowing it to incubate on the filter for 2-3 minutes.  After elution, a 
second volume of 30	   μl of prewarmed Buffer EB was added to the filter to 
ensure all DNA was eluted.  Libraries were prepared for sequencing by 
excising a 250 bp band (D-BSSE Quantitative genomics facility, Basel, 
Switzerland) and DNA concentration was then verified by ND3300 using 
PicoGreen and multiplex sequencing performed with Illumina Next Generation 
sequencing (HISeq2000).  Peak alignment and mapping to the genome of 
Mus musculus build NCBI37/mm9 was performed by Robert Ivanek of the 
DBM (University of Basel, Basel, Switzerland).  Targets were then identified 
by a Union of peaks shared in multiple replicates and verified with peak 
specific qRT-PCR primers on ChIP elutes. 
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6.2 Materials 
Table 2: Plasmids used in experiments.
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Table 3: Primers used in experiments. 
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Table 4: qRT-PCR Primers used in experiments 
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Table 5: Chemicals and consumables used in experiments 
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Table 5: Chemicals and consumables used in experiments (continued) 
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8 Appendix 
 
8.1 Published Article 
8.1.1 Background	  for	  Published	  Article	  
N-cadherins play a critical role in maintaining tissue structure and the stem 
cell niche in the developing neocortex (Kadowaki, Nakamura et al. 2007).  
Spatial and temporal regulation of N-cadherin expression throughout 
development is carefully controlled, however the mechanisms underlying this 
remain for the most part unknown.  miRNAs have been shown to regulate 
neurogenesis, with many being specific for neural development (Lagos-
Quintana, Rauhut et al. 2002, Landgraf, Rusu et al. 2007, Bak, Silahtaroglu et 
al. 2008, He, Liu et al. 2012).  This study aimed to address the regulation of 
N-cadherin expression through miRNAs, specifically the miR379–410 cluster. 
8.1.2 Statement	  of	  Contribution	  	  
For this paper, I participated in performing the IUE experiments in which the 
miR379–410 cluster were either over expressed or abolished in the 
developing neocortex of E13.5 embryos. 
8.1.3 Key	  Findings	  
One of the key findings of this study is that miRNAs from the miR379-410 
cluster (miR369-3p, miR496 and miR543) can directly modulate the 
expression level of N-cadherin in the developing neocortex, and subsequently 
regulate the development of NSCs, neuronal migration and the timing of 
neurogenesis.  In previous studies, insufficient levels of N-cadherins resulted 
in an increased number of cells leaving cell cycle and premature neuronal 
differentiation (Zhang, Woodhead et al. 2010).  In this study, through the 
overexpression of three miRNAs using IUE, premature neuronal differentiation 
and migration was observed, which recapitulates findings from previous 
studies.  Additionally, N-cadherin rescue experiments were able to rescue the 
phenotype.  
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